{"title":"Nasal Decongestant Drugs","description":"\u003cp\u003e\u003cspan\u003eDecongestant medications for the treatment of nasal congestion and cold symptoms. Nasal sprays, drops, and tablets with vasoconstrictor active ingredients such as phenylephrine, xylometazoline, oxymetazoline, and naphazoline. Products for adults and children that help clear nasal passages obstructed by colds, sinusitis, and allergies. Fast and long-lasting action for easier breathing. Fast shipping within 24-48 hours.\u003c\/span\u003e\u003c\/p\u003e","products":[{"product_id":"rinazina-spray-nasale-decongestionante-15ml-0-1","title":"Rinazina Decongestant Nasal Spray 15ml 0.1%","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNasal decongestant during acute catarrhal rhinitis and pharyngitis, allergic rhinitis, acute sinusitis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e1 ml of solution contains: Active ingredient: naphazoline nitrate 1 mg \u003cu\u003eExcipients with known effects\u003c\/u\u003e: benzalkonium chloride For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eRINAZINA 1 mg\/ml nasal drops, solution: sodium chloride, disodium edetate, monobasic sodium phosphate dihydrate, concentrated phosphoric acid, \u003cb\u003ebenzalkonium chloride\u003c\/b\u003e, purified water. RINAZINA 1 mg\/ml nasal spray, solution: sodium chloride, disodium edetate, monobasic sodium phosphate dihydrate, concentrated phosphoric acid, \u003cb\u003ebenzalkonium chloride\u003c\/b\u003e, balsamic aroma, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. Severe heart disease and arterial hypertension. Glaucoma. Hyperthyroidism. \u003cb\u003e \u003cu\u003eThe medicine is contraindicated in children under 12 years of age.\u003c\/u\u003e \u003c\/b\u003e Do not administer during and in the two weeks following therapy with antidepressant drugs.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eNasal drops:\u003c\/b\u003e Adults: 2-3 drops in each nostril, 2-3 times a day \u003cb\u003eNasal spray:\u003c\/b\u003e Adults: 1-2 sprays in each nostril, 2-3 times a day. \u003ci\u003ePediatric population\u003c\/i\u003e: The medicine is contraindicated in children under 12 years of age (see section 4.3). Carefully follow the recommended doses. A higher dosage of the product, even if taken topically and for a short period of time, can give rise to serious systemic effects. In the absence of a complete therapeutic response within a few days, consult your doctor; in any case, the treatment must not be continued for more than a week.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eRINAZINA 1 mg\/ml nasal spray, solution:\u003c\/i\u003e This medicinal product does not require any special storage conditions. \u003ci\u003eRINAZINA 1 mg\/ml nasal drops, solution\u003c\/i\u003e: Store below 25°C. Store upright.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUse with caution in the elderly and in those with prostatic hypertrophy due to the risk of urinary retention. In patients with cardiovascular diseases, especially in hypertensive patients, the use of nasal decongestants must in any case be subject to the doctor's judgment from time to time. The prolonged use of vasoconstrictors can alter the normal function of the mucosa of the nose and paranasal sinuses, also inducing addiction to the drug. Repeating applications over a long period of time can be harmful. RINAZINA nasal drops and nasal spray contain 0.1 mg\/ml of benzalkonium chloride. Benzalkonium chloride (BAC) contained as a preservative in RINAZINA nasal drops and nasal spray can cause irritation and swelling of the nasal mucosa, especially if used for long periods. If such a reaction (persistent nasal congestion) is suspected, a medicinal product for nasal use without BAC should be used, if possible. If such medicinal products for nasal use without BAC are not available, another pharmaceutical form should be considered. May cause bronchospasm. The use, especially if prolonged, of topical products can give rise to sensitization phenomena; in this case it is necessary to interrupt the treatment and, if necessary, institute suitable therapy. Rare cases of posterior reversible encephalopathy\/reversible cerebral vasoconstriction syndrome have been reported with the use of sympathomimetic drugs, to which naphazoline also belongs. Reported symptoms include sudden onset of severe headache, nausea, vomiting and vision disturbances. Most cases improve or resolve within a few days following appropriate treatment. The use of naphazoline should be discontinued immediately and a doctor should be consulted if signs and\/or symptoms of posterior reversible encephalopathy\/reversible cerebral vasoconstriction syndrome occur.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe drug may interact with antidepressant drugs.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe product can locally cause rebound phenomena of sensitization and congestion of the mucous membranes. Due to rapid absorption of naphazoline through inflamed mucous membranes, systemic effects consisting of arterial hypertension, reflex bradycardia, headache, urination disorders may occur. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe product, if accidentally ingested or if used for a long period in excessive doses, can cause toxic phenomena. It should be kept out of the reach of children as accidental ingestion can cause severe sedation. In case of overdose, arterial hypertension, tachycardia, photophobia, intense headache, chest tightness and, in children, hypothermia and severe depression of the Central Nervous System with marked sedation may appear, which require the adoption of adequate emergency measures.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDuring pregnancy and breastfeeding, RINAZINA must be used only after consulting your doctor and evaluating with him the risk\/benefit ratio in your case.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no known side effects on the ability to drive or use machines.\u003c\/p\u003e","brand":"Gsk","offers":[{"title":"Default Title","offer_id":40207824191603,"sku":"000590051","price":11.59,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/glaxosmithkline-c-health-spa-rinazina-spray-nasale-decongestionante-15ml-0-1-farmacia-dottor-tili-1213792738.webp?v=1767126771"},{"product_id":"vicks-sinex-aloe-spray-nasale-15-ml","title":"Vicks Sinex Aloe Nasal Spray 15ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDecongestant of the nasal mucosa, especially in case of colds.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Active ingredient: oxymetazoline hydrochloride 0.0500% w\/v. 1 ml of product contains 0.5 mg of oxymetazoline hydrochloride. 1 spray (50 microlitres) contains approximately 25 micrograms of oxymetazoline hydrochloride. - Excipients with known effects: benzalkonium chloride, benzyl alcohol For the complete list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eLevomenthol, sodium citrate, anhydrous citric acid, benzalkonium chloride solution, disodium edetate, eucalyptol (cineole), non-crystallizable liquid sorbitol, aloe vera, acesulfame potassium, Lcarvone, polysorbate 80, benzyl alcohol and purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1, prostatic hypertrophy, severe heart disease and arterial hypertension. Glaucoma, hyperthyroidism. Do not administer during and in the two weeks following therapy with antidepressant drugs (MAOI). Inflammation or lesions of the oral mucosa or the skin around the nostrils. The drug is contraindicated in children under 12 years of age.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdults and children over 12 years: 1-2 sprays per nostril every 8 - 12 hours, unless otherwise indicated by the doctor. Hold the bottle in a vertical position, insert its end into the nostril and press the nebulizer quickly and firmly. After application, inhale deeply with your mouth closed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eUse with caution in the first months of pregnancy and, due to the risk of urinary retention, in the elderly. Also use with caution in patients with angina and diabetes. If symptoms persist, a clinical reassessment must be considered; in any case, treatment must not be continued for more than 4 consecutive days to avoid a rebound effect and rhinitis phenomena induced by the drug. Carefully follow the recommended doses. Accidental ingestion may cause severe sedation. It should not be used orally. Avoid contact of the liquid with the eyes. Prolonged use of vasoconstrictors can alter the normal function of the mucosa of the nose and paranasal sinuses, also inducing addiction to the drug. Repeating applications for long periods can be harmful. The use, especially if prolonged, of topical products can give rise to sensitization phenomena; in this case it is necessary to interrupt the treatment and institute suitable therapy. \u003ci\u003eImportant information about some excipients\u003c\/i\u003e Vicks Sinex Aloe 0.05% nebulizer solution contains benzalkonium chloride may cause bronchospasm. This medicine contains 0.01 mg of benzalkonium chloride per dose (1 spray) which is equivalent to 0.2 mg\/ml. Benzalkonium chloride can cause irritation and swelling inside the nose, especially if used for long periods. Vicks Sinex Aloe 0.05% spray solution contains benzyl alcohol. This medicine contains 0.1 mg of benzyl alcohol per dose (1 spray), equivalent to 2 mg\/ml. Benzyl alcohol can cause allergic reactions. Benzyl alcohol may cause mild local irritation\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere is the possibility of interaction between sympathomimetic amines such as oxymetazoline with anti-MAO drugs, therefore use is not recommended during or in the two weeks following treatment with anti-MAO drugs (see section 4.3). Oxymetazoline could reduce the effectiveness of beta-blocking drugs, methyl dopa or other antihypertensive drugs. Hypertension and arrhythmias may occur when tricyclic antidepressants are administered with sympathomimetic drugs such as oxymetazoline. Increased cardiovascular toxicity may occur when sympathomimetic drugs are administered concomitantly with antiparchinsonian drugs such as bromocriptines.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIf accidentally ingested or if used for a long period in excessive doses, the product can cause toxic phenomena. The product can locally cause sensitization phenomena and rebound congestion of the mucous membranes. In general, no serious side effects were observed. Due to rapid absorption of oxymetazoline through inflamed mucous membranes, side effects may occur divided into the following frequencies: very common (≥1\/10); common (≥1\/100, \u003c1\/10); uncommon (≥1\/1000, \u003c1\/100); rare (≥1\/10000, \u003c1\/1000); very rare (\u003e1\/10000); not known (frequency cannot be estimated from the available data). \u003cb\u003e \u003cu\u003eRare:\u003c\/u\u003e \u003c\/b\u003e \u003ci\u003eEye pathologies\u003c\/i\u003e: eye irritation, discomfort or redness. \u003ci\u003eRespiratory, thoracic and mediastinal disorders\u003c\/i\u003e: discomfort or irritation of the nose, mouth or throat, sneezing. \u003cb\u003e \u003cu\u003eVery rare:\u003c\/u\u003e \u003c\/b\u003e \u003ci\u003eCardiac diseases\u003c\/i\u003e: tachycardia, palpitations, increased blood pressure, reflex bradycardia. \u003ci\u003eCentral nervous system disorders\u003c\/i\u003e: insomnia, nervousness, tremor, anxiety, agitation, irritability and headache. \u003ci\u003eGastrointestinal disorders\u003c\/i\u003e: nausea. \u003ci\u003eRenal and urinary disorders\u003c\/i\u003e: urination disorders. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eSymptoms\u003c\/b\u003e Symptoms due to moderate or acute overdose may include mydriasis, nausea, cyanosis, fever, tachycardia, cardiac arrhythmias, hypertension, dyspnea, cardiac arrest, photophobia, headache, intense chest tightness and, in children, severe Central Nervous System depression with symptoms such as decreased body temperature, bradycardia, hypotension, apnea and loss of consciousness requiring the adoption of appropriate emergency measures. \u003cb\u003eTreatment\u003c\/b\u003e Treatment should be symptomatic. In more serious cases, intubation and artificial respiration are required.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no studies on the use of the product during pregnancy and breastfeeding. Use with caution in the first months of pregnancy. Administration should only be considered if the expected benefit to the mother outweighs the risk to the baby.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo effects on the ability to drive and use machines have been observed.\u003c\/p\u003e","brand":"Procter \u0026 Gamble","offers":[{"title":"Default Title","offer_id":40207824322675,"sku":"023198029","price":11.88,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/procter-gamble-srl-vicks-sinex-aloe-spray-nasale-15-ml-farmacia-dottor-tili-1213792733.webp?v=1767126758"},{"product_id":"tonimer-hypertonic-spray-100-ml","title":"Tonimer Hypertonic Spray 100 ml","description":"\u003cdiv\u003e\n      \u003cp\u003e\n        \u003cstrong\u003eTonimer Hypertonic Spray\u003c\/strong\u003e is a hypertonic solution based on sea water, designed to relieve nasal congestion and promote cleansing of the upper airways. Thanks to its mineral-rich composition, it helps to thin excess mucus and clear stuffy noses, improving breathing. It is suitable for both adults and children and can be used daily during periods of colds, sinusitis or allergies.\n      \u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy use Tonimer Hypertonic Spray 100 ml? What is it for?\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eTonimer Hypertonic Spray\u003c\/strong\u003e it is indicated for: - Reducing nasal congestion in case of colds or allergies. - Facilitate breathing by improving the fluidity of mucus. - Hydrate and cleanse the nasal mucous membranes in situations of dryness or irritation. - Suitable for use by adults and children.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Tonimer Hypertonic Spray 100 ml contain?\u003c\/h3\u003e\n\u003cp\u003eMaris aqua (sea water), aqua (water).\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Tonimer Hypertonic Spray 100 ml?\u003c\/h3\u003e\n\u003cp\u003eAfter removing the cap, adults and children capable of using the product independently can use it in any position.\u003cbr\u003eHowever, it is advisable to stand over the sink, keep your head tilted to one side and insert the dispenser into the upper nostril. Press on the dispenser to release the product. Repeat the identical procedure with the other nostril.\u003cbr\u003eFor newborns and small children: lay the child on his side, insert the nozzle into the upper nostril and press. Lay the baby on the other side and repeat with the other nostril.\u003cbr\u003eAfter use, clean and dry the dispenser and close the package with the appropriate cap.\u003cbr\u003eRepeat the application every 3-4 hours 2-3 times a day for 15 days, or according to medical advice.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Tonimer Hypertonic Spray 100 ml?\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor children under 6 years of age, use the product only on pediatric advice.\u003cbr\u003eDo not use in case of sensitive nasal mucosa and subject to epistaxis.\u003cbr\u003eIn case of side effects, discontinue use and consult your doctor.\u003cbr\u003eAvoid contact with eyes; if necessary, wash them with water.\u003cbr\u003ePressurized container: may burst if heated. Keep away from heat, hot surfaces, sparks, open flames or other sources of ignition. Don't smoke.\u003cbr\u003eDo not pierce or burn, even after use.\u003cbr\u003eProtect from sunlight.\u003cbr\u003eDo not expose to temperatures above 50°C\/122°F.\u003cbr\u003eKeep out of reach of children.\u003cbr\u003eDo not use other than intended.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Tonimer Hypertonic Spray 100 ml not be used and what side effects can it cause?\u003c\/h3\u003e\n\u003cp\u003eDo not use \u003cstrong\u003eTonimer Hypertonic Spray\u003c\/strong\u003e in case of hypersensitivity to one of the ingredients. Avoid use in newborns and consult a doctor in case of prolonged use or for particular conditions.\u003c\/p\u003e\n\u003cp\u003eSide effects are rare, but may include irritation or temporary dryness of the mucous membranes. In case of adverse reactions, discontinue use and consult a doctor.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Tonimer Hypertonic Spray 100 ml stored?\u003c\/h3\u003e\n\u003cp\u003eStore at a temperature not exceeding 50°C.\u003cbr\u003eValidity with intact packaging: 36 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Tonimer Hypertonic Spray 100 ml?\u003c\/h3\u003e\n\u003cp\u003e100 ml bottle\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Ganassini","offers":[{"title":"Default Title","offer_id":40207831335027,"sku":"986792265","price":13.86,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/ganassini-tonimer-hypertonic-spray-100-ml-farmacia-dottor-tili-1254211158.jpg?v=1786732060"},{"product_id":"tonimer-lab-hypertonic-18-flaconcini-monodose","title":"Tonimer Lab Hypertonic 18 Single-Dose Vials","description":"\u003cdiv\u003e\n      \u003cp\u003e\n        \u003cstrong\u003eTonimer Lab Hypertonic\u003c\/strong\u003e is a hypertonic solution specific for the treatment of nasal congestion and hydration of the mucous membranes. Thanks to its formulation based on hypertonic sea water, it helps to decongest the nose naturally, reducing excess mucus and facilitating breathing. It is ideal for use in infants, children and adults, particularly if they have colds, sinusitis or allergies. The product is packaged in practical sterile single-dose vials, easy to use and hygienic.\n      \u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Tonimer Lab Hypertonic 18 Single-Dose Vials used? What is it for?\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eTonimer Lab Hypertonic\u003c\/strong\u003e it is indicated for: - Decongesting the nasal passages in case of colds, sinusitis or allergies. - Reduce excess mucus and improve breathing. - Hydrate and cleanse dry or irritated nasal mucous membranes. - Can be used by babies, children and adults.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Tonimer Lab Hypertonic 18 Single-Dose Vials contain?\u003c\/h3\u003e\n\u003cp\u003eMaris aqua (sea water), aqua (water).\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Tonimer Lab Hypertonic 18 Single-Dose Vials?\u003c\/h3\u003e\n\u003cp\u003eBreak the upper part of the vial with a twisting motion. Lay the child on his side, insert the tip of the vial into the upper nostril and press. Lay the baby on the other side and repeat with the other nostril.\u003cbr\u003eFor children capable of using the product independently, it is recommended to position themselves over the sink, keep their head tilted to one side, insert the tip of the vial into the upper nostril and press. Repeat the identical procedure with the other nostril.\u003c\/p\u003e\n\u003cp\u003eUse half the contents of the vial in each nostril and repeat the application every 3-4 hours 2-3 times a day for 15 days or according to medical advice. In case of aerosol administration, use once or twice a day for 15 days or according to medical advice.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Tonimer Lab Hypertonic 18 Single-Dose Vials?\u003c\/h3\u003e\n\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNot injectable.\u003cbr\u003eDo not blow your nose for 10 minutes following administration.\u003cbr\u003eDo not reuse after opening, as the product may no longer be sterile.\u003cbr\u003eKeep out of the reach and sight of children.\u003cbr\u003eIn case of side effects, discontinue use and consult your doctor.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Tonimer Lab Hypertonic 18 single-dose vials not be used and what side effects can it cause?\u003c\/h3\u003e\n\u003cp\u003eDo not use \u003cstrong\u003eTonimer Lab Hypertonic\u003c\/strong\u003e in case of hypersensitivity or allergy to one of the ingredients. Consult your doctor before use in infants or in case of pre-existing medical conditions.\u003c\/p\u003e\n\u003cbr\u003e\u003cbr\u003e\u003cp\u003eSide effects are rare, but may include irritation or temporary dryness of the nasal mucosa. If any unwanted symptoms appear, discontinue use and consult a doctor.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Tonimer Lab Hypertonic 18 Single-Dose Vials stored?\u003c\/h3\u003e\n\u003cp\u003eStore away from light and do not expose to temperatures above 40°C.\u003cbr\u003eValidity with intact packaging: 36 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Tonimer Lab Hypertonic 18 Single-Dose Vials?\u003c\/h3\u003e\n\u003cp\u003e18 single-dose vials of 5 ml\u003c\/p\u003e\n\u003c\/div\u003e","brand":"Ganassini","offers":[{"title":"Default Title","offer_id":40207831466099,"sku":"935205551","price":9.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/ganassini-tonimer-lab-hypertonic-18-flaconcini-monodose-farmacia-dottor-tili-1254211157.jpg?v=1786732032"},{"product_id":"vicks-inalante-rinforzato-flacone-1-g","title":"Vicks Inhalant Reinforced Bottle 1 g","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn colds and congestion of the nasal mucosa, it frees the stuffy nose and promotes breathing.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach stick contains: 1.00 ml of medicinal liquor, absorbed onto a piece of cellulose. ACTIVE INGREDIENTS: menthol 415.4 mg, camphor 415.4 mg. For the complete list of excipients see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSiberian pine essential oil, methyl salicylate.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1. Children up to 30 months of age. Children with a history of epilepsy or febrile seizures.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVicks Inhalant is contraindicated in children up to 30 months of age (see paragraph 4.3) and its use is not recommended in children under 6 years of age. Unscrew the cap and insert the tip of the nasal stick into one nostril, closing the other with a finger and inhale deeply. Repeat in each nostril several times a day. Do not exceed the recommended doses. \u003ci\u003eThe duration of treatment should not exceed 3 days.\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNone.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis product contains terpene derivatives which, in excessive doses, can cause neurological disorders such as seizures in infants and children. Vicks Inhalant is contraindicated in children up to 30 months of age and its use is not recommended in children under 6 years of age. The treatment must not be prolonged for more than 3 days due to the risks associated with the accumulation of terpene derivatives, such as \u003ci\u003ecamphor, cineol, niaouli, wild thyme, terpineol, terpine, citral, menthol and essential oils of pine needle, eucalyptus and turpentine\u003c\/i\u003e (due to their lipophilic properties the rate of metabolism and disposal is not known) in tissues and the brain, in particular neuropsychological disorders. A higher dose than the recommended one should not be used to avoid a greater risk of adverse reactions to the medicinal product and disorders associated with overdose (see section 4.9). The product is flammable, it must not be brought close to flames. Prolonged use may cause sensitization. In this case or in the absence of therapeutic effect, discontinue use and consult your doctor. Use the product according to the instructions. External use.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVicks Inhalant must not be used concomitantly with other products (medicines or cosmetics) containing terpene derivatives, regardless of the route of administration (oral, rectal, cutaneous, nasal or inhalation).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn general, no serious or serious side effects are expected with this product. Cases of nasal pain have been reported very rarely. Due to the presence of camphor and menthol and in case of non-compliance with the recommended doses there may be a risk of convulsions in children and infants. The use, especially if prolonged, of products for topical use can cause sensitization phenomena. In this case it is necessary to interrupt the treatment and institute suitable therapy. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reaction via the national reporting system reported on the website: www.agenziafarmaco.gov.it\/it\/responsabili dell'Agenzia Italiana del Farmaco.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo clinically significant cases of overdose have been reported. \u003ci\u003eIn case of accidental oral intake or incorrect administration in newborns and children there may be a risk of neurological disorders.\u003c\/i\u003e \u003ci\u003eIf necessary, administer appropriate symptomatic treatment in specialized treatment centers.\u003c\/i\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e There are no or limited data available on the use of camphor and menthol in pregnant women. Vicks Inhalant is not recommended during pregnancy and in women of childbearing potential who are not using contraceptive measures. \u003cu\u003eBreastfeeding\u003c\/u\u003e There is insufficient information on the excretion of camphor and menthol in breast milk. Vicks Inhalant should not be used during breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNot applicable.\u003c\/p\u003e","brand":"Procter \u0026 Gamble","offers":[{"title":"Default Title","offer_id":40207831597171,"sku":"003136025","price":7.42,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/procter-gamble-srl-vicks-inalante-rinforzato-flacone-1-g-farmacia-dottor-tili-1213793061.jpg?v=1767128289"},{"product_id":"isomar-spray-acqua-di-mare-e-acido-ialuronico-100ml","title":"Isomar Spray Sea Water and Hyaluronic Acid 100ml","description":"\u003cp\u003e\u003cspan style=\"text-align: justify;\" data-mce-style=\"text-align: justify;\"\u003eIsomar Spray is an isotonic and sterile solution based on \u003cstrong\u003eCinque Terre sea water and hyaluronic acid,\u003c\/strong\u003e for daily nose and ear hygiene. \u003c\/span\u003e\u003c\/p\u003e\n\u003cp\u003eIsomar Spray Sea Water and Hyaluronic Acid is a solution suitable for \u003cstrong\u003ecolds, bronchitis, sinusitis, asthma, allergies\u003c\/strong\u003e generally also from pollen and for those who work in closed environments in the presence of dust. Indispensable for those who have suffered \u003cstrong\u003enasal interventions and for those who snore during sleep\u003c\/strong\u003e(acute and chronic bronchopathies).\u003c\/p\u003e\n\u003cp\u003eIsomar Daily Hygiene Spray is particularly recommended in pediatric age, starting from the first year of age, in pregnant women and during the breastfeeding period. With its characteristic \u003cstrong\u003efluidizing action\u003c\/strong\u003e it can be\u003cstrong\u003e used daily to increase the humidity of the nasal mucosa\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eIn children who have not yet fully mastered blowing their nose, it promotes greater patency of the nostrils. In adults it allows better drainage of nasal mucus. With its physiological action it is the \u003cstrong\u003eoptimal product for prolonged and frequent use for both children and adults\u003c\/strong\u003e. \u003c\/p\u003e\n\u003cp\u003eWith the \u003cstrong\u003ealternative nebulizer\u003c\/strong\u003e is indicated for \u003cstrong\u003eear cleaning and washing\u003c\/strong\u003e. It prevents the formation of earwax plugs and the accumulation of unwanted particles which could cause hearing problems. \u003cstrong\u003eIt also helps keep the auditory canal clear\u003c\/strong\u003e in the subjects \u003cstrong\u003ehearing aid wearers\u003c\/strong\u003e. The nebulization feature prevents any overpressure on the tympanic membrane.\u003cbr\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003e2 nose and ear nebulizers.\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cbr\u003e\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy use Isomar Spray Sea Water and Hyaluronic Acid 100ml? What is it for?\u003c\/h3\u003e\u003cp\u003eSterile isotonic solution based on sea water and hyaluronic acid, indicated for the daily hygiene of the nose and ears; thanks to its fluidifying and hydrating action on the nasal mucous membranes, it is useful as an adjuvant in case of colds, sinusitis and allergies, and is also indicated in pediatric age from the first year of life, during pregnancy and during breastfeeding.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Isomar Spray Sea Water and Hyaluronic Acid 100ml contain?\u003c\/h3\u003e\u003cp\u003eIsotonic sea water.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Isomar Spray Sea Water and Hyaluronic Acid 100ml?\u003c\/h3\u003e\u003cp\u003eFor the nose: one\/two 2-second sprays per nostril. We recommend using it in a vertical position, to allow the product to flow out evenly and to obtain over 300 sprays.\u003cbr\u003eFor the ear: spray once\/twice. It can be used several times a day.\u003cbr\u003eFor those who practice underwater disciplines: use regularly before and after diving. Humidifies the nasal mucosa dried out by the mask or the compressed air from the cylinders.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Isomar Spray Sea Water and Hyaluronic Acid 100ml?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003ePressurized container. Protect from sunlight and do not expose to temperatures above 50°C. Do not burn or pierce even after use.\u003cbr\u003eUse the product only for its intended use.\u003cbr\u003eKeep out of reach of children.\u003cbr\u003eFailure to check the integrity of the product could alter its functional characteristics.\u003cbr\u003eDo not use after the expiry date.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Isomar Spray Sea Water and Hyaluronic Acid 100ml?\u003c\/h3\u003e\u003cp\u003e100ml spray bottle, with 2 nose and ear sprays.\u003c\/p\u003e","brand":"Euritalia Pharma","offers":[{"title":"Default Title","offer_id":40207831728243,"sku":"906059427","price":13.3,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/euritalia-pharma-div-coswell-isomar-spray-acqua-di-mare-e-acido-ialuronico-100ml-farmacia-dottor-tili-1213793058.jpg?v=1767128351"},{"product_id":"narhinel-soluzione-fisiologica-neonati-20-fiale-5ml","title":"Narhinel Newborn Physiological Solution 20 vials 5ml","description":"\u003cp\u003eNarhinel Physiological Solution is indicated for children and newborns thanks to its \u003cstrong\u003edelicate cleansing action of the nasal cavities\u003c\/strong\u003e. Narhinel Physiological Solution \u003cstrong\u003esoftens mucus\u003c\/strong\u003e and promotes its expulsion thanks to its emollient and fluidifying action. It:\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eis indicated in case of \u003cstrong\u003eblocked nose, allergy, cold\u003c\/strong\u003e;\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003eGently wash your nasal cavities\u003c\/strong\u003e of children, infants and adults;\u003c\/li\u003e\n\u003cli\u003e\n\u003cstrong\u003erelieves irritation\u003c\/strong\u003e and protects the mucosa from external agents;\u003c\/li\u003e\n\u003cli\u003ehelps little ones who don't yet know how to blow their nose to feel better and rest well;\u003c\/li\u003e\n\u003cli\u003eit is \u003cstrong\u003eideal for daily washing\u003c\/strong\u003e of the nasal cavities;\u003c\/li\u003e\n\u003cli\u003eis in \u003cstrong\u003esterile disposable bottles\u003c\/strong\u003e;\u003c\/li\u003e\n\u003cli\u003ecan also be used in \u003cstrong\u003eaerosol therapy\u003c\/strong\u003e.\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Narhinel Physiological Solution for Newborns 20 vials 5ml used? What is it for?\u003c\/h3\u003e\u003cp\u003ePhysiological solution in sterile disposable vials, indicated for daily cleansing and washing of the nasal cavities of newborns, children and adults in case of blocked nose, allergy or cold; softens mucus by promoting its expulsion and hydrates irritated or dry nasal mucosa.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eACTIVE INGREDIENTS AND EXCIPIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat is the composition of Narhinel Physiological Solution for Newborns 20 vials 5ml?\u003c\/h3\u003e\u003cp\u003eNarhinel Physiological Solution contains 0.9% sodium chloride and purified water.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eDOSAGE\u003c\/h2\u003e\n\u003ch3\u003eHow to take Narhinel Physiological Solution for Newborns 20 vials 5ml?\u003c\/h3\u003e\u003cp\u003eNarhinel Saline solution is \u003cstrong\u003esuitable for babies, children and adults\u003c\/strong\u003e.\u003c\/p\u003e\u003cp\u003eFor newborns under 2 weeks, pediatrician advice is recommended before use.\u003c\/p\u003e\u003cp\u003eThe normal frequency of use of Narhinel Saline Solution is 2-4 times per day per nostril. Do this when hiring:\u003c\/p\u003e\u003cp\u003eBefore opening the vial, wash your hands thoroughly. Blow your nose if necessary. Separate a single vial by removing the cap. Lean your head back and insert the nozzle of the vial just behind the nostril. Press the vial carefully to obtain a few drops and with more force if more thorough cleaning is necessary. Wait a few seconds and blow your nose if necessary.\u003c\/p\u003e\u003cp\u003eFor hygienic reasons to avoid infections, the vial must be used by only one person.\u003c\/p\u003e\u003cp\u003eInstructions for use in \u003cstrong\u003eaerosol therapy of Narhinel Physiological Solution for Newborns 20 vials\u003c\/strong\u003e 5ml:\u003c\/p\u003e\u003cp\u003eIf Narhinel Saline Solution for Newborns is used alone, carefully read the instructions given by the manufacturer of the aerosol device.\u003c\/p\u003e\u003cp\u003eIf Narhinel Saline Solution for Newborns is used to dilute a medicine, carefully read the instructions in the medicine leaflet.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Narhinel Physiological Solution for Newborns 20 vials 5ml?\u003c\/h3\u003e\u003cp\u003eNarhinel Physiological Solution is stored in single-dose vials, for external use only. Do not use an open vial. Do not use the product if damaged or broken. Keep out of the reach and sight of children. Do not use the product after the expiry date indicated on the package.\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cp\u003eDue to its cleaning capabilities, it is recommended to use Narhinel before using another nasal product for local use (for example for colds or allergic rhinitis).\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Narhinel Physiological Solution for Newborns 20 vials 5ml not be used and what side effects can it cause?\u003c\/h3\u003e\u003cp\u003eDo not use the product if you have a known hypersensitivity to any of the ingredients.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003ePREGNANCY AND BREASTFEEDING\u003c\/h2\u003e\n\u003ch3\u003eCan Narhinel Physiological Solution for Newborns 20 vials 5ml be used during pregnancy and breastfeeding?\u003c\/h3\u003e\u003cp\u003eIt can be used during pregnancy and breastfeeding. \u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cp\u003eNarhinel Saline Solution can be used during pregnancy and breastfeeding.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Narhinel Physiological Solution for Newborns 20 vials 5ml stored?\u003c\/h3\u003e\u003cp\u003eStore Narhinel Saline Solution for Newborns at room temperature. Protect from heat.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Narhinel Physiological Solution for Newborns 20 vials 5ml?\u003c\/h3\u003e\u003cp\u003ePack of 20 vials of 5 ml.\u003c\/p\u003e","brand":"Gsk","offers":[{"title":"Default Title","offer_id":46466547220807,"sku":"903367148","price":3.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/glaxosmithkline-c-health-srl-narhinel-soluzione-fisiologica-neonati-20-fiale-5ml-farmacia-dottor-tili-1213792498.jpg?v=1767112428"},{"product_id":"actifed-decongestionante-12-compresse-2-5mg-60mg","title":"Actifed Decongestant 12 tablets 2.5mg + 60mg","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDecongestant of the nasal mucosa, especially in case of colds.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eACTIFED tablets\u003c\/b\u003e One tablet contains: • active ingredients: triprolidine hydrochloride 2.5 mg; pseudoephedrine hydrochloride 60.0 mg; • excipients with known effects: lactose. \u003cb\u003eACTIFED syrup\u003c\/b\u003e 100 ml of syrup contains: • active ingredients: triprolidine hydrochloride 0.025 g; pseudoephedrine hydrochloride 0.600 g; • excipients with known effects: sucrose, methyl parahydroxybenzoate, sunset yellow (E110), sodium benzoate. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eACTIFED tablets\u003c\/u\u003e Each tablet contains: lactose; corn starch; povidone; magnesium stearate. \u003cu\u003eACTIFED syrup \u003c\/u\u003e 100 ml of syrup contains: glycerol; sucrose; methyl parahydroxybenzoate; sodium benzoate; quinoline yellow (E104); sunset yellow (E110); purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e• hypersensitivity to the active substances, to other antihistamines or to any of the excipients listed in paragraph 6.1; • children under the age of 12; • Pregnancy and breastfeeding; • in patients being treated with monoamine oxidase inhibitors (MAOIs) or in the two weeks following such treatment, and in the treatment of lower respiratory tract diseases, including bronchial asthma. In such cases the concomitant use of ACTIFED may cause an increase in blood pressure or hypertensive crisis; • glaucoma, prostatic hypertrophy, bladder neck obstruction, pyloric and duodenal stenosis or other tracts of the gastrointestinal and urogenital system (due to its anticholinergic effects); • cardiovascular diseases, arterial hypertension, hyperthyroidism, epilepsy and diabetes.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e \u003cb\u003eACTIFED syrup\u003c\/b\u003e The package includes a measuring cup with indicated level marks corresponding to the capacities of 5 and 10 ml. \u003ci\u003eAdults and children over 12 years old\u003c\/i\u003e: a dose of 10 ml of syrup 2 - 3 times a day. \u003cb\u003eACTIFED tablets\u003c\/b\u003e \u003ci\u003eAdults and children over 12 years old:\u003c\/i\u003e one tablet 2 - 3 times a day. \u003cb\u003eDo not exceed the recommended doses\u003c\/b\u003e. \u003cu\u003eMethod of administration \u003c\/u\u003e Oral use\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eACTIFED syrup\u003c\/u\u003e Store away from light. \u003cu\u003eACTIFED tablets \u003c\/u\u003e Store at a temperature not exceeding 25°C, in a dry place.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIf symptoms persist or worsen, or if new symptoms appear, patients should stop using the medicine and consult a doctor. If symptoms do not improve within 7 days or if high fever or other side effects appear, patients should be advised to stop treatment and consult their doctor. Before taking triprolidine, patients with the following respiratory conditions such as emphysema, chronic bronchitis, or acute or chronic bronchial asthma, should be advised to consult a doctor. Triprolidine may cause drowsiness and may increase the sedative effects of substances that depress the central nervous system such as alcohol, sedatives, tranquilizers. It is necessary to inform patients that the use of alcoholic beverages should be avoided during treatment with ACTIFED and that it is advisable to consult the doctor before taking ACTIFED concomitantly with medicines that depress the central nervous system. At common therapeutic doses, antihistamines present secondary reactions that vary greatly from subject to subject and from compound to compound. For the dosage in the elderly it is necessary to consider their greater sensitivity towards antihistamines and pseudoephedrine. Although pseudoephedrine did not produce important effects on the blood pressure of normotensive subjects, ACTIFED should not be taken by patients treated with antihypertensives, tricyclic antidepressants, sympathomimetic agents, such as decongestants, anorectics, amphetamine-like agents. Rare cases of posterior reversible encephalopathy have been reported with sympathomimetic drugs, including pseudoephedrine (\u003ci\u003eposterior reversible encephalopathy\u003c\/i\u003e, PRES)\/reversible cerebral vasoconstriction syndrome (\u003ci\u003ereversible cerebral vasoconstriction syndrome\u003c\/i\u003e, RCVS). Reported symptoms include sudden onset of severe headache, nausea, vomiting, and visual disturbances. If signs or symptoms of PRES\/RCVS develop, treatment with pseudoephedrine should be discontinued and a doctor should be consulted immediately. Ischemic colitis Some cases of ischemic colitis have been reported with medicinal products containing pseudoephedrine. If sudden abdominal pain, rectal tenesmus, rectal bleeding or other symptoms of ischemic colitis develop (see section 4.8), the use of pseudoephedrine should be discontinued and medical advice should be sought. Ischemic optic neuropathy Cases of ischemic optic neuropathy have been reported with pseudoephedrine. Pseudoephedrine should be discontinued if sudden loss of vision or reduction in visual acuity occurs, for example in the case of a scotoma. Skin Safety Serious skin reactions such as acute generalized exanthematous pustulosis (AGEP) may occur with products containing pseudoephedrine. This acute pustular eruption may occur within the first 2 days of treatment, with fever and numerous, small, mostly non-follicular pustules resulting from a widespread edematous erythema and localized mainly on the skin folds, trunk and upper limbs. Patients should be carefully monitored. If signs and symptoms such as pyrexia, erythema, or numerous small pustules are observed, the administration of ACTIFED should be stopped and appropriate measures taken if necessary (see section 4.8). ACTIFED should not be used by patients with severe liver disease or reduced kidney function unless the doctor deems it necessary. \u003cu\u003eImportant information about some excipients\u003c\/u\u003e: \u003cb\u003eACTIFED syrup\u003c\/b\u003e contains: • \u003cb\u003esucrose\u003c\/b\u003e. Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine. This medicine contains 7 g of sucrose per dose. To be taken into consideration in people suffering from diabetes mellitus; • \u003cb\u003emethyl parahydroxybenzoate\u003c\/b\u003e. May cause allergic reactions (even delayed); • \u003cb\u003esunset yellow (E110)\u003c\/b\u003e. May cause allergic reactions; • 10 mg of sodium benzoate per dose (10 ml of syrup) • less than 1 mmol (23 mg) of sodium per dose (10 ml of syrup), i.e. essentially “sodium-free”. \u003cb\u003eACTIFED tablets\u003c\/b\u003e contains\u003cb\u003e lactose\u003c\/b\u003e: • Patients suffering from rare hereditary problems of galactose intolerance, total lactase deficiency, or glucose-galactose malabsorption should not take this medicine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDuring concomitant use of monoamine oxidase inhibitors (MAOIs) and sympathomimetic amines, acute hypertensive crises have been reported in the medical literature. Pseudoephedrine exerts a vasoconstrictor action by stimulating adrenergic receptors and releasing norepinephrine from neuronal sites. Monoamine oxidase inhibitors (MAOIs) may enhance the pressor effect of pseudoephedrine, as they prevent the metabolism of sympathomimetic amines and increase the releasable amount of norepinephrine in adrenergic nervous tissue. The effects of antihistamines are made more evident by alcohol, hypnotics, sedatives, tranquilizers, and other substances with an anticholinergic action or depressant effect on the central nervous system, which therefore should not be taken during therapy. Antihistamines can shorten the duration of action of oral anticoagulants. The use of antihistamines can mask the early signs of ototoxicity of certain antibiotics. Furazolidone causes a progressive inhibition of monoamine oxidase, so it should not be taken at the same time as ACTIFED. The effect of antihypertensives that interfere with sympathetic activity (e.g. methyldopa, alpha and beta blockers, debrisoquine, guanethidine, betanidine and bretylium) can be partially canceled out by ACTIFED, which therefore, also in this case, should not be taken at the same time.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following are adverse reactions reported with a frequency ≥1%, identified in randomized placebo-controlled studies, with formulations containing pseudophedrine as the single active ingredient: dry mouth, nausea, dizziness, insomnia and nervousness. There are no placebo-controlled clinical studies with sufficient data regarding adverse reactions for the combination of the active ingredients pseuoephedrine and triprolidine. Adverse reactions identified during post-marketing experience with pseudoephedrine, triprolidine or the combination are reported in Table 1 according to frequency categories using the following convention: § very common (≥ 1\/10); • common (≥ 1\/100 and \u003c1\/10); • uncommon (≥ 1\/1,000 and \u003c 1\/100); • rare (≥ 1\/10,000 and \u003c1\/1,000); • very rare (\u003c1\/10,000); • not known (frequency cannot be estimated from the available data).\u003c\/p\u003e\n\u003cp\u003ePsychiatric disorders.\u003c\/p\u003e\n\u003cp\u003eVery rare: Anxiety, euphoric mood, hallucination, restlessness, visual hallucination.\u003c\/p\u003e\n\u003cp\u003eNervous system disorders.\u003c\/p\u003e\n\u003cp\u003eVery Rare: Headache, paraesthesia, psychomotor hyperactivity (in the pediatric population), drowsiness, tremor.\u003c\/p\u003e\n\u003cp\u003eNot known: Cerebrovascular accident*, posterior reversible encephalopathy (PRES), reversible cerebral vasoconstriction syndrome (RCVS) (see section 4.4).\u003c\/p\u003e\n\u003cp\u003eCardiac diseases.\u003c\/p\u003e\n\u003cp\u003eVery Rare: Arrhythmia, extrasystoles, palpitations, tachycardia.\u003c\/p\u003e\n\u003cp\u003eNot known: Myocardial infarction\/Myocardial ischemia*.\u003c\/p\u003e\n\u003cp\u003eSystemic pathologies and conditions relating to the administration site.\u003c\/p\u003e\n\u003cp\u003eVery Rare: Asthenia.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders.\u003c\/p\u003e\n\u003cp\u003eVery rare: Hypersensitivity\u003c\/p\u003e\n\u003cp\u003eRespiratory, thoracic and mediastinal disorders.\u003c\/p\u003e\n\u003cp\u003eVery rare: Epistaxis.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eVery rare: Vomiting, abdominal discomfort.\u003c\/p\u003e\n\u003cp\u003eNot known: Ischemic colitis (see section 4.4)*.\u003c\/p\u003e\n\u003cp\u003ePathologies of the skin and subcutaneous tissue.\u003c\/p\u003e\n\u003cp\u003eVery rare: Pruritus, rash, urticaria, angioedema. acute generalized exanthematous pustulosis (AGEP) (see section 4.4), angioedema.\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders.\u003c\/p\u003e\n\u003cp\u003eVery rare: Dysuria, urinary retention.\u003c\/p\u003e\n\u003cp\u003eDiagnostic tests.\u003c\/p\u003e\n\u003cp\u003eVery rare: Increased blood pressure.\u003c\/p\u003e\n\u003cp\u003eEye pathologies.\u003c\/p\u003e\n\u003cp\u003eNot known: Ischemic optic neuropathy.\u003c\/p\u003e\n\u003cp\u003e*adverse reactions collected during post-marketing experience with pseudoephedrine ACTIFED can also cause dizziness, photosensitivity reaction, diarrhea, hyperviscosity of bronchial secretions, very rarely blood changes and especially in the elderly, hypotension. \u003cb\u003eReporting of suspected adverse reactions.\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioniavverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn case of overdosage, marked depressant (due to triprolidine) or stimulant (due to pseudoephedrine) effects on the CNS are generally observed. Effects of triprolidine: drowsiness, lethargy, respiratory depression, hypertension, hyperthermia, anticholinergic syndrome (mydriasis, flushing, fever, dry mouth, urinary retention, reduced borborygmi) tachycardia, hypotension, nausea, vomiting, agitation, confusional state, hallucinations, psychosis, convulsions, arrhythmias. Patients suffering from prolonged agitation, coma, or seizures may rarely experience rhabdomyolysis and renal failure Effects of pseudoephedrine: Overdose may cause nausea, vomiting, sympathomimetic symptoms including CNS stimulation, insomnia, mydriasis, irritability, convulsions, anxiety, agitation, hallucinations, palpitations, tachycardia, hypertension, reflex bradycardia. Other effects may include arrhythmias, hypertensive crisis, intracerebral hemorrhage, myocardial infarction, psychosis, rhabdomyolysis, hypokalemia, intestinal infarction. In children the dominant action is the exciting one with accentuated tremors, insomnia, hyperactivity and convulsions, drowsiness has also been reported. Keep out of reach of children. In case of overdose, seek medical help or contact a poison control center immediately.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eACTIFED is contraindicated during pregnancy and breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eACTIFED may cause drowsiness; this may impair your ability to drive or use machinery. If this side effect occurs, the patient should avoid driving vehicles and using machinery.\u003c\/p\u003e","brand":"Johnson \u0026 Johnson","offers":[{"title":"Default Title","offer_id":46656369262919,"sku":"018723080","price":12.5,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/products\/johnson-johnson-spa-actifed-decongestionante-12-compresse-2-5mg-60mg-farmacia-dottor-tili-1213792476.jpg?v=1767112659"},{"product_id":"rinofluimucil-1-0-5-spray-nasale-soluzione-10ml","title":"Rinofluimucil 1% + 0.5% nasal spray solution 10ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Acute and subacute rhinitis, especially with mucopurulent and slowly resolving exudates. - Chronic and mucus-crusty rhinitis. - Vasomotor rhinitis. - Sinusitis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 ml of solution contains: \u003cb\u003eActive ingredients\u003c\/b\u003e N-Acetylcysteine: 1,000 g; Tuaminoheptane sulphate: 0.500 g. Excipients with known effects: benzalkonium chloride Mint flavor containing d-limonene For the full list of excipients, see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBenzalkonium chloride, Dithiothreitol, Sodium edetate, Dibasic sodium phosphate, Monobasic sodium phosphate, Sodium hydroxide, Alcohol, Hypromellose, Sorbitol 70%, Natural mint flavor (containing d-limonene), Purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hypersensitivity to the active substance or to any of the excipients. - Cardiovascular disease, including hypertension. - Previous cerebrovascular disease, including the presence of important risk factors (due to alpha-sympathomimetic activity). - Previous convulsions. - Narrow angle glaucoma. - Hyperthyroidism. - During and in the two weeks following therapy with monoamine oxidase inhibitors (MAOIs). - Children under the age of 12. - Pheochromocytoma. - During use of other sympathomimetic agents, including other nasal decongestants. - Hypophysectomy or surgical interventions with exposure of the dura mater.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eRINOFLUIMUCIL is used for applications in the nasal cavities, using the appropriate dosage dispenser (see paragraph 6.6). ADULTS: 2 sprays in each nostril 3-4 times a day. CHILDREN over 12 years: 1 spray in each nostril 3-4 times a day. Do not exceed the indicated doses. The bottle, when opened, can be used for a period not exceeding 20 days.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo details.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdminister with caution in subjects suffering from occlusive vascular disease, asthma, diabetes and in therapy with beta-blocking drugs. Rinofluimucil should be administered with caution in pediatric age and is in any case contraindicated in children under 12 years of age. Prolonged use of preparations containing vasoconstrictors can alter the normal function of the mucosa of the nose and paranasal sinuses, also inducing addiction to the drug. Repeating applications for long periods can therefore be harmful. Use the product with caution due to the risk of urinary retention in the elderly and in those with prostatic hypertrophy. The use, especially if prolonged, of topical products can give rise to sensitization phenomena: in this case it is necessary to interrupt the treatment and, if necessary, institute a suitable therapy. However, in the absence of a complete therapeutic response within a few days, consult your doctor; in any case the treatment must not be continued for more than a week. The action of the preparation can be integrated, in the doctor's opinion, with an appropriate antibacterial covering. Patients should be advised to discontinue treatment if they develop arterial hypertension, tachycardia, palpitations, heart rhythm disturbances, nausea or any neurological signs and symptoms (such as headache or worsening of existing headache). Tuaminoheptane sulfate can cause a positive anti-doping test. The preparation is not for ophthalmic use. \u003ci\u003eImportant information about some excipients\u003c\/i\u003e: This medicine contains 0.005 mg of benzalkonium chloride in each actuation. Prolonged use may cause edema of the nasal mucosa. The mint flavoring in this medicine contains d-limonene which may cause allergic reactions. In addition to allergic reactions in patients sensitive to the allergen, non-sensitive patients may become sensitive.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDespite the poor systemic absorption of tuaminoheptane administered intranasally, the following potential interactions must be taken into consideration: - monoamine oxidase inhibitors (MAOIs), including reversible monoamine oxidase inhibitors (RIMA): increased risk of hypertensive crisis; - antihypertensives (including adrenergic neuron blockers and beta blockers): can block hypotensive effects; - cardiac glycosides: they can increase the risk of dysrhythmia; - ergot alkaloids: they can increase the risk of ergotism; - antiparkinsonian drugs: they can increase the risk of cardiovascular toxicity; - oxytocin: may increase the risk of hypertension.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eSecurity Profile Summary:\u003c\/b\u003e Prolonged use can alter the normal functionality of the nasal and paranasal mucosa, causing nasal congestion and inducing addiction to the drug. \u003cb\u003eSummary table of adverse reactions:\u003c\/b\u003e Frequent administration of the preparation at higher doses can cause sympathomimetic side effects (such as increased excitability, heart palpitations, tremor, etc.). Sometimes dryness of the nose and throat, acne rashes may occur. These effects disappear completely when treatment is discontinued. The following side effects may be associated with the use of Rinofluimucil:\u003c\/p\u003e\n\u003cp\u003eImmune system disorders - Adverse reactions Frequency not known°: Hypersensitivity\u003c\/p\u003e\n\u003cp\u003ePsychiatric disorders - Adverse reactions Frequency not known°: anxiety*, hallucination*, delirium*.\u003c\/p\u003e\n\u003cp\u003eNervous system disorders - Adverse reactions Frequency not known°: headache*, restlessness*, agitation*, insomnia*, tremor*.\u003c\/p\u003e\n\u003cp\u003eCardiac disorders - Adverse reactions Frequency not known°: palpitations*, tachycardia*, arrhythmia*.\u003c\/p\u003e\n\u003cp\u003eVascular disorders - Adverse reactions Frequency not known°: Hypertension.\u003c\/p\u003e\n\u003cp\u003eRespiratory, thoracic and mediastinal disorders - Adverse reactions Frequency not known°: dry nose and throat*, nasal discomfort*, nasal congestion*.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Adverse reactions Frequency not known°: Nausea.\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders - Adverse reactions Frequency not known°: Urticaria, rash.\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders - Adverse reactions Frequency not known°: Urinary retention.\u003c\/p\u003e\n\u003cp\u003eSystemic pathologies and conditions relating to the site of administration - Adverse reactions Frequency not known°: irritability,* habituation to the drug*.\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003e° not known (cannot be estimated from available data)\u003c\/i\u003e * Particularly with prolonged and\/or excessive use \u003cb\u003ePediatric population:\u003c\/b\u003e The product is contraindicated in children under 12 years of age (see section 4.3). \u003cb\u003eReporting of suspected adverse reactions.\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn case of overdose in adults, arterial hypertension, photophobia, intense headache, chest tightness may appear. \u003cb\u003ePediatric population\u003c\/b\u003e In case of overdose, hypothermia with marked sedation may appear in children. \u003cb\u003eTreatment\u003c\/b\u003e These events require the adoption of appropriate emergency measures.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e: Data relating to a limited number of pregnant women exposed to N-acetylcysteine ​​have not indicated any negative effects on the pregnancy itself or on the health of the foetus\/newborn. At present, no further relevant epidemiological data are available. Animal studies with N-acetylcysteine ​​have demonstrated no direct or indirect harmful effects regarding reproductive toxicity. There are no data on exposed pregnant women or animal studies with tuaminoheptane or N-acetylcysteine ​​+ tuaminoheptane. The product is not recommended during pregnancy. \u003cu\u003eBreastfeeding\u003c\/u\u003e: There is no information available on the excretion of N-acetylcysteine and thyaminoheptane in breast milk. A risk to the infant cannot be excluded. The product should not be used by breastfeeding mothers. \u003cu\u003eFertility:\u003c\/u\u003e There are no animal fertility studies available with N-acetylcysteine + thyaminoheptane. Furthermore, no data on humans is available.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no assumptions or evidence that the drug can change attention skills and reaction times. However, patients should be informed that effects such as hallucinations have been reported.\u003c\/p\u003e","brand":"Zambon","offers":[{"title":"Default Title","offer_id":51131205026119,"sku":"021993050","price":8.56,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/zambon-italia-srl-rinofluimucil-1-0-5-spray-nasale-soluzione-10ml-farmacia-dottor-tili-1213792382.jpg?v=1767132971"},{"product_id":"isomar-spray-decongestionante-con-acido-ialuronico","title":"Isomar decongestant spray with hyaluronic acid","description":"\u003cp\u003eIsomar decongestant spray with hyaluronic acid is an innovative hypertonic solution, designed to offer immediate and long-lasting relief from stuffy nose. Thanks to its formulation based on \u003cstrong\u003ehypertonic sea water\u003c\/strong\u003e e \u003cstrong\u003ehyaluronic acid\u003c\/strong\u003e, this spray is ideal for those suffering from allergic rhinitis, sinusitis or colds. The natural salt concentration of sea water, around 3%, promotes a decongestant action by osmosis, helping to drain nasal secretions delicately and effectively.\u003c\/p\u003e\n\u003cp\u003eHyaluronic acid, known for its hydrating properties, keeps the nasal mucosa soft and well hydrated, reducing the risk of dryness and microlesions that can occur during episodes of severe congestion. This makes Isomar decongestant spray particularly suitable for frequent use, without inducing habituation, and also safe during pregnancy.\u003c\/p\u003e\n\u003cp\u003eFree of preservatives and colourants, Isomar spray is a \u003cstrong\u003emedical device\u003c\/strong\u003e which guarantees optimal nasal hygiene for adults and children. Its natural and delicate formulation makes it a precious ally for those looking for an effective and safe product for the well-being of the respiratory tract. \u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Isomar decongestant spray with hyaluronic acid used? What is it for?\u003c\/h3\u003e\u003cp\u003eNasal spray based on hypertonic sea water and hyaluronic acid, indicated for the relief of stuffy nose in case of allergic rhinitis, sinusitis or cold; the decongestant action by osmosis promotes the drainage of nasal secretions, while hyaluronic acid hydrates the mucosa.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Isomar decongestant spray with hyaluronic acid contain?\u003c\/h3\u003e\u003cp\u003eHypertonic sea water (Natural salt concentration of sea water around 3%), sodium hyaluronate.\u003cbr\u003eInert propellant gas: nitrogen.\u003cbr\u003eIt contains neither preservatives nor colourants.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Isomar decongestant spray with hyaluronic acid?\u003c\/h3\u003e\u003cp\u003eApply the nose regulator to the cylinder. Spray one\/two 2-second sprays into each nostril, wait a few seconds for the solution to drip slightly and blow your nose. To better reach all the recesses of the nasal septum and therefore have greater and rapid cleansing, we recommend using the bottle vertically. To facilitate use in children, even in a lying position, the product can also be used in a horizontal or upside-down position.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Isomar decongestant spray with hyaluronic acid?\u003c\/h3\u003e\u003cp\u003eValidity with intact packaging: 60 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Isomar decongestant spray with hyaluronic acid stored?\u003c\/h3\u003e\u003cp\u003eValidity with intact packaging: 60 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Isomar decongestant spray with hyaluronic acid?\u003c\/h3\u003e\u003cp\u003e100 ml bottle.\u003c\/p\u003e","brand":"Euritalia Pharma","offers":[{"title":"Default Title","offer_id":51131273838919,"sku":"927143925","price":14.23,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/euritalia-pharma-div-coswell-isomar-spray-decongestionante-con-acido-ialuronico-farmacia-dottor-tili-1213792266.jpg?v=1767133330"},{"product_id":"rinazina-aquamarina-spray-nasale-ipertonico","title":"Rinazine Aquamarina hypertonic nasal spray","description":"\u003cp\u003eThe \u003cstrong\u003eRinazine Aquamarina hypertonic nasal spray\u003c\/strong\u003e is an innovative medical device designed to offer quick and natural relief from nasal congestion. Formulated with \u003cstrong\u003ehypertonic sea water\u003c\/strong\u003e, this spray uses the osmotic effect to reduce the swelling of the nasal mucosa, making breathing easier. Enriched with \u003cstrong\u003eEucalyptus essential oil\u003c\/strong\u003e and wild mint extract, the product not only decongests, but also offers a pleasant sensation of freshness.\u003c\/p\u003e\n\n\u003cp\u003eIdeal for those who suffer from \u003cstrong\u003ecolds\u003c\/strong\u003e e \u003cstrong\u003erhinosinusitis\u003c\/strong\u003e, Rinazine Aquamarina acts with a \u003cstrong\u003etriple action\u003c\/strong\u003e: decongestant, purifying and hydrating. Its natural formulation, free of medicines and propellant gases, makes it suitable for daily use by adults and children aged 6 and over. Thanks to the mechanical action of the spray, it helps to remove viruses and bacteria, helping to keep the nasal cavities clean and protected.\u003c\/p\u003e\n\n\u003cp\u003eThe Rinazine Aquamarina hypertonic nasal spray is a precious ally for those looking for an effective and natural remedy against nasal congestion, guaranteeing a \u003cstrong\u003enasal relief\u003c\/strong\u003e immediate and lasting. Its preservative-free formulation ensures safe and delicate use, respecting the natural physiology of the respiratory tract.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Rinazine Aquamarina hypertonic nasal spray used? What is it for?\u003c\/h3\u003e\u003cp\u003eMedical device based on hypertonic sea water with eucalyptus essential oil and wild mint extract, indicated for rapid relief from nasal congestion in cases of colds and rhinosinusitis; the osmotic action reduces the swelling of the mucous membranes, facilitating breathing, for adults and children from 6 years old.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Rinazine Aquamarina hypertonic nasal spray contain?\u003c\/h3\u003e\u003cp\u003eSea water (hypertonic with a salt concentration of 2.2%).\u003cbr\u003eExcipients: Eucalyptus globulus essential oil, menthol extracted from Mentha arvensis.\u003cbr\u003eWithout preservatives. Without propellant gases.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Rinazine Aquamarina hypertonic nasal spray?\u003c\/h3\u003e\u003cp\u003eFor children aged 6 years and older and adults: 2-3 sprays in each nostril up to 6 times a day.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Rinazine Aquamarina hypertonic nasal spray?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not use during pregnancy, breastfeeding, in case of allergy to any of the ingredients and in children under 6 years.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Rinazine Aquamarina hypertonic nasal spray stored?\u003c\/h3\u003e\u003cp\u003eKeep the product out of the reach and sight of children. Do not use the product after the expiry date or 6 months after opening. Store in the original packaging.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Rinazine Aquamarina hypertonic nasal spray?\u003c\/h3\u003e\u003cp\u003e20 ml pre-measured nasal spray\u003c\/p\u003e","brand":"Haleon","offers":[{"title":"Default Title","offer_id":51131297300807,"sku":"971101136","price":10.46,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/haleon-italy-srl-rinazina-aquamarina-spray-nasale-ipertonico-farmacia-dottor-tili-1213792201.jpg?v=1767127049"},{"product_id":"rinoway-doccia-irrigazione-nasale","title":"Rinoway nasal irrigation shower","description":"\u003cp\u003eThe \u003cstrong\u003eRinoway nasal irrigation shower\u003c\/strong\u003e is a medical device designed to improve the hygiene and health of the upper respiratory tract. Ideal for those who suffer from \u003cstrong\u003esinusitis\u003c\/strong\u003e, \u003cstrong\u003eallergic rhinitis\u003c\/strong\u003e or cold, this tool uses a \u003cstrong\u003esaline solution\u003c\/strong\u003e to carry out an effective nasal wash, removing allergens and excess mucus. Its structure in \u003cstrong\u003esturdy plastic\u003c\/strong\u003e guarantees long life and resistance to daily use.\u003c\/p\u003e\n\n\u003cp\u003eThanks to its ability to perform gentle but effective nasal irrigation, the Rinoway nasal shower helps keep the nasal cavities clean, improving the \u003cstrong\u003ebreathing\u003c\/strong\u003e and reducing congestion. It is particularly useful for those who live in environments with a high presence of \u003cstrong\u003eallergens\u003c\/strong\u003e or air pollutants. Regular use of this device can help prevent infection \u003cstrong\u003eupper respiratory tract\u003c\/strong\u003e and improve general well-being.\u003c\/p\u003e\n\n\u003cp\u003eThe Rinoway nasal shower is compatible with \u003cstrong\u003eisotonic salts\u003c\/strong\u003e e \u003cstrong\u003ehypertonic salts\u003c\/strong\u003e, offering flexibility in treating different nasal conditions. Its ergonomic design and \u003cstrong\u003enebulizer\u003c\/strong\u003e integrated facilitate the application of the solution, making the cleaning process simple and comfortable. Perfect for home use, the Rinoway nasal irrigation shower is an indispensable ally for those who want to maintain optimal nasal hygiene and improve the quality of their breathing.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy do you use Rinoway nasal irrigation douche? What is it for?\u003c\/h3\u003e\u003cp\u003eMedical device for washing the upper respiratory tract using saline solution, indicated in cases of sinusitis, allergic rhinitis or colds; helps remove allergens and excess mucus, promoting breathing and cleaning the nasal cavities.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Rinoway nasal irrigation douche contain?\u003c\/h3\u003e\u003cp\u003eSodium chloride, sodium bicarbonate, panthenol (vitamin B5), hyaluronic acid sodium salt.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Rinoway nasal irrigation shower?\u003c\/h3\u003e\u003cp\u003eTo be used with isotonic or hypertonic saline solutions, depending on the problem.\u003cbr\u003ePressure mode: for a strong wash. Drain mode: for slower, gentler watering.\u003cbr\u003eFor children the nebulizer nozzle can be used.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Rinoway nasal irrigation shower?\u003c\/h3\u003e\u003cp\u003eDo not use in case of known hypersensitivity to the product components. In case of adverse reactions, discontinue use of the product and consult your doctor. Close the container tightly after use. Do not use the product after the expiry date indicated on the packaging. Do not use the product if the packaging or bottle is not intact. Keep out of reach of children. Avoid contact with eyes. Do not inject. Do not ingest. Do not dispose of the bottle in the environment after use. Avoid promiscuous use of the product. Store at a temperature not exceeding 30°C and away from heat sources. Validity with intact packaging: 24 months. Post-opening validity: 90 days.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Rinoway nasal irrigation shower?\u003c\/h3\u003e\u003cp\u003eAvailable in packs of 15, 30 or 60 sachets of 2.25 g. With nebulizer.\u003c\/p\u003e","brand":"Envicon Medical","offers":[{"title":"Default Title","offer_id":51131313586503,"sku":"932720978","price":16.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/envicon-medical-rinoway-doccia-irrigazione-nasale-farmacia-dottor-tili-1258975938.jpg?v=1789561602"},{"product_id":"breathe-right-classici-30-pezzi","title":"Breathe Right Classics 30 Pieces","description":"\u003cp\u003eI \u003cstrong\u003eBreathe Right classics 30 pieces\u003c\/strong\u003e are nasal patches designed to improve breathing and sleep quality. These adhesive patches, equipped with elastic strips, are easily applied to the nose and work by gently lifting the nasal passages. This mechanism allows you to increase up to \u003cstrong\u003e31% airflow\u003c\/strong\u003e, offering immediate relief from nasal congestion caused by allergies, colds or deviated septum. Thanks to their effectiveness, Breathe Right patches can also help reduce or eliminate snoring, significantly improving the quality of sleep.\u003c\/p\u003e\n\u003cp\u003eThe package contains \u003cstrong\u003e30 pieces\u003c\/strong\u003e, ensuring prolonged and continuous use. The patches are available in different sizes to fit most noses, ensuring optimal adhesion and long-lasting comfort. They are ideal for those looking for a practical and non-invasive solution to breathe better and sleep peacefully.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy do you use Breathe Right classic 30 pieces? What is it for?\u003c\/h3\u003e\u003cp\u003eNasal patches with elastic strips that gently lift the nasal passages while increasing airflow; device indicated for the relief of nasal congestion due to allergies, colds or deviated septum, and to help reduce snoring.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Breathe Right classic 30 pieces?\u003c\/h3\u003e\u003cp\u003eCorrect application guarantees a better result. It is important to use plasters of the right size for your nose to obtain the best result. The small\/medium nose pads fit 75% of noses, while the large ones are intended for adults with larger noses. Do not use if you are allergic to latex or nasal strips. Not suitable for children under 5 years of age. Keep out of the sight and reach of children. For external use only. Do not use after the indicated expiry date.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Breathe Right classic 30 pieces?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eNasal patches are contraindicated in children, in patients allergic to latex, carefully read the information leaflet in the package.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Breathe Right classics 30 pieces not be used and what side effects can it cause?\u003c\/h3\u003e\u003cp\u003eNasal patches are contraindicated in children, in patients allergic to latex, carefully read the information leaflet in the package.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Breathe Right classic 30 pieces?\u003c\/h3\u003e\u003cp\u003ePacks of 30 plasters.\u003c\/p\u003e","brand":"Efas","offers":[{"title":"Default Title","offer_id":51131316666695,"sku":"982483556","price":22.33,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/e-fa-s-spa-breathe-right-classici-30-pezzi-farmacia-dottor-tili-1213792112.jpg?v=1767136029"},{"product_id":"isomar-flaconcini-decongestionanti-20x5ml","title":"Isomar decongestant vials 20x5ml","description":"\u003cp\u003e\u003cstrong\u003eIsomar decongestant vials 20x5ml\u003c\/strong\u003e is a hypertonic solution based on pure sea water, designed to offer a natural decongestant action on the nasal mucous membranes. Thanks to its formulation, this medical device is ideal for freeing the nose from excess mucus through an osmosis process, making it particularly suitable for use in aerosol therapy. The hypertonic saline solution, with a higher salt concentration than body fluids, promotes the drainage of secretions, helping to reduce airway edema and improve breathing.\u003c\/p\u003e\n\n\u003cp\u003eThese single-dose vials are suitable for both adults and children, offering a practical and hygienic option for daily nasal hygiene. They are particularly useful in cases of allergic rhinitis, sinusitis and colds, helping to keep the nasal cavities clean and free from obstructions. Regular use of \u003cstrong\u003eIsomar decongestant vials\u003c\/strong\u003e can help improve respiratory comfort, especially during periods of intense nasal congestion.\u003c\/p\u003e\n\n\u003cp\u003ePackaged in handy 5ml vials, these nasal decongestants are easy to use and transport, ensuring quick and effective relief wherever you are. Their hypertonic seawater-based formulation is free of preservatives and colorants, ensuring a delicate and safe treatment for the nasal mucous membranes. Choose \u003cstrong\u003eIsomar decongestant vials\u003c\/strong\u003e for a natural decongestant action and optimal respiratory well-being.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy use Isomar decongestant vials 20x5ml? What is it for?\u003c\/h3\u003e\u003cp\u003eHypertonic solution based on sea water, medical device indicated for the decongestion of nasal mucous membranes and the drainage of secretions in case of colds, allergic rhinitis or sinusitis; can also be used in aerosol therapy for adults and children.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Isomar decongestant vials 20x5ml contain?\u003c\/h3\u003e\u003cp\u003eSterile hypertonic seawater.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Isomar decongestant vials 20x5ml?\u003c\/h3\u003e\u003cp\u003eUse up to a maximum of 3 times a day and for no longer than 2 weeks of treatment. Prolonged use could cause dehydration of the nasal mucosa.\u003cbr\u003eOpen the sealed vial by twisting the cap. Introduce the single-dose vial into the nostrils of the lying child. Press the vial until the desired dose comes out. For children able to use Isomar Decongestant Vials alone and for adults, alternately introduce the vial into the nostrils, pressing each time, with the head up, inhaling and closing the other nostril with the finger.\u003cbr\u003eFor aerosol therapy: insert the liquid into the aerosol device following the instructions for use on the device.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Isomar decongestant vials 20x5ml?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not use Isomar Decongestant Vials in infants under 6 months of age. Do not use in case of nosebleeds.\u003cbr\u003eSterile, non-injectable solution. Do not use in conjunction with other topical treatments. Do not use the same single-dose bottle for both nasal hygiene and aerosol therapy. Do not mix with other solutions. Keep the vial out of the reach of children. After opening, the vial should be used immediately and discarded after use. Failure to check the integrity of the vial could alter the functional characteristics of the product. Do not use beyond the expiry date. Do not dispose of empty bottles in the environment. In aerosol therapy it is recommended to alternate the application of Isomar Decongestant Vials with pharmacological treatments. In some cases the product may be minimally irritating.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Isomar 20x5ml decongestant vials stored?\u003c\/h3\u003e\u003cp\u003eStore in a dry place, away from heat sources at a temperature below 25°C.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Isomar 20x5ml decongestant vials?\u003c\/h3\u003e\u003cp\u003e20 single-dose vials of 5 ml.\u003c\/p\u003e","brand":"Euritalia Pharma","offers":[{"title":"Default Title","offer_id":51131318174023,"sku":"984177927","price":9.77,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/euritalia-pharma-div-coswell-isomar-flaconcini-decongestionanti-20x5ml-farmacia-dottor-tili-1213792103.jpg?v=1767136151"},{"product_id":"rinoflux-soluzione-fisiologica-20-flaconcini-2ml","title":"Rinoflux physiological solution 20 vials 2ml","description":"\u003cp\u003eThe \u003cstrong\u003eRinoflux physiological solution 20 vials 2ml\u003c\/strong\u003e it is a versatile and practical medical device, ideal for daily use in both adults and children. This sterile physiological solution is composed of \u003cstrong\u003esodium chloride\u003c\/strong\u003e and purified water, and is packaged in practical single-dose vials, ready to use to ensure maximum hygiene and convenience. \u003c\/p\u003e\n\n\u003cp\u003ePerfect for\u003cstrong\u003eaerosol therapy\u003c\/strong\u003e, Rinoflux helps to thin secretions and humidify the nasal mucous membranes, making it a precious ally in case of colds or nasal congestion. It is particularly suitable for \u003cstrong\u003enasal cleaning\u003c\/strong\u003e, facilitating the drainage of excess secretions and preventing obstructions due to stagnation. \u003c\/p\u003e\n\n\u003cp\u003eIn addition to nasal use, the solution can also be used for external eye hygiene, making it a multifunctional product for the whole family. Its sterile formulation with no contraindications makes it safe for prolonged use, always guaranteeing maximum effectiveness. \u003c\/p\u003e\n\n\u003cp\u003eThe pack of 20 2 ml vials is ideal for those looking for a reliable product that is always at hand, perfect for dealing with the daily needs of \u003cstrong\u003enasal hygiene\u003c\/strong\u003e e \u003cstrong\u003ecare of the mucous membranes\u003c\/strong\u003e. Choose Rinflux for free breathing and deep, delicate cleansing. \u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Rinflux saline solution 20 vials 2ml used? What is it for?\u003c\/h3\u003e\u003cp\u003eSterile physiological solution based on sodium chloride, in single-dose vials, indicated for cleaning and hydrating the nasal mucous membranes in case of colds or congestion, also in aerosol therapy; It can also be used for external eye hygiene.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Rinoflux saline solution 20 vials 2ml contain?\u003c\/h3\u003e\u003cp\u003eSodium chloride 0.9%; acqua sterile q. b. to 100 ml.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Rinoflux physiological solution 20 vials 2ml?\u003c\/h3\u003e\u003cp\u003eTo clean the nose: open the sterile vial by rotating the butterfly closure; tilt the head to the left, in the case of a child place him on his side, supporting his head with his hand, delicately place the mouth of the vial on the upper nostril and irrigate abundantly with solution. Repeat the operation with the other nostril. Wait a few moments for the solution to work. Remove the secretions with a tissue, in the case of a child lift it and remove the secretions with a tissue or with the nasal aspirator. Use as many times as deemed necessary, in any case according to your doctor's instructions.\u003cbr\u003eIn aerosol therapy:\u003cbr\u003eOpen the sterile vial by turning the butterfly cap. open the aerosol vial by turning it counterclockwise; enter the desired quantity of solution. Close the aerosol vial by turning it clockwise and attach the other necessary accessories (connecting tube, mask or mouthpiece); start the application.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Rinoflux saline solution 20 vials 2ml?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eFor external use. Not injectable. Sterile product only if the packaging is intact and not damaged.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Rinoflux saline solution 20 vials 2ml stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place, do not expose to sources of light and heat.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Rinoflux saline solution 20 vials 2ml?\u003c\/h3\u003e\u003cp\u003ePack of 20 vials of 2 ml.\u003c\/p\u003e","brand":"Pic Solution","offers":[{"title":"Default Title","offer_id":51131323842887,"sku":"925366763","price":7.35,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/pikdare-spa-rinoflux-soluzione-fisiologica-20-flaconcini-2ml-farmacia-dottor-tili-1213792073.jpg?v=1767136489"},{"product_id":"pic-soluzione-fisiologica-20-flaconcini-5ml","title":"Pic physiological solution 20 vials 5ml","description":"\u003cp\u003eThe \u003cstrong\u003ePic saline solution 20 vials 5ml\u003c\/strong\u003e It is a versatile and indispensable product for daily health care. This sterile saline solution is designed to offer a wide range of applications, making it ideal for the whole family, including adults and children. Each 5 ml single-dose vial is composed of an isotonic mixture of \u003cstrong\u003esodium chloride\u003c\/strong\u003e e \u003cstrong\u003epurified water\u003c\/strong\u003e, ensuring safe and practical use.\u003c\/p\u003e\n\n\u003cp\u003ePerfect for \u003cstrong\u003edilution of drugs\u003c\/strong\u003e intended for\u003cstrong\u003eaerosol therapy\u003c\/strong\u003e, Pic saline is also an excellent choice for \u003cstrong\u003enasal cleaning\u003c\/strong\u003e. It helps humidify the nasal mucous membranes, alleviating the symptoms of \u003cstrong\u003enasal congestion\u003c\/strong\u003e, \u003cstrong\u003ecold\u003c\/strong\u003e e \u003cstrong\u003eallergies\u003c\/strong\u003e. Furthermore, it is suitable for\u003cstrong\u003eocular hygiene\u003c\/strong\u003e, particularly useful in case of the onset of conjunctivitis or for newborns with obstruction of the tear duct.\u003c\/p\u003e\n\n\u003cp\u003eThanks to its format in disposable vials, the Pic physiological solution offers maximum \u003cstrong\u003epracticality\u003c\/strong\u003e e \u003cstrong\u003esafety\u003c\/strong\u003e of use, eliminating the risk of contamination. This product is a precious ally for maintaining optimal hygiene and daily well-being, effectively supporting the needs of the whole family.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy do you use Pic saline solution 20 vials 5ml? What is it for?\u003c\/h3\u003e\u003cp\u003eSterile single-dose physiological solution (sodium chloride and purified water), indicated for nasal cleaning and hygiene, useful for relieving nasal congestion linked to colds or allergies, for diluting aerosol therapy drugs and for ocular hygiene, even in the case of the onset of conjunctivitis or obstruction of the lacrimal duct in newborns.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Pic saline solution 20 vials 5ml contain?\u003c\/h3\u003e\u003cp\u003eThe solution is composed of sodium chloride and purified water. It is a sterile physiological solution always ready for use, packaged in disposable vials.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Pic saline solution 20 vials 5ml?\u003c\/h3\u003e\u003cp\u003ePic physiological solution is indicated for diluting drugs for aerosol therapy, for cleaning the nose in adults and children, and for humidifying the nasal mucous membranes. It is also used for the external hygiene of the eyes in case of the onset of conjunctivitis and in newborns in case of obstruction of the lacrimal duct.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Pic saline solution 20 vials 5ml?\u003c\/h3\u003e\u003cp\u003eUse the product following the instructions of your doctor or pharmacist. Do not use if the packaging is damaged. Keep out of reach of children. Store in a cool, dry place, away from heat sources. Do not use after the expiry date indicated on the package.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Pic saline solution 20 vials 5ml?\u003c\/h3\u003e\u003cp\u003epack of 10 vials of 2 ml and 10 ml and pack of 20 vials of 5 ml\u003c\/p\u003e","brand":"Pic Solution","offers":[{"title":"Default Title","offer_id":51131329216839,"sku":"912071370","price":9.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/pikdare-spa-pic-soluzione-fisiologica-20-flaconcini-5ml-farmacia-dottor-tili-1213792074.jpg?v=1767136873"},{"product_id":"rilevante-spray-30ml","title":"Relevant spray 30ml","description":"\u003cp\u003e\u003cstrong\u003eRelevant spray 30ml\u003c\/strong\u003e is a medical device designed for \u003cstrong\u003eeffective cleaning of the nasal passages\u003c\/strong\u003e thanks to its mechanical action. This nasal spray is ideal for adults and children, offering immediate relief and a feeling of freshness thanks to its unique formulation. Contains natural ingredients such as \u003cstrong\u003eEucalyptus globulus oil\u003c\/strong\u003e, known for its refreshing and decongestant properties, and \u003cstrong\u003ementhol\u003c\/strong\u003e, which contributes to a feeling of freshness and opening of the respiratory tract.\u003c\/p\u003e\n\u003cp\u003eIts composition also includes \u003cstrong\u003eParaffinum liquidum\u003c\/strong\u003e, \u003cstrong\u003echlorobutanol\u003c\/strong\u003e, \u003cstrong\u003ecamphor\u003c\/strong\u003e, \u003cstrong\u003elimonene\u003c\/strong\u003e, \u003cstrong\u003etymol\u003c\/strong\u003e e \u003cstrong\u003elimalool\u003c\/strong\u003e, which work synergistically to ensure a delicate but effective action. The practical format from \u003cstrong\u003e30ml\u003c\/strong\u003e makes it easy to carry and use at any time of the day, ensuring optimal nasal hygiene.\u003c\/p\u003e\n\u003cp\u003eRelevant spray 30ml is a high quality product, made by \u003cstrong\u003eLevante Srl\u003c\/strong\u003e, and represents a safe choice for those looking for a natural and non-invasive method to keep the nasal passages clean and free.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Relevante spray 30ml used? What is it for?\u003c\/h3\u003e\u003cp\u003eNasal spray, mechanically acting medical device, indicated for cleaning the nasal passages in adults and children; with eucalyptus and menthol it offers a sensation of freshness and promotes the opening of the respiratory tract.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Relevante spray 30ml contain?\u003c\/h3\u003e\u003cp\u003eParaffinum Liquidum, Eucalyptus Globulus Oil, Chlorobutanol, Camphor, Menthol, Limonene, Tymol, Limalool.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Relevante spray 30ml?\u003c\/h3\u003e\u003cp\u003eAdults: 4\/5 sprays per nasal cavity 4 times a day.\u003cbr\u003eChildren: 3\/4 sprays per nasal cavity 4 times a day.\u003cbr\u003eAs needed or as prescribed by a doctor.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Relevante spray 30ml?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003e- The product is a medical device.\u003cbr\u003e- The product must not be used in case of hypersensitivity to Rilevante components.\u003cbr\u003e- If undesirable effects occur, it is advisable to discontinue use and consult your doctor.\u003cbr\u003e- Keep the product out of the reach of children.\u003cbr\u003e- In case of accidental contact with eyes, rinse with cold water.\u003cbr\u003e- Do not use the product on pregnant and breastfeeding women and on children under 12 years of age.\u003cbr\u003eThe expiry date refers to the product in intact packaging, correctly stored.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Relevante spray 30ml stored?\u003c\/h3\u003e\u003cp\u003eStore at a temperature not exceeding 40°C.\u003cbr\u003eValidity with intact packaging: 36 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Relevante spray 30ml?\u003c\/h3\u003e\u003cp\u003e30 ml vial.\u003c\/p\u003e","brand":"Levante","offers":[{"title":"Default Title","offer_id":51131334000967,"sku":"981515861","price":16.72,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/levante-srl-rilevante-spray-30ml-farmacia-dottor-tili-1213792045.jpg?v=1767137310"},{"product_id":"breathe-right-balsamici-10-pezzi","title":"Breathe Right balsamic 10 pieces","description":"\u003cp\u003eI \u003cstrong\u003eBreathe Right balsamics 10 pieces\u003c\/strong\u003e are innovative nasal patches designed to offer immediate relief from nasal congestion. Thanks to \u003cstrong\u003ebalsamic aromas\u003c\/strong\u003e, these patches help open the nasal passages without the use of medications, making them ideal for those looking for a natural alternative to relieve a stuffy nose. Perfect for those who suffer from \u003cstrong\u003ecold\u003c\/strong\u003e, \u003cstrong\u003eallergies\u003c\/strong\u003e or has a \u003cstrong\u003edeviated nasal septum\u003c\/strong\u003e, Breathe Right patches improve airflow, making breathing easier.\u003c\/p\u003e\n\n\u003cp\u003eTheirs \u003cstrong\u003eanatomical shape\u003c\/strong\u003e and the special adhesive guarantee optimal adhesion, while the disposable design ensures impeccable hygiene. Can also be used to reduce \u003cstrong\u003esnore\u003c\/strong\u003e, these patches are a \u003cstrong\u003emedical device\u003c\/strong\u003e safe and practical for outdoor use. The package contains 10 pieces, offering a convenient option for those who need quick and effective relief from nasal congestion.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy do you use Breathe Right balsamic 10 pieces? What is it for?\u003c\/h3\u003e\u003cp\u003eNasal patch medical device with balsamic aromas, indicated for the relief of nasal congestion linked to colds, allergies or deviated nasal septum; improves airflow and can also be used to reduce snoring.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Breathe Right balsamic 10 pieces contain?\u003c\/h3\u003e\u003cp\u003eBreathe Right balsamic patches are made with hypoallergenic materials and contain balsamic aromas for a refreshing effect. They do not contain medicines.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Breathe Right balsamic 10 pieces?\u003c\/h3\u003e\u003cp\u003eApply the nasal patch to the clean, dry skin of the nose. Make sure the ends of the patch are positioned correctly to ensure optimal adhesion. Use one patch nightly or as needed to relieve nasal congestion.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Breathe Right balsamic 10 pieces?\u003c\/h3\u003e\u003cp\u003eDo not use on irritated or injured skin. If irritation or allergic reaction occurs, discontinue use and consult a doctor. Keep out of reach of children. Store in a cool, dry place.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Breathe Right balsamic 10 pieces?\u003c\/h3\u003e\u003cp\u003ePack of 10 pieces\u003c\/p\u003e","brand":"Efas","offers":[{"title":"Default Title","offer_id":51131334033735,"sku":"982483529","price":9.03,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/e-fa-s-spa-breathe-right-balsamici-10-pezzi-farmacia-dottor-tili-1213792053.jpg?v=1767137291"},{"product_id":"momenxsin-200mg-30mg-12-compresse-rivestite","title":"Momenxsin 200mg\/30mg 12 coated tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of nasal congestion associated with acute rhinosinusitis of suspected viral origin with headache and\/or fever. Momenxsin is indicated in adults and adolescents aged 15 years and older.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach film-coated tablet contains 200 mg of ibuprofen and 30 mg of pseudoephedrine hydrochloride. \u003cu\u003eExcipient with known effects:\u003c\/u\u003e sodium. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eTablet core:\u003c\/u\u003e Microcrystalline cellulose; Calcium hydrogen phosphate anhydrous; Croscarmellose sodium\u003cb\u003e;\u003c\/b\u003e Corn starch; Colloidal anhydrous silica; Magnesium stearate. \u003cu\u003eTablet coating:\u003c\/u\u003e Hypromellose; Macrogol 400; Talc; Titanium dioxide (E171); Yellow iron oxide (E172).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e• Hypersensitivity to ibuprofen, pseudoephedrine hydrochloride or to any of the excipients listed in paragraph 6.1; • Patients under 15 years of age; • Women in the third trimester of pregnancy (see section 4.6); • Breastfeeding women (see section 4.6); • Patients with a history of hypersensitivity reactions (for example bronchospasm, asthma, rhinitis, angioedema or urticaria) associated with acetylsalicylic acid or other non-steroidal anti-inflammatory drugs (NSAIDs); • History of gastrointestinal bleeding or perforation associated with previous NSAID therapy; • Current or past recurrent peptic hemorrhage\/ulcer (at least two distinct episodes of demonstrated ulceration or bleeding); • Cerebrovascular or other bleeding; • Hematopoietic abnormalities of unknown origin; • Severe liver failure; • Severe renal failure; • Severe heart failure; • Severe cardiovascular disorders, coronary heart disease (heart disease, hypertension, angina pectoris), tachycardia, hyperthyroidism, diabetes, pheochromocytoma; • History of stroke or presence of risk factors for stroke (due to the α-–sympathomimetic activity of pseudoephedrine hydrochloride); • Risk of closed-angle glaucoma; • Risk of urinary retention related to urethroprostatic disorders; • History of myocardial infarction; • History of seizures; • Systemic lupus erythematosus; • Concomitant use of other vasoconstrictors such as nasal decongestants, administered orally or nasally (e.g. phenylpropanolamine, phenylephrine and ephedrine), and methylphenidate (see section 4.5); • Concomitant use of non-selective monoamine oxidase inhibitors (MAOIs) (iproniazid) (see section 4.5) or use of monoamine oxidase inhibitors in the last two weeks.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage.\u003c\/u\u003e \u003ci\u003eAdults and adolescents aged 15 years and older\u003c\/i\u003e: 1 tablet (equivalent to 200 mg of ibuprofen and 30 mg of pseudoephedrine hydrochloride) every 6 hours if necessary. In case of more intense symptoms, 2 tablets (equivalent to 400 mg of ibuprofen and 60 mg of pseudoephedrine hydrochloride) every 6 hours if necessary, up to a maximum total daily dose of 6 tablets (equivalent to 1200 mg of ibuprofen and 180 mg of pseudoephedrine hydrochloride). Do not exceed the maximum total daily dose of 6 tablets (equivalent to 1200 mg of ibuprofen and 180 mg of pseudoephedrine hydrochloride). For short-term use. \u003cb\u003eIf symptoms worsen, consult a doctor. The maximum duration of treatment is 4 days for adults and 3 days for adolescents aged 15 years and older.\u003c\/b\u003e In cases where symptoms consist predominantly of pain\/fever or nasal congestion, administration of a product containing a single active ingredient is preferable. \u003ci\u003eSide effects can be contained by using the lowest effective dose for the shortest time necessary to control symptoms (see section 4.4).\u003c\/i\u003e\u003ci\u003ePediatric population\u003c\/i\u003e: Momenxsin is contraindicated in pediatric patients under 15 years of age (see section 4.3). \u003cu\u003eMethod of administration:\u003c\/u\u003e For oral use. The tablets should be swallowed whole and not chewed, with a glass of water, preferably during meals.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not store above 30°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eConcomitant use of Momenxsin and other NSAIDs, including selective cyclooxygenase (COX)-2 inhibitors, should be avoided. Side effects can be reduced by using for the shortest possible time the minimum effective dose necessary to control symptoms (see the paragraphs \"Gastrointestinal effects\" and \"Cardiovascular and cerebrovascular effects\" below). If symptoms persist beyond the maximum recommended duration of treatment with this medicine (4 days for adults and 3 days for adolescents), the measures to be implemented should be re-evaluated, in particular the possible usefulness of antibiotic treatment. Acute rhinosinusitis of suspected viral origin is defined as a series of bilateral rhinological symptoms of moderate intensity, dominated by nasal congestion with severe or purulent rhinorrhea, occurring in an epidemic context. The purulent appearance of rhinorrhea is common and does not systematically correspond to bacterial superinfection. Pain in the paranasal sinuses in the first days of the disease is associated with congestion of the related mucosa (acute congestive rhinosinusitis) and in most cases resolves spontaneously. In case of acute bacterial sinusitis, the use of antibiotic therapy is justified. \u003cb\u003e \u003ci\u003eSpecial warnings regarding pseudoephedrine hydrochloride\u003c\/i\u003e: \u003c\/b\u003e • The dosage, the maximum recommended duration of treatment (4 days for adults and 3 days for adolescents) and contraindications must be strictly respected (see section 4.8); • Patients must be informed that treatment must be suspended if hypertension, tachycardia, palpitations, cardiac arrhythmias, nausea or any neurological signs appear, such as the onset or worsening of headache; • Ischemic colitis Some cases of ischemic colitis have been reported with pseudoephedrine. If sudden abdominal pain, rectal bleeding, or other symptoms of ischemic colitis develop, pseudoephedrine should be discontinued and a physician should be consulted. \u003ci\u003eSevere skin reactions:\u003c\/i\u003e Serious skin reactions such as acute generalized exanthematous pustulosis (AGEP) may occur with products containing pseudoephedrine. This acute pustular eruption may occur within the first 2 days of treatment, with fever and numerous, small, mostly non-follicular pustules resulting from a widespread edematous erythema and localized mainly on the skin folds, trunk and upper limbs. Patients should be carefully monitored. If signs and symptoms such as pyrexia, erythema or numerous small pustules are observed, the administration of Momenxsin should be stopped and appropriate measures taken if necessary. Before using this medicine, patients should consult their doctor if they have: • hypertension, heart disease, hyperthyroidism, psychosis or diabetes; • concomitant use of anti-migraine drugs, in particular vasoconstrictors based on ergot alkaloids (due to the α-sympathomimetic activity of pseudoephedrine); • mixed connective tissue disease: increased risk of aseptic meningitis (see section 4.8); • neurological symptoms such as convulsive seizures, hallucinations, behavioral disorders, agitation and insomnia have been described following the administration of systemic vasoconstrictors, especially during feverish episodes or in cases of overdose. Such symptoms have been reported more commonly in the pediatric population. It is therefore advisable to: • avoid administering Momenxsin in association with drugs that can lower the epileptogenic threshold, such as terpene derivatives, clobutinol, atropine-like substances and local anaesthetics, or in the presence of a history of convulsive seizures; • strictly adhere, in all cases, to the recommended dosage and inform patients about the risks of overdose if Momenxsin is taken concomitantly with other medicinal products containing vasoconstrictors. Patients with urethroprostatic disorders are more susceptible to developing symptoms such as dysuria and urinary retention. Elderly patients may be more sensitive to central nervous system (CNS) effects. \u003cb\u003e \u003ci\u003ePrecautions for use relating to pseudoephedrine hydrochloride\u003c\/i\u003e: \u003c\/b\u003e • In patients who are to undergo a planned surgical operation in which the use of halogenated volatile anesthetics is expected, it is preferable to suspend treatment with Momenxsin several days before the operation, in consideration of the risk of acute hypertension (see section 4.5); • Athletes should be informed that treatment with pseudoephedrine hydrochloride may result in positive doping tests. \u003cu\u003eInterferences with serological tests: \u003c\/u\u003e Pseudoephedrine may potentially reduce iobenguane i-131 uptake in neuroendocrine tumors, thus interfering with scintigraphy. \u003cb\u003e \u003ci\u003eSpecial warnings regarding ibuprofen\u003c\/i\u003e: \u003c\/b\u003e In patients suffering from bronchial asthma or allergic diseases or with a history of such diseases, bronchospasm may occur. In case of asthma, the product must not be taken without first consulting a doctor (see section 4.3). Patients suffering from asthma associated with chronic rhinitis, chronic sinusitis and\/or nasal polyposis are exposed to a greater risk of allergic reactions if they take acetylsalicylic acid and\/or NSAIDs. Administration of Momenxsin may trigger an acute asthma attack, particularly in some patients allergic to acetylsalicylic acid or an NSAID (see section 4.3). Prolonged use of any type of painkiller for headache can cause it to get worse. Where this situation is encountered or suspected, medical advice should be sought and treatment discontinued. The diagnosis of medication overuse headache (MOH) should be suspected in patients who experience frequent or daily headaches despite (or because of) regular use of headache medications. Before using this medicine, patients suffering from blood clotting disorders should consult their doctor.\u003ci\u003e \u003cu\u003eGastrointestinal effects: \u003c\/u\u003e \u003c\/i\u003e Gastrointestinal haemorrhage, ulceration or perforation, sometimes fatal, have been reported at any stage of treatment with the use of all NSAIDs, with or without warning symptoms or previous gastrointestinal events. The risk of gastrointestinal haemorrhage, ulceration or perforation, sometimes fatal, increases with higher doses of NSAIDs, in patients with a history of ulcer, particularly if complicated by bleeding or perforation (see section 4.3) and in the elderly. These patients should start treatment with the lowest available dose. For these patients and for those taking concomitant treatment with low doses of acetylsalicylic acid or other medicinal products that may increase the risk of gastrointestinal events, combination therapy with gastroprotectants (e.g. misoprostol or proton pump inhibitors) should be considered (see below and section 4.5). Patients with a history of gastrointestinal toxicity, especially elderly patients, should report any unusual abdominal symptoms (particularly gastrointestinal bleeding), especially in the initial stages of treatment. Particular caution is advised in patients receiving concomitant treatment with drugs that may increase the risk of ulceration or bleeding, such as oral corticosteroids, anticoagulants such as warfarin, selective serotonin reuptake inhibitors (SSRIs) or antiplatelet agents such as acetylsalicylic acid (see section 4.5). Treatment with Momenxsin must be stopped immediately in case of gastrointestinal bleeding or ulceration. NSAIDs should be administered with caution to patients with a history of gastrointestinal diseases (ulcerative colitis, Crohn's disease), because these conditions could be exacerbated (see section 4.8). In case of concomitant alcohol intake, the use of NSAIDs may increase side effects related to the active ingredient, in particular those affecting the gastrointestinal tract or central nervous system. \u003ci\u003e \u003cu\u003eCardiovascular and cerebrovascular effects: \u003c\/u\u003e \u003c\/i\u003e The following conditions are subject to contraindications due to the presence of pseudoephedrine hydrochloride (see section 4.3): severe cardiovascular disorders, coronary heart disease (cardiopathy, hypertension, angina pectoris), tachycardia, hyperthyroidism, diabetes, pheochromocytoma, history of stroke or presence of risk factors for stroke, history of myocardial infarction. Clinical studies suggest that the use of ibuprofen, particularly at high doses (2400 mg\/day), may be associated with a slight increase in the risk of arterial thrombotic events (e.g. myocardial infarction or stroke). Overall, epidemiological studies do not suggest that low-dose ibuprofen (e.g. ≤ 1200 mg\/day) is associated with an increased risk of arterial thrombotic events. Patients suffering from uncontrolled hypertension, heart failure (NYHA II-III), established ischemic heart disease, peripheral arterial disease and\/or cerebrovascular disorders should be treated with ibuprofen only after careful evaluation and high doses (2400 mg\/day) should be avoided. Careful evaluation must also be carried out before patients with risk factors for cardiovascular events (e.g. hypertension, hyperlipidaemia, diabetes mellitus, smoking) undertake long-term treatment, particularly if high doses of ibuprofen (2400 mg\/day) are required. \u003ci\u003e \u003cu\u003eSevere skin reactions:\u003c\/u\u003e \u003c\/i\u003e Serious skin reactions, some of them fatal, including exfoliative dermatitis, Stevens-Johnson syndrome and toxic epidermal necrolysis, have been reported very rarely in association with the use of NSAIDs (see section 4.8). In the early stages of therapy, patients appear to be at higher risk for these reactions: the onset of the reaction occurs in most cases within the first month of treatment. Severe skin reactions, such as acute generalized exanthematous pustulosis (PEAG), may occur with medicines containing ibuprofen and pseudoephedrine. This acute pustular eruption may occur within the first 2 days of treatment, with fever and numerous, small, mostly non-follicular pustules resulting from a widespread edematous erythema and localized mainly on the skin folds, trunk and upper limbs. Patients should be carefully monitored. If signs and symptoms such as pyrexia, erythema or numerous small pustules are observed, as well as the appearance of skin rash, mucosal lesions or any other sign of hypersensitivity, the administration of Momenxsin must be discontinued and appropriate measures must be taken if necessary. \u003ci\u003eMasking symptoms of underlying infections:\u003c\/i\u003e Momenxsin may mask the symptoms of infection, which could delay the initiation of appropriate treatment and therefore worsen the outcome of the infection. This has been observed in community-acquired bacterial pneumonia and bacterial complications of chickenpox. When Momenxsin is administered for the relief of fever or pain related to infection, monitoring of the infection is recommended. In non-hospital settings, the patient should seek medical attention if symptoms persist or worsen. \u003cb\u003e \u003ci\u003ePrecautions for use relating to ibuprofen:\u003c\/i\u003e \u003c\/b\u003e • Elderly: the pharmacokinetics of ibuprofen are not modified by age, therefore dosage adjustments are not necessary in the elderly. However, elderly patients should be carefully monitored, as they are more sensitive to NSAID-related side effects, especially gastrointestinal bleeding and perforation, which can be fatal; • Caution and special monitoring are required when ibuprofen is administered to patients with a history of gastrointestinal diseases (such as peptic ulcer, hiatal hernia or gastrointestinal haemorrhage); • In the initial stages of treatment, careful monitoring of urine output and renal function is necessary in patients with heart failure, in patients with chronic impairment of renal or hepatic function, in patients taking diuretics, in patients hypovolemic due to major surgery and, in particular, in elderly patients. Dehydrated adolescents are at risk of kidney damage; • In case of visual disturbances during treatment, the patient must undergo a complete ophthalmological examination. \u003ci\u003e \u003cu\u003eImportant information about some excipients.\u003c\/u\u003e \u003c\/i\u003e Momenxsin contains:- \u003cb\u003eSodium:\u003c\/b\u003e This medicinal product contains less than 1 mmol (23 mg) sodium per dose, i.e. essentially 'sodium-free'.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNon-selective MAOIs (iproniazid) - Possible reaction: Paroxysmal hypertension and hyperthermia, which can be fatal. Due to the long duration of action of MAOIs, this interaction may occur up to 15 days after discontinuation of the MAOI.\u003c\/p\u003e\n\u003cp\u003eOther sympathomimetics or vasoconstrictors with indirect action administered orally or nasally, α-sympathomimetic drugs, phenylpropanolamine, phenylephrine, ephedrine, methylphenidate - Possible reaction: Risk of vasoconstriction and\/or hypertensive crisis.\u003c\/p\u003e\n\u003cp\u003eReversible monoamine oxidase A (RIMA) inhibitors, linezolid, dopaminergic ergot alkaloids, vasoconstrictor ergot alkaloids - Possible reaction: Risk of vasoconstriction and\/or hypertensive crisis.\u003c\/p\u003e\n\u003cp\u003eHalogenated volatile anesthetics - Possible reaction: Acute perioperative hypertension. If you have scheduled surgery, stop taking Momenxsin several days in advance.\u003c\/p\u003e\n\u003cp\u003eGuanethidine, reserpine and methyldopa - Possible reaction: The effect of pseudoephedrine may be attenuated.\u003c\/p\u003e\n\u003cp\u003eTricyclic antidepressants - Possible reaction: The effect of pseudoephedrine may be attenuated or enhanced.\u003c\/p\u003e\n\u003cp\u003eDigitalis, quinidine or tricyclic antidepressants - Possible reaction: Increased frequency of arrhythmias.\u003c\/p\u003e\n\u003cp\u003eOther NSAIDs, including salicylates and selective COX-2 inhibitors - Possible reaction: Concomitant administration of several NSAIDs could increase the risk of gastrointestinal bleeding and ulcers due to a synergistic effect. Therefore, the concomitant use of ibuprofen with other NSAIDs should be avoided (see section 4.4).\u003c\/p\u003e\n\u003cp\u003eDigoxin - Possible reaction: The concomitant use of Momenxsin with digoxin-based preparations could increase the serum levels of the latter. With proper use (maximum 4 days), monitoring of serum digoxin levels is generally not necessary.\u003c\/p\u003e\n\u003cp\u003eCorticosteroids - Possible reaction: Corticosteroids could increase the risk of adverse reactions, particularly affecting the gastrointestinal tract (gastrointestinal haemorrhage or ulceration) (see section 4.3).\u003c\/p\u003e\n\u003cp\u003eAntiplatelet agents - Possible reaction: Increased risk of gastrointestinal bleeding (see section 4.4).\u003c\/p\u003e\n\u003cp\u003eAcetylsalicylic acid - Possible reaction: Concomitant administration of ibuprofen and acetylsalicylic acid is generally not recommended due to the potential for increased adverse effects. Experimental data suggest that ibuprofen may cause competitive inhibition of the effect of low-dose acetylsalicylic acid on platelet aggregation when the two medicines are taken simultaneously. Despite doubts regarding the applicability of these data to clinical situations, the possibility that long-term regular use of ibuprofen may reduce the cardioprotective effect of low-dose acetylsalicylic acid cannot be excluded. No clinically relevant effects are considered likely following occasional use of ibuprofen (see section 5.1).\u003c\/p\u003e\n\u003cp\u003eAnticoagulants (e.g. warfarin, ticlopidine, clopidogrel, Tirofiban, eptifibatide, abciximab, iloprost) - Possible reaction: NSAIDs such as ibuprofen may potentiate the effects of anticoagulants (see section 4.4).\u003c\/p\u003e\n\u003cp\u003ePhenytoin - Possible reaction: Concomitant use of Momenxsin with phenytoin-based preparations could increase serum levels of the latter. With proper use (maximum 4 days), monitoring of phenytoin serum levels is generally not necessary.\u003c\/p\u003e\n\u003cp\u003eSelective serotonin reuptake inhibitors (SSRIs) - Possible reaction: Increased risk of gastrointestinal bleeding (see section 4.4).\u003c\/p\u003e\n\u003cp\u003eLithium - Possible reaction: The concomitant use of Momenxsin with lithium-based preparations could increase serum levels of the latter. With proper use (maximum 4 days), monitoring of serum lithium levels is generally not necessary.\u003c\/p\u003e\n\u003cp\u003eProbenecid and sulfinpyrazone - Possible reaction: Medicines containing probenecid or sulfinpyrazone may delay the excretion of ibuprofen.\u003c\/p\u003e\n\u003cp\u003eDiuretics, ACE inhibitors, beta blockers and angiotensin II antagonists - Possible reaction: NSAIDs could reduce the effect of diuretics and other antihypertensive medicines. In some patients with impaired renal function (e.g. dehydrated patients or elderly patients with impaired renal function), concomitant administration of ACE inhibitors, beta-blockers or angiotensin II antagonists and agents that inhibit cyclo-oxygenase could lead to further deterioration of renal function, including possible acute renal failure which is usually reversible. Therefore, this combination must be administered with caution, especially in the elderly. Patients should be adequately hydrated and consideration should be given to monitoring renal function after initiation of concomitant therapy and periodically thereafter.\u003c\/p\u003e\n\u003cp\u003ePotassium-sparing diuretics - Possible reaction: Concomitant administration of Momenxsin and potassium-sparing diuretics may cause hyperkalemia (monitoring of serum potassium levels is recommended).\u003c\/p\u003e\n\u003cp\u003eMethotrexate - Possible reaction: Administration of Momenxsin in the 24 hours before or after taking methotrexate may increase its concentrations and toxic effects.\u003c\/p\u003e\n\u003cp\u003eCiclosporin - Possible reaction: The risk of cyclosporine-induced renal damage is increased by concomitant use of some non-steroidal anti-inflammatory drugs. This effect cannot be excluded even in the case of simultaneous intake of ciclosporin and ibuprofen.\u003c\/p\u003e\n\u003cp\u003eTacrolimus - Possible reaction: The risk of nephrotoxicity increases if the two medicines are administered simultaneously.\u003c\/p\u003e\n\u003cp\u003eZidovudine - Possible reaction: There is evidence of an increased risk of hemarthrosis and hematoma in HIV (+) hemophiliac patients receiving concomitant treatment with zidovudine and ibuprofen.\u003c\/p\u003e\n\u003cp\u003eSulfonylureas - Possible reaction: Clinical research has demonstrated the existence of interactions between nonsteroidal anti-inflammatory drugs and antidiabetics (sulfonylureas). Although no interactions between ibuprofen and sulphonylureas have been described so far, in case of concomitant use of these two drugs it is advisable, as a precaution, to check blood sugar values.\u003c\/p\u003e\n\u003cp\u003eQuinolone antibiotics - Possible reaction: Animal studies indicate that NSAIDs may increase the risk of seizures associated with the use of quinolone antibiotics. Patients taking NSAIDs and quinolones may be at increased risk of experiencing seizures.\u003c\/p\u003e\n\u003cp\u003eHeparins; gingko biloba - Possible reaction: Increased risk of bleeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe most commonly observed ibuprofen-related adverse reactions are gastrointestinal in nature. Peptic ulcers, perforation or gastrointestinal bleeding, even fatal, may occur, particularly in the elderly (see section 4.4). Following its administration, nausea, vomiting, diarrhoea, flatulence, constipation, dyspepsia, abdominal pain, melena, haematemesis, ulcerative stomatitis, exacerbation of colitis and Crohn's disease have been reported (see section 4.4 Special warnings and precautions for use). Gastritis was detected less frequently. In general, the risk of experiencing adverse reactions (in particular serious gastrointestinal complications) increases with increasing dose and duration of treatment. Hypersensitivity reactions have been reported following treatment with ibuprofen, which may include: (a) nonspecific allergic reactions and anaphylaxis; (b) airway reactivity, including asthma, aggravated asthma, bronchospasm, or dyspnea; (c) various skin disorders, including various types of skin rashes, pruritus, urticaria, purpura, angioedema and, more rarely, exfoliative and bullous dermatoses (including epidermal necrolysis and erythema multiforme). In patients with existing autoimmune disorders (such as systemic lupus erythematosus or mixed connective tissue disease), isolated cases of symptoms of aseptic meningitis, such as stiff neck, headache, nausea, vomiting, fever or disorientation have been observed during treatment with ibuprofen. Edema, hypertension and heart failure have been reported in association with the intake of NSAIDs. Clinical studies suggest that the use of ibuprofen, especially at high doses (2400 mg\/day), may be associated with a slight increase in the risk of arterial thrombotic events (e.g. myocardial infarction or stroke) (see section 4.4). The list of adverse reactions reported below refers to reactions occurring with ibuprofen and pseudoephedrine hydrochloride at the doses contained in over-the-counter drugs, for short-term use. In the treatment of chronic conditions, additional adverse reactions may occur during long-term treatment. Patients should be advised to immediately stop taking Momenxsin and consult a doctor in case of a serious adverse reaction to the drug. very common (≥1\/10); common (≥1\/100, \u003c1\/10); uncommon (≥1\/1,000, \u003c1\/100); rare (≥1\/10,000, \u003c1\/1,000); very rare (\u003c1\/10,000); not known (frequency cannot be estimated from the available data).\u003c\/p\u003e\n\u003cp\u003eInfections and infestations: Ibuprofen Very rare Exacerbation of inflammation of an infectious nature (e.g. necrotizing fasciitis), aseptic meningitis (neck stiffness, headache, nausea, vomiting, fever or disorientation) in patients suffering from pre-existing autoimmune diseases (systemic lupus erythematosus (SLE), mixed connective tissue disease).\u003c\/p\u003e\n\u003cp\u003eBlood and lymphatic system disorders: Ibuprofen Very rare Hematopoietic disorders (anaemia, leukopenia, thrombocytopenia, pancytopenia, agranulocytosis).\u003c\/p\u003e\n\u003cp\u003eImmune system disorders: Ibuprofen Uncommon Hypersensitivity reactions with urticaria, itching and asthma attacks (with drop in blood pressure).\u003c\/p\u003e\n\u003cp\u003eImmune system disorders: Ibuprofen and Pseudoephedrine hydrochloride Very rare Severe generalized hypersensitivity reactions, the signs of which may be facial edema, angioedema, dyspnoea, tachycardia, reduction in blood pressure, anaphylactic shock.\u003c\/p\u003e\n\u003cp\u003ePsychiatric disorders: Ibuprofen Very rare Psychotic reactions, depression.\u003c\/p\u003e\n\u003cp\u003ePsychiatric disorders: Pseudoephedrine hydrochloride Not known Agitation, hallucinations, anxiety, abnormal behavior, insomnia.\u003c\/p\u003e\n\u003cp\u003eNervous system disorders: Ibuprofen Uncommon Central nervous system disorders, such as headache, dizziness, insomnia, agitation, irritability or tiredness.\u003c\/p\u003e\n\u003cp\u003eNervous system disorders: Pseudoephedrine hydrochloride Rare Insomnia, nervousness, anxiety, restlessness, tremors, hallucinations.\u003c\/p\u003e\n\u003cp\u003eNervous system disorders: Pseudoephedrine hydrochloride Not known Haemorrhagic stroke, ischemic stroke, convulsions, headache.\u003c\/p\u003e\n\u003cp\u003eEye disorders: Ibuprofen Uncommon Visual disturbances.\u003c\/p\u003e\n\u003cp\u003eEar and labyrinth disorders: Ibuprofen Rare Tinnitus.\u003c\/p\u003e\n\u003cp\u003eCardiac disorders: Ibuprofen Very rare Palpitations, heart failure, myocardial infarction.\u003c\/p\u003e\n\u003cp\u003eCardiac disorders: Pseudoephedrine hydrochloride Not known Palpitations, tachycardia, chest pain, arrhythmia.\u003c\/p\u003e\n\u003cp\u003eVascular disorders: Ibuprofen Very rare Arterial hypertension.\u003c\/p\u003e\n\u003cp\u003eVascular disorders: Pseudoephedrine hydrochloride Not known Hypertension.\u003c\/p\u003e\n\u003cp\u003eRespiratory, thoracic and mediastinal disorders: Pseudoephedrine hydrochloride Rare Exacerbation of asthma or hypersensitivity reaction with bronchospasm.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders: Ibuprofen Common Gastrointestinal discomfort, dyspepsia, abdominal pain, nausea, vomiting, flatulence, diarrhoea, constipation, mild gastrointestinal bleeding which in rare cases leads to anemia.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders: Ibuprofen Uncommon Gastrointestinal ulcers in some cases associated with bleeding and\/or perforation, gastritis, ulcerative stomatitis, exacerbation of colitis and Crohn's disease (see section 4.4).\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders: Ibuprofen Very rare Esophagitis, pancreatitis, diaphragm-like intestinal stenosis.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders: Pseudoephedrine hydrochloride Not known Dry mouth, thirst, nausea, vomiting, ischemic colitis.\u003c\/p\u003e\n\u003cp\u003eHepatobiliary disorders: Ibuprofen Very rare Liver dysfunction, liver damage, especially in case of prolonged therapy, liver failure, acute hepatitis.\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders: Ibuprofen Uncommon Various skin rashes.\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders: Ibuprofen Very rare Bullous reactions, including Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome), alopecia, severe skin infections and soft tissue complications in case of chickenpox infection.\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders: Ibuprofen Not known Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome) Acute generalized exanthematous pustulosis (AGEP).\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders: Pseudoephedrine hydrochloride Not known Rash, urticaria, pruritus, hyperhidrosis, severe skin reactions including acute generalized exanthematous pustulosis (AGEP).\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders: Ibuprofen Rare Damage to renal tissue (papillary necrosis) and high concentrations of uric acid in the blood.\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders: Ibuprofen Very rare Increased serum creatinine, edema (particularly in patients suffering from arterial hypertension or renal failure), nephrotic syndrome, interstitial nephritis, acute renal failure.\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders: Pseudoephedrine hydrochloride Not known Difficulty in urination.\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003e \u003cu\u003eReporting of suspected adverse reactions:\u003c\/u\u003e \u003c\/i\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reaction via the national reporting system: at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe clinical effects of overdose are more likely due to the presence of pseudoephedrine hydrochloride in this product, rather than ibuprofen. The effects are not clearly related to the dose taken due to the different sensitivity of various individuals to the sympathomimetic properties. \u003ci\u003eSymptoms due to the sympathomimetic effect \u003c\/i\u003e CNS depression: e.g. sedation, apnoea, cyanosis, coma. CNS stimulation (more likely in children): e.g. insomnia, hallucinations, convulsions, tremors. In addition to the symptoms already mentioned as side effects, the following symptoms may occur: hypertensive crisis, cardiac arrhythmias, muscle weakness and tension, euphoria, excitement, thirst, chest pain, dizziness, tinnitus, ataxia, blurred vision, hypotension. \u003ci\u003eSymptoms related to ibuprofen (in addition to the gastrointestinal and neurological ones already mentioned as side effects) \u003c\/i\u003e Drowsiness, nystagmus, tinnitus, hypotension, loss of consciousness. In cases of severe poisoning, metabolic acidosis may occur. \u003ci\u003eTherapeutic measures \u003c\/i\u003e There are no specific antidotes available. If the patient presents within an hour of taking a potentially toxic amount of medication, oral activated charcoal may be considered. An electrolyte check and an ECG are also necessary. In case of symptomatic cardiovascular instability and\/or electrolyte imbalance, symptomatic treatment should be initiated.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy.\u003c\/u\u003e \u003ci\u003ePseudoephedrine hydrochloride:\u003c\/i\u003e Animal studies have demonstrated reproductive toxicity (see section 5.3). The use of pseudoephedrine hydrochloride reduces the mother's uterine blood flow, but clinical data regarding the effects on pregnancy are insufficient. \u003ci\u003eIbuprofen\u003c\/i\u003e: Inhibition of prostaglandin synthesis may negatively affect pregnancy and\/or embryonic\/fetal development. Results of epidemiological studies suggest an increased risk of miscarriage, cardiac malformation and gastroschisis following the use of prostaglandin synthesis inhibitors in the early stages of pregnancy. The risk is believed to increase proportionally to the dose and duration of therapy. It has been shown that in animals the administration of a prostaglandin synthesis inhibitor causes an increase in pre- and post-implantation losses and embryonic\/fetal lethality. Furthermore, an increased incidence of various malformations, including cardiovascular ones, has been reported in animals administered a prostaglandin synthesis inhibitor during the organogenetic period. During the first and second trimester of pregnancy, ibuprofen should not be administered unless strictly necessary. If a woman who is trying to conceive or is in the first or second trimester of pregnancy must take ibuprofen, the dose and duration of treatment should be kept as low as possible. \u003cu\u003eDuring the third trimester of pregnancy, all prostaglandin synthesis inhibitors can expose the fetus to:\u003c\/u\u003e - cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension); - renal dysfunction, which can progress to renal failure with oligohydramnios; \u003cu\u003ethe mother and child, at the end of pregnancy: \u003c\/u\u003e - possible prolongation of bleeding time, an anti-aggregating effect which can occur even at very low doses; - inhibition of uterine contractions resulting in delay or prolongation of labor. Consequently, this medicine is: contraindicated in the third trimester of pregnancy and should only be administered where strictly necessary in the first and second trimesters. \u003cu\u003eBreastfeeding:\u003c\/u\u003e The need to take measures during breastfeeding arises from the presence of pseudoephedrine hydrochloride in the formulation of the medicine: pseudoephedrine hydrochloride is excreted in breast milk. Taking into account the potential cardiovascular and neurological effects of vasoconstrictors, taking this medicine is contraindicated during breastfeeding. \u003cu\u003eFertility: \u003c\/u\u003e There is evidence that cyclooxygenase\/prostaglandin synthesis inhibitors may impair female fertility by affecting ovulation. The effect is reversible upon discontinuation of treatment.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMomenxsin has minor or moderate influence on the ability to drive and use machines. Patients who experience dizziness, hallucinations, unusual headaches, and impaired vision or hearing should avoid driving or using machinery. Generally, a single administration or the use of this medicine for short periods does not require the adoption of any particular precautions.\u003c\/p\u003e","brand":"Angelini Pharma","offers":[{"title":"Default Title","offer_id":51131350778183,"sku":"043682020","price":9.49,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/angelini-pharma-italia-spa-momenxsin-200mg-30mg-12-compresse-rivestite-farmacia-dottor-tili-1213791971.jpg?v=1767149890"},{"product_id":"actifed-decongestionante-1mg-ml-spray-nasale-soluzione-10ml","title":"Actifed decongestant 1mg\/ml nasal spray solution 10ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTemporary symptomatic treatment of nasal congestion due to rhinitis or sinusitis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eXylometazoline hydrochloride 1 mg in 1 ml of solution: Each spray-dose (140mcl) contains 140 mcg of xylometazoline hydrochloride. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSodium hyaluronate, Sorbitol (E420), Glycerol (E422), Sodium dihydrogen phosphate dihydrate, Disodium phosphate dihydrate, Sodium chloride, Water for injections.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eACTIFED DECONGESTANT must not be used: - in patients with hypersensitivity to the active ingredient or to any of the excipients listed in paragraph 6.1; - in patients with high intraocular pressure, particularly in the presence of narrow-angle glaucoma; - in patients with \"dry\" inflammation of the nasal mucosa (\u003ci\u003eDry rhinitis\u003c\/i\u003e); - in children under 12 years of age; - after transsphenoidal hypophysectomy or other transnasal\/transoral surgery with exposure of the dura mater; - in patients being treated with monoamine oxidase inhibitors (MAOIs) or who have used these drugs in the previous 2 weeks, or in patients taking other medicinal products with potential hypertensive effect; - in patients with atrophic or vasomotor rhinitis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFor nasal use. \u003cu\u003eAdults and children over 12 years old\u003c\/u\u003e: One spray in each nostril no more than three times a day. This medicine must be used for a maximum of 7 days, unless otherwise prescribed by a doctor. To minimize the risk of infection, the product should not be used by more than one person and the nozzle should be cleaned after each use. \u003cb\u003eChildren\u003c\/b\u003e: ACTIFED DECONGESTANT is contraindicated in children under 12 years of age (see paragraph 4.3). \u003cb\u003eElderly\u003c\/b\u003e: Same dosage as adults.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not store above 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eXylometazoline, like other medicines belonging to the same pharmacological category, should be administered with caution in patients with a marked reaction to sympathomimetic substances. The use of substances of this type can cause a series of disorders in such patients, such as insomnia, dizziness, tremors, arrhythmia or increased blood pressure. Particular caution is necessary in the case of patients suffering from cardiovascular diseases, hypertension, hyperthyroidism or diabetes, as well as in the case of patients with prostatic hypertrophy and pheochromocytoma. Patients with long QT syndrome treated with xylometazoline may be at increased risk of serious ventricular arrhythmias. In case of prolonged treatment with xylometazoline, the reappearance of the symptoms of rhinitis and edema of the mucous membrane is sometimes observed upon discontinuation of therapy. In these cases, it may also be the so-called \"rebound\" phenomenon caused by the medicine itself, which progresses to chronic edema and atrophy of the nasal mucosa (\u003ci\u003eRhinitis medicamentosa and Rhinitis sicca)\u003c\/i\u003e. To avoid this, the duration of treatment should be as short as possible (see section 4.2). Nasal and paranasal inflammations of bacterial origin must be treated appropriately. For the treatment of allergic rhinitis, this product can only be used temporarily as supportive therapy.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use of the product is not recommended in conjunction with tricyclic or tetracyclic antidepressant drugs or monoamine oxidase inhibitor drugs (MAOI), or within two weeks following the use of MAO inhibitors.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe most frequently reported side effects of this medicine are tingling or burning of the nose and throat and dryness of the nasal mucosa. Based on their frequency, side effects have been divided into the following categories: Very common ≥1\/10; Common ≥1\/100 to \u003c1\/10; Uncommon ≥1\/1000 to \u003c1\/100; Rare ≥1\/10,000 to \u003c1\/1000; Very rare \u003c1\/10,000 including isolated reports; Not known, frequency cannot be estimated from the available data.\u003c\/p\u003e\n\u003cp\u003eImmune System Disorders - Rare: Systemic allergic reactions.\u003c\/p\u003e\n\u003cp\u003ePsychiatric disorders - Rare: Nervousness, insomnia.\u003c\/p\u003e\n\u003cp\u003eNervous system pathology - Rare: Headache, dizziness.\u003c\/p\u003e\n\u003cp\u003eEye disorders - Rare: Transient visual disturbances.\u003c\/p\u003e\n\u003cp\u003eCardiac disorders - Rare: Palpitation.\u003c\/p\u003e\n\u003cp\u003eVascular disorders - Rare: Increased blood pressure.\u003c\/p\u003e\n\u003cp\u003eRespiratory, thoracic and mediastinal disorders - Common: Tingling and burning of the nose and throat and dryness of the nasal mucosa. Uncommon: Epistaxis. Not known: Rebound effect.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Rare: Nausea.\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e. Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBeing an imidazoline, systemic overdose of xylometazoline can cause a wide range of symptoms referable to cardiac and nervous system stimulation or depression. Cases of overdose are mainly linked to the use of the medicine in children. Reported symptoms of intoxication include severe paralysis of the central nervous system, sedation, dry mouth and sweating, as well as symptoms caused by stimulation of the sympathetic nervous system (tachycardia, irregular pulse and increased blood pressure). One drop (single dose) of the adult preparation xylometazoline (1 mg\/ml) administered intranasally caused a 4-hour coma in a 15-day-old infant. During follow-up, the newborn completely recovered. Treatment of intoxication is nosotropic and may include administration of charcoal, gastric lavage, and oxygen inhalation. To reduce blood pressure, 5 mg of phentolamine in saline solution is administered slowly intravenously or 100 mg orally. If necessary, antipyretics and anticonvulsants are administered. The use of vasopressors is contraindicated.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThere are no data regarding the trans-placental passage of xylometazoline, nor its secretion into breast milk. Due to the potential systemic effect of vascular constriction, this medicine should not be used during pregnancy. During breastfeeding, this medicine should be used with caution as it is not known whether or not the active ingredient is transferred into breast milk.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eWhen used correctly, xylometazoline is not known to have any influence on the ability to drive or use machinery.\u003c\/p\u003e","brand":"Johnson \u0026 Johnson","offers":[{"title":"Default Title","offer_id":51131354153287,"sku":"040282016","price":10.43,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/johnson-johnson-spa-actifed-decongestionante-1mg-ml-spray-nasale-soluzione-10ml-farmacia-dottor-tili-1213791917.jpg?v=1767141070"},{"product_id":"breathe-right-classici-grandi-30-pezzi","title":"Breathe Right Classic Large 30 Pieces","description":"\u003cp\u003eI \u003cstrong\u003eBreathe Right classics large 30 pieces\u003c\/strong\u003e are nasal patches designed to offer immediate relief from nasal congestion, improving breathing and reducing snoring. These patches, ideal for adults with larger noses, use advanced technology that gently widens the nasal passages, allowing for an increase in airflow by up to 31%. They are particularly effective in cases of allergies, colds or deviated nasal septum, offering optimal comfort without the use of medicines.\u003c\/p\u003e\n\n\u003cp\u003eMade as single-use medical devices, Breathe Right patches feature a secure adhesive and an anatomical shape that fits perfectly to the nose, ensuring comfortable application and gentle removal. Their transparency makes them discreet, allowing them to be used at any time of the day or during the night for a more peaceful rest. Thanks to their effectiveness, these patches are a practical and non-invasive solution for those looking to improve the quality of their daily breathing.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy do you use Breathe Right Classic Large 30 Pieces? What is it for?\u003c\/h3\u003e\u003cp\u003eNasal patch, disposable medical device, indicated for the relief of nasal congestion and to improve breathing by reducing snoring; It works by delicately widening the nasal passages, being useful in case of allergies, colds or deviated nasal septum, without the use of medicines.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Breathe Right classic large 30 pieces?\u003c\/h3\u003e\u003cp\u003eRemove the oiled film that protects the glue. Make the patch adhere perfectly to the wings of the nose (at the root), pressing lightly on the sides of the device with your fingers. To remove: moisten the patch with warm water and gently remove by lifting the adhesive starting from the flaps.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Breathe Right Classic Large 30 Pieces?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eNasal patches are not indicated in cases of nasal polyposis, deviation of the nasal septum, tonsillar\/adenoid hypertrophy and sleep apnea. Adult nasal plasters are contraindicated for children. Read the information leaflet contained inside the package carefully before use. The product is not indicated in patients allergic to latex.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Breathe Right classic large 30 pieces not be used and what side effects can it cause?\u003c\/h3\u003e\u003cp\u003eNasal patches are not indicated in cases of nasal polyposis, deviation of the nasal septum, tonsillar\/adenoid hypertrophy and sleep apnea. Adult nasal plasters are contraindicated for children. Read the information leaflet contained inside the package carefully before use. The product is not indicated in patients allergic to latex.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Breathe Right Classics Large 30 Pieces?\u003c\/h3\u003e\u003cp\u003ePack of 30 standard classic nasal plasters.\u003c\/p\u003e","brand":"Efas","offers":[{"title":"Default Title","offer_id":51131366900039,"sku":"982483582","price":23.5,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/e-fa-s-spa-breathe-right-classici-grandi-30-pezzi-farmacia-dottor-tili-1213791899.jpg?v=1767150148"},{"product_id":"actigrip-2-5mg-60mg-500mg-12-compresse","title":"Actigrip 2.5mg\/60mg\/500mg 12 tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTreatment of cold symptoms characterized by nasal obstruction, watery rhinorrhea, headache and\/or fever.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach tablet contains: • \u003ci\u003e \u003cu\u003eactive ingredients:\u003c\/u\u003e \u003c\/i\u003e triprolidine hydrochloride 2.5 mg (triprolidine free base 2.091 mg); pseudoephedrine hydrochloride 60.0 mg (pseudoephedrine free base 49.154 mg); paracetamol 500.0 mg; For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach tablet contains: pregelatinized corn starch, povidone, crospovidone, stearic acid, microcrystalline cellulose, colloidal anhydrous silica, magnesium stearate.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e• Hypersensitivity to the active substances, to other antihistamines or to any of the excipients listed in paragraph 6.1. • Children under the age of 12. • During pregnancy and breastfeeding (see section 4.6). • Patients being treated with monoamine oxidase inhibitors (MAOIs) or in the two weeks following such treatment. In such cases the concomitant use of Actigrip can cause an increase in blood pressure or hypertensive crisis (see section 4.5) and in the treatment of lower respiratory tract diseases, including bronchial asthma. • The association with indirect sympathomimetic drugs, alpha sympathetic mimetics (orally and\/or nasally) (see section 4.5 Interactions with other medicinal products and other forms of interaction). • Due to its anticholinergic effects, do not use in case of glaucoma, prostatic hypertrophy, obstruction of the bladder neck, pyloric and duodenal stenosis or other tracts of the gastrointestinal and urogenital system. • Patients with pre-existing cardiovascular disease, particularly those with coronary heart disease, hypertension and thyroid disease. • In patients with a history of stroke or who have risk factors for stroke, due to the alphasympathomimetic activity of the vasoconstrictor, § Epilepsy. • Diabetes. • Severe liver and kidney disease. • Paracetamol-based medicines are contraindicated in patients with manifest glucose-6-phosphate dehydrogenase insufficiency and in those suffering from severe hemolytic anemia. • Severe hepatocellular failure.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage.\u003c\/u\u003e \u003ci\u003eAdults\u003c\/i\u003e: one tablet 2 - 3 times a day, for a maximum of 5 days of therapy. \u003ci\u003ePediatric population (children over 12 years old up to 18 years old)\u003c\/i\u003e: one tablet 2 - 3 times a day, for a maximum of 3 days of therapy. \u003cb\u003eDo not exceed the recommended doses\u003c\/b\u003e; in particular elderly patients must adhere to the minimum dosages indicated above. \u003cu\u003eMethod of administration:\u003c\/u\u003e Take the tablets orally. The medicine must be taken on a full stomach.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore in a dry place, at a temperature not exceeding 25°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use of Actigrip should be avoided if you are already using any other medicine containing paracetamol. People suffering from alcoholism should contact their doctor before taking paracetamol. Patients with liver disease should consult their doctor before taking Actigrip. Migraine patients treated with ergotamine alkaloid vasoconstrictors should consult their doctor before taking Actigrip (see section 4.5). In patients treated with paracetamol, serious skin reactions such as acute generalized exanthematous pustulosis (PEAG), Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) have been reported very rarely. Patients should be informed of the signs of serious skin reactions and use should be discontinued at the first signs of skin rash or any other sign of hypersensitivity. In the early stages of therapy, patients appear to be at higher risk: the onset of the reaction occurs in most cases in the early stages of treatment. Serious skin reactions such as acute generalized exanthematous pustulosis (AGEP) have been reported very rarely with products containing pseudoephedrine. This acute pustular eruption may occur within the first 2 days of treatment, with fever and numerous, small, mostly non-follicular pustules resulting from a widespread edematous erythema and localized mainly on the skin folds, trunk and upper limbs. Patients should be carefully monitored. If signs and symptoms such as formation of numerous small pustules with or without pyrexia or erythema are observed, administration of ACTIGRIP should be discontinued (see section 4.8). If fever persists for more than three days or if symptoms do not improve or others appear within five days or are accompanied by high fever, rash, excessive amount of mucus and persistent cough, consult your doctor before continuing administration. Due to the presence of pseudoephedrine, patients must be informed that treatment must be discontinued in the event of: hypertension, tachycardia, palpitations or cardiac arrhythmia, nausea or any neurological signs (such as the appearance or exacerbation of headache). If sudden abdominal pain, rectal bleeding or other symptoms of ischemic colitis develop (see section 4.8), pseudoephedrine should be discontinued and medical advice should be sought. Ischemic optic neuropathy: Cases of ischemic optic neuropathy have been reported with pseudoephedrine. Pseudoephedrine should be discontinued if sudden loss of vision or reduction in visual acuity occurs, for example in the case of a scotoma. The use of antihistamines can mask the first signs of ototoxicity of certain antibiotics. Patients with respiratory conditions such as emphysema and chronic bronchitis should be advised to consult a doctor before using triprolidine. May cause drowsiness (see section 4.8). Triprolidine may increase the sedative effects of substances that depress the central nervous system such as alcohol, sedatives, tranquilizers (see section 4.5). It is necessary to inform patients that the use of alcoholic beverages should be avoided during treatment with Actigrip and that it is advisable to consult the doctor before taking Actigrip concomitantly with medicines that depress the central nervous system. Patients with reduced kidney function should not take Actigrip unless advised by their doctor. High or prolonged doses of the medicine can cause high-risk liver disease and even serious changes in the kidney and blood. In case of renal and hepatocellular insufficiency, use only if clearly necessary and under direct medical supervision. During treatment with paracetamol before taking any other medicine, check that it does not contains the same active ingredient, since if paracetamol is taken in high doses, serious adverse reactions may occur. Overdose can lead to liver damage. Careful medical supervision is therefore necessary for both adults and children even if no obvious signs or symptoms appear. Invite the patient to contact the doctor before combining any other drug (see section 4.5). The use of the medicine is not recommended if the patient is being treated with anti-inflammatory drugs. \u003ci\u003eSpecial populations:\u003c\/i\u003e Consult your doctor to determine the dose in the elderly due to their greater sensitivity towards the drug.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eAnticoagulant drugs (e.g. warfarin)\u003c\/i\u003e: Concomitant use of paracetamol with oral anticoagulants may lead to slight changes in INR values. In this case, patients should seek advice from their doctor or pharmacist before using Actigrip if they are already taking blood-thinning medications, such as warfarin or other coumarin derivatives. \u003ci\u003eMonoamine oxidase inhibitors (MAOIs)\u003c\/i\u003e: Pseudoephedrine exerts its vasoconstrictor properties by stimulating adrenergic receptors and promoting the release of norepinephrine from neuronal sites. Because MAOIs impair the metabolism of sympathomimetic amines by increasing the availability of releasable norepinephrine in the nervous system, they may potentiate the pressor effect of pseudoephedrine. Cases of acute hypertensive crises due to the concomitant use of MAOIs and sympathomimetic amines have been reported in the literature. \u003ci\u003eSubstances that depress the CNS (Alcohol, sedatives, tranquilizers)\u003c\/i\u003e: The medicine may interact with alcohol, tricyclic antidepressants, neuroleptics or other drugs with a depressant action on the central nervous system such as barbiturates, sedatives, tranquilizers, hypnotics which should not be taken during therapy. Related to the presence of pseudoephedrine, associations with indirect sympathomimetics (ephedrine, methylphenidate, phenylephrine) and oral and\/or nasal alpha sympathomimetics (naphazoline, oxymetazoline, phenylephrine, tetrizoline, tramazoline, tuaminoheptane) are contraindicated due to the possible risk of vasoconstriction and\/or hypertensive crisis (see section 4.3 \"Contraindications\"). Concomitant administration of dopaminergic ergot alkaloids (bromocriptine, cabergoline, lisuride, pergolide) and vasoconstrictor ergot alkaloids (dihydroergotamine, ergotamine, methylergometrine) can induce vasoconstriction and\/or hypertensive crisis. Likewise, antihypertensives, oral hypoglycemics, metoclopramide, other substances with anticholinergic action should not be taken at the same time as ACTIGRIP, as they could cause significant interactions. Associations requiring precautions for use: Halogenated anesthetic gases: risk of perioperative hypertensive crisis. It is advisable to stop treatment with ACTIGRIP a few days before a scheduled surgery. Furazolidone causes progressive inhibition of monoamine oxidase, so it should not be taken at the same time as ACTIGRIP. The effect of antihypertensives that interfere with sympathetic activity (e.g. methyldopa, alpha and beta blockers, debrisoquine, guanethidine, betanidine and bretylium) can be partially canceled out by ACTIGRIP, which therefore, also in this case, should not be taken at the same time. The habitual ingestion of anticonvulsant drugs or oral contraceptives can, through an enzymatic induction mechanism, accelerate the metabolism of paracetamol. Use with extreme caution and under strict control during chronic treatment with drugs that can cause the induction of hepatic monooxygenases or in case of exposure to substances that can have this effect (for example rifampicin, cimetidine, antiepileptics such as glutetimide, phenobarbital, carbamazepine). The administration of paracetamol can interfere with the determination of uric acid (using the phosphotungstic acid method) and with that of blood sugar (using the glucose-oxidase-peroxidase method).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003e \u003ci\u003eData from clinical trials\u003c\/i\u003e: \u003c\/b\u003e There are insufficient data to report adverse reactions from randomized placebo-controlled studies for the combination of parcetamol, pseudoephedrine and triprolidine. The following are adverse reactions reported with a frequency ≥1%, identified in randomized placebo-controlled studies: - with formulations containing pseudophedrine as the single active substance: dry mouth, nausea, dizziness, insomnia and nervousness; - with formulations containing paracetamol and pseudoephedrine: nervousness. \u003cb\u003e \u003ci\u003eData from post-marketing experience\u003c\/i\u003e: \u003c\/b\u003e The following are adverse events identified during post-marketing experience with paracetamol, pseudoephedrine, the combination of pseudoephedrine and triprolidine, the combination of pseudoephedrine and paracetamol, or the combination of paracetamol, pseudoephedrine and triprolidine. Adverse reactions are reported in Table 1 according to frequency categories using the following convention: Very common (≥ 1\/10); Common (≥ 1\/100, \u003c1\/10); Uncommon (≥ 1\/1,000, \u003c 1\/100); Rare (≥1\/10,000, \u003c1\/1,000); Very rare (\u003c1\/10,000); Not known (frequency cannot be estimated from the available data).\u003c\/p\u003e\n\u003cp\u003ePsychiatric disorders.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse reactions: anxiety, nervousness, restlessness, visual hallucination, insomnia.\u003c\/p\u003e\n\u003cp\u003eNervous system disorders.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse reactions: convulsions, dizziness, excitation, headache (especially in the elderly), cerebrovascular accident.\u003c\/p\u003e\n\u003cp\u003eCardiac diseases.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse reactions: Palpitations, myocardial infarction.\u003c\/p\u003e\n\u003cp\u003eRespiratory, thoracic and mediastinal disorders.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse reactions: Epistaxis.\u003c\/p\u003e\n\u003cp\u003ePathologies of the skin and subcutaneous tissue.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse reactions: pruritus, urticaria, acute generalized exanthematous pustulosis, rash, severe skin reactions, including cases of erythema multiforme, Stevens Johnson syndrome and toxic epidermal necrolysis, photosensitization.\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse reactions: Dysuria, urinary retention.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse reactions: Ischemic colitis.\u003c\/p\u003e\n\u003cp\u003eDiagnostic tests.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse reactions: increased blood pressure.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders: - Adverse reactions: hypersensitivity reactions, anaphylactic reaction.\u003c\/p\u003e\n\u003cp\u003eEye pathologies.\u003c\/p\u003e\n\u003cp\u003eNot known - Adverse reactions: Ischemic optic neuropathy.\u003c\/p\u003e\n\u003cp\u003eSide effects related to the presence of Paracetamol: \u003cb\u003eSkin and subcutaneous tissue disorders:\u003c\/b\u003e itchy skin rash, angioedema. \u003cb\u003eSystemic disorders and conditions relating to the administration site:\u003c\/b\u003e asthenia. \u003cb\u003ePathologies of the blood and lymphatic system\u003c\/b\u003e: thrombocytopenia, leukopenia, neutropenia, anemia, agranulocytosis. \u003cb\u003eHepatobiliary disorders:\u003c\/b\u003e liver function disorders, hepatitis. \u003cb\u003eRenal and urinary disorders\u003c\/b\u003e: kidney alterations, acute renal failure, interstitial nephritis, hematuria. \u003cb\u003eGastrointestinal disorders\u003c\/b\u003e: dry mouth, abdominal discomfort, constipation, nausea, vomiting, diarrhea. \u003cb\u003e Diagnostic tests\u003c\/b\u003e: increase in transaminases*. \u003csup\u003e*\u003c\/sup\u003ea slight increase in transaminase levels may occur in some patients taking recommended dosages of acetaminophen. These cases are not accompanied by liver failure and generally resolve with the continuation or suspension of paracetamol therapy. Side effects related to the presence of Pseudoephedrine: \u003cb\u003ePsychiatric disorders:\u003c\/b\u003e hallucinations. \u003cb\u003eNervous system disorders:\u003c\/b\u003e paresthesia, psychomotor hyperactivity, tremors, cerebrovascular accident. \u003cb\u003eCardiac disorders:\u003c\/b\u003e arrhythmia, tachycardia, myocardial infarction. \u003cb\u003eSkin and subcutaneous tissue disorders:\u003c\/b\u003e angioedema. \u003cb\u003eSystemic disorders and conditions relating to the administration site:\u003c\/b\u003e sweating. \u003cb\u003eGastrointestinal Pathologies:\u003c\/b\u003e ischemic colitis. Side effects related to the presence of Triprolidine: \u003cb\u003ePsychiatric disorders:\u003c\/b\u003e euphoria. \u003cb\u003eNervous system disorders:\u003c\/b\u003e drowsiness. \u003cb\u003eGastrointestinal disorders\u003c\/b\u003e: dry mouth, abdominal discomfort, constipation, nausea, vomiting, diarrhea. \u003cb\u003eCardiac diseases\u003c\/b\u003e: hypotension (especially in the elderly). \u003cb\u003eRespiratory, thoracic and mediastinal disorders:\u003c\/b\u003e increased hyperviscosity of bronchial secretions. \u003cb\u003eEye disorders:\u003c\/b\u003e acute attack of angle-closure glaucoma, mydriasis, blurred vision. In isolated cases, hemorrhagic stroke has occurred in patients who used drugs containing pseudoephedrine. Notably, these cerebrovascular accidents have occurred during overdose, misuse and\/or in patients with vascular risk factors. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e. Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn case of pseudoephedrine overdose, nausea, vomiting, marked depressive or stimulant effects on the central nervous system, insomnia, tremors, mydriasis, anxiety, agitation, hallucinations, palpitations, tachycardia, reflex bradycardia, drowsiness, lethargy, respiratory depression, hypertension, irritability, convulsions are generally observed. Other effects may concern dysrhythmia, hypertensive crisis, intracerebral hemorrhage, myocardial infarction, psychosis, rhabdomyolysis, hypocalemia and ischemic infarction of the intestine. In children the dominant action is the exciting one with accentuated tremors, drowsiness, insomnia, hyperactivity and convulsions. Pallor, anorexia, nausea and vomiting are frequently the first signs of paracetamol overdose. Hepatic necrosis is a complication related to paracetamol overdose. Liver enzymes may become elevated and prothrombin time prolonged for 12 to 48 hours but clinical signs may not appear until the 6th day after ingestion. Alcohol may potentiate the hepatoxicity of acetaminophen overdose and may have contributed to acute pancreatitis in a patient who had taken excessive amounts of acetaminophen. In case of overdose, paracetamol, contained in ACTIGRIP, can cause hepatic cytolysis and can evolve towards massive and irreversible necrosis. Keep out of reach of children. In case of overdose, seek medical help or contact a poison control center immediately. \u003cb\u003eManagement\u003c\/b\u003e • Immediate transfer of the patient to hospital. • Taking a plasma sample to determine the initial dosage of paracetamol. • Rapid evacuation of the ingested product through gastric lavage. • Acidify the urine by administering ammonium chloride (to increase the elimination of pseudoephedrine). • Usually the treatment of overdose includes the administration of the antidote N-acetylcysteine ​​intravenously or orally as soon as possible and, if possible, before the tenth hour. • Symptomatic treatment.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eACTIGRIP is contraindicated during pregnancy and breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAt common therapeutic doses, antihistamines present secondary reactions that vary greatly from subject to subject and from compound to compound. The most frequent secondary effect is sedation which can manifest itself with drowsiness, of which those who can drive motor vehicles or carry out operations that require an intact level of vigilance must be warned.\u003c\/p\u003e","brand":"Johnson \u0026 Johnson","offers":[{"title":"Default Title","offer_id":51131372208455,"sku":"024823080","price":11.77,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/johnson-johnson-spa-actigrip-2-5mg-60mg-500mg-12-compresse-farmacia-dottor-tili-1213791873.jpg?v=1767137627"},{"product_id":"viscoflu-10-flaconcini-5ml","title":"Viscoflu 10 vials 5ml","description":"\u003cp\u003eThe \u003cstrong\u003eViscoflu 10 vials 5ml\u003c\/strong\u003e is a disposable medical device designed for the treatment of respiratory tract diseases characterized by dense and viscous hypersecretion. This sterile hypertonic saline solution is particularly suitable for conditions such as \u003cstrong\u003eacute bronchitis\u003c\/strong\u003e, \u003cstrong\u003echronic bronchitis\u003c\/strong\u003e and its exacerbations, \u003cstrong\u003epulmonary emphysema\u003c\/strong\u003e, \u003cstrong\u003emucoviscidosis\u003c\/strong\u003e, \u003cstrong\u003ebronchiectasis\u003c\/strong\u003e, \u003cstrong\u003erhinosinusitis\u003c\/strong\u003e e \u003cstrong\u003emidsecretory otitis\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003eThanks to its formulation, Viscoflu can be used in different ways to ensure effective therapeutic action. It can be \u003cstrong\u003enebulized\u003c\/strong\u003e with aerosol devices for inhalation, allowing the solution to directly reach the bronchial district. Furthermore, it is possible to instill it directly to wash the nasal and ear cavities, or at an endobronchial level via permanent tubes or a bronchoscope.\u003c\/p\u003e\n\n\u003cp\u003eThe composition of Viscoflu includes \u003cstrong\u003eN-acetylcysteine\u003c\/strong\u003e (300 mg) e \u003cstrong\u003esodium chloride\u003c\/strong\u003e (150 mg), supported by excipients such as sodium hydroxide, sodium edetate and water for injections. This combination of ingredients is designed to thin secretions, facilitating their expulsion and improving breathing.\u003c\/p\u003e\n\n\u003cp\u003eThe product is packaged in practical 5 ml vials, with a total of 10 vials per pack, ensuring simple and hygienic use. Viscoflu is an ideal solution for those looking for an effective and targeted treatment for respiratory problems, supported by the quality and reliability of \u003cstrong\u003ePharma Line Srl\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Viscoflu 10 vials 5ml used? What is it for?\u003c\/h3\u003e\u003cp\u003eDisposable sterile hypertonic saline solution (medical device), indicated as an adjuvant in respiratory tract diseases with dense and viscous hypersecretion (acute and chronic bronchitis, pulmonary emphysema, mucoviscidosis, bronchiectasis, rhinosinusitis, midsecretory otitis); it can be nebulized by aerosol or used for nasal and ear washes.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Viscoflu 10 vials 5ml contain?\u003c\/h3\u003e\u003cp\u003eN-acetylcysteine ​​(300 mg), Sodium chloride (150 mg).\u003cbr\u003eExcipients: sodium hydroxide, sodium edetate, water for injections.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Viscoflu 10 vials 5ml?\u003c\/h3\u003e\u003cp\u003eSterile solution which can be:\u003cbr\u003e- Nebulized with aerosol devices to be inhaled in order to reach the bronchial district.\u003cbr\u003e- Instilled directly for washing the nasal and ear cavities.\u003cbr\u003e- Instilled endobronchially via permanent tubes, bronchoscope, etc.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Viscoflu 10 vials 5ml?\u003c\/h3\u003e\u003cp\u003ePack containing 10 vials of 5 ml\u003c\/p\u003e","brand":"Pharma Line","offers":[{"title":"Default Title","offer_id":51131378368839,"sku":"934038276","price":14.06,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/pharma-line-srl-viscoflu-10-flaconcini-5ml-farmacia-dottor-tili-1213791721.jpg?v=1767140890"},{"product_id":"argotone-0-12-spray-nasale","title":"Argotone 0-12 nasal spray","description":"\u003cp\u003eArgotone 0-12 nasal spray is a \u003cstrong\u003emedical device\u003c\/strong\u003e designed to provide relief to children with problems \u003cstrong\u003estuffy nose\u003c\/strong\u003e and symptoms from \u003cstrong\u003ecold\u003c\/strong\u003e. This nasal spray is particularly suitable for the treatment of \u003cstrong\u003einflammation\u003c\/strong\u003e of the nasal cavities, even of bacterial origin, thanks to its action \u003cstrong\u003efluidizing\u003c\/strong\u003e e \u003cstrong\u003edecongestant\u003c\/strong\u003e. Its unique formulation, enriched with \u003cstrong\u003ecolloidal silver\u003c\/strong\u003e, helps cleanse and fluidize nasal secretions, improving breathing and tubal ventilation.\u003c\/p\u003e\n\u003cp\u003eArgotone 0-12 is ideal for children, thanks to its delicate and free composition \u003cstrong\u003egluten\u003c\/strong\u003e e \u003cstrong\u003elactose\u003c\/strong\u003e. Ingredients like \u003cstrong\u003ecarboxymethyl-betaglucan\u003c\/strong\u003e and the \u003cstrong\u003epotassium sorbate\u003c\/strong\u003e they help keep the nasal cavities clean and free, while the strawberry aroma makes the application more pleasant for the little ones. This nasal spray is a precious ally during flu and flu conditions \u003cstrong\u003erhinitis\u003c\/strong\u003e, offering an action \u003cstrong\u003eantiseptic\u003c\/strong\u003e e \u003cstrong\u003eanti-inflammatory\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cp\u003eProduced by \u003cstrong\u003eDompé Farmaceutici\u003c\/strong\u003e, Argotone 0-12 is available in a practical 20 ml bottle with nebulizer, easy to use and take with you.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Argotone 0-12 nasal spray used? What is it for?\u003c\/h3\u003e\u003cp\u003eNasal spray (medical device) based on colloidal silver, indicated for children with stuffy nose and cold symptoms, even in the presence of inflammation of the nasal cavities of bacterial origin; cleanses and fluidizes nasal secretions, improving breathing.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Argotone 0-12 nasal spray contain?\u003c\/h3\u003e\u003cp\u003eCarboxymethyl-betaglucan, colloidal silver, potassium sorbate, sorbic acid, sodium benzoate, sodium N-hydroxymethylglycinate, strawberry flavor, monobasic sodium phosphate, dibasic sodium phosphate, purified water.\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e, without \u003cstrong\u003elactose\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Argotone 0-12 nasal spray?\u003c\/h3\u003e\u003cp\u003eTo prepare the bottle, remove the cap from the nebulizer pump and without placing it on any surface to avoid contamination, insert it into the bottle.\u003cbr\u003eCarry out 1-2 sprays 2-3 times a day up to a maximum of 7 days. The product can also be used in the presence of small lesions of the skin around the nostrils or of the nasal mucosa.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Argotone 0-12 nasal spray?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not use in case of known hypersensitivity to the product components. In case of adverse reactions, discontinue use of the product and consult your doctor. Close the container tightly after use. Do not use the product after the expiry date indicated on the package. Do not use the product if the packaging or bottle is not intact. Keep out of reach of children. Avoid contact with eyes. Do not inject. Do not ingest. Do not dispose of the bottle in the environment after use. Avoid promiscuous use of the product.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Argotone 0-12 nasal spray stored?\u003c\/h3\u003e\u003cp\u003eStore at a temperature not exceeding 30°C and away from heat sources.\u003cbr\u003eValidity with intact packaging: 24 months.\u003cbr\u003ePost-opening validity: 90 days.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Argotone 0-12 nasal spray?\u003c\/h3\u003e\u003cp\u003e20 ml bottle with nebulizer.\u003c\/p\u003e","brand":"Dompé","offers":[{"title":"Default Title","offer_id":51131381907783,"sku":"981996008","price":12.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/dompe-farmaceutici-spa-argotone-0-12-spray-nasale-farmacia-dottor-tili-1213791711.jpg?v=1767144191"},{"product_id":"rinazina-antiallergica-1mg-ml-spray-nasale-10ml","title":"Antiallergic Rinazine 1mg\/ml nasal spray 10ml","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term symptomatic treatment of allergic rhinitis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e1 bottle contains: Active ingredient: Azelastine hydrochloride 1 mg\/mL Excipients with known effects: benzalkonium chloride For the complete list of excipients, see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypromellose, disodium edetate, \u003cb\u003ebenzalkonium chloride solution\u003c\/b\u003e, anhydrous citric acid, disodium phosphate dodecahydrate, sodium chloride, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1. Children under six years of age. Pregnant and breastfeeding women (see section 4.6)\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOne spray (0.14 mg) dosed in each nostril 1 or 2 times a day, equal to 0.28 - 0.56 mg of azelastine hydrochloride per day. The 5 ml bottle ensures the total delivery of 36 sprays. The 10 ml bottle ensures the total delivery of 72 sprays. During application the head must be kept in an upright position.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not store above 25°C. Store in an upright position. Do not turn upside down.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not use the medicine after 6 months from first opening the vial. This medicinal product contains 0.0175 mg of benzalkonium chloride per single spray, equivalent to 0.125 mg\/ml. Prolonged use of Benzalkonium chloride (BAC) contained as a preservative in RINAZINA ANTIALLERGICA can cause edema of the nasal mucosa. If such a reaction (persistent nasal congestion) is suspected, a medicinal product for nasal use without BAC should be used, if possible. If such medicinal products for nasal use without BAC are not available, another pharmaceutical form should be considered. May cause bronchospasm.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo interactions have been observed with other drugs frequently used at the same time.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA sensation of bitter taste has been described, typical of the drug itself, which can occur above all due to an incorrect position of the head, thrown back, during administration. In rare cases, irritation of the nasal mucosa with possible modest bleeding has been observed. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo cases of poisoning due to overdose have been reported so far. Based on experimental studies, toxic doses can lead to symptoms affecting the central nervous system (malaise, excitement, convulsions, sedation); in these cases symptomatic treatment must be implemented. There is no known specific antidote for azelastine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eRINAZINA ANTIALLERGICA must not be used during pregnancy and breastfeeding (see section 4.3).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo particular negative effects on vigilance are to be expected with the use of RINAZINA ANTIALLERGICA.\u003c\/p\u003e","brand":"Haleon","offers":[{"title":"Default Title","offer_id":51131382825287,"sku":"041174020","price":13.62,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/haleon-italy-srl-rinazina-antiallergica-1mg-ml-spray-nasale-10ml-farmacia-dottor-tili-1213791702.jpg?v=1767144370"},{"product_id":"argotone-1-0-9-20-ml-gocce-nasali-soluzione","title":"Argotone 1% + 0.9% 20 ml nasal drops solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAntiseptic and nasal decongestant.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 ml of solution contains: - Vitellinate silver 1 g - Ephedrine hydrochloride 0.9 g For the complete list of excipients, see paragraph 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Sodium chloride - Anhydrous sodium thiosulphate - Purified water\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active ingredients, to sympathomimetic amines in general or to any of the excipients listed in paragraph 6.1, Heart disease and severe arterial hypertension, Glaucoma, Prostatic hypertrophy, Hyperthyroidism, Pheochromocytoma. Do not administer during or in the two weeks following therapy with monoamine oxidase inhibitors (MAOIs). The drug is contraindicated in children under 12 years of age.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdults and children over 12 years: 3 drops in each nostril 2-3 times a day. Treatment must not be continued for more than 7 days. Carefully follow the recommended doses. A higher dosage of the product, even if taken topically and for a short period of time, can give rise to serious systemic effects.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTHIS MEDICINAL PRODUCT DOES NOT REQUIRE ANY SPECIAL STORAGE CONDITIONS For storage conditions after first opening see section 6.3\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn patients with cardiovascular diseases, and in hypertensive patients, the use of nasal decongestants must be subject to the doctor's judgment from time to time. Cardiovascular effects may be observed with the use of sympathetic mimetic drugs, such as Argotone. There is evidence, from post-marketing data and published literature, of rare cases of myocardial ischemia in association with the use of beta agonists. Patients taking Argotone should be advised to seek medical advice if they experience chest pain or other symptoms of worsening of a pre-existing heart condition. Attention should be paid to the evaluation of symptoms such as dyspnea and chest pain, as they can be of both respiratory and cardiac origin. The prolonged use of vasoconstrictors can alter the normal function of the mucosa of the nose and paranasal sinuses, also inducing addiction to the drug. Repeating applications for longer periods than recommended can, therefore, be harmful. Use with caution in diabetics and, due to the risk of urinary retention, in elderly subjects. The use of topical products, especially if prolonged, can give rise to sensitization phenomena; in this case it is necessary to interrupt treatment and, if necessary, institute appropriate therapy. In the absence of a complete therapeutic response within a few days, consult your doctor; in any case, the treatment must not be continued for more than a week. Carefully follow the recommended doses. The medicine, if accidentally ingested or if used for a long period in excessive doses, can cause toxic phenomena. It should be kept out of the reach of children. It should not be used orally. Avoid contact of the liquid with the eyes.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEphedrine reduces the plasma half-life of corticosteroids. Asthma patients being treated with these drugs should therefore avoid taking ephedrine-based products. Ephedrine contained in ARGOTONE can interact negatively with monoamine oxidase inhibitors (MAOIs). The administration of the product during or in the two weeks following antidepressant drug therapy is consequently contraindicated. Ephedrine may reduce the pharmacological effectiveness of antihypertensive drugs; associated with clonidine, it can cause an increase in norepinephrine levels and an increase in blood pressure with an increased risk of arrhythmias. Urinary excretion of ephedrine is pH dependent; acetazolamide, antacids, ammonium chloride and sodium bicarbonate are able to alkalinize the urine, and consequently slow down the elimination of ephedrine. The contemporary association of ephedrine with digoxin, phenylpropanolamine, cyclopropane and pseudoephedrine is associated with a greater risk of adverse cardiovascular events (increased risk of arrhythmias). Reserpine, causing norepinephrine depletion, may reduce the effectiveness of ephedrine. Theophylline may cause a greater incidence of central and gastrointestinal adverse effects, which occur following the administration of ephedrine. Thyroid hormones: Caution is required in the concomitant use of sympathetic mimetics and thyroid hormones. Volatile anaesthetics: Ephedrine should be avoided in patients undergoing anesthetic treatment with halogenated anaesthetics.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe medicine can cause local sensitization or rebound mucous congestion phenomena. The following side effects have been reported with the use of systemic ephedrine and may occur following the use of ephedrine-based nasal drops. Undesirable effects are described according to system organ class according to MedDRA and on the basis of the frequency estimated from post-marketing experience. Frequencies are defined as follows: very common (≥1\/10); common (≥1\/100, \u003c1\/10); uncommon: (≥1\/1,000, \u003c1\/100); rare (≥1\/10,000, \u003c1\/1000); very rare (\u003c1\/10,000); not known (frequency cannot be estimated from the available data). \u003cb\u003eNervous system disorders\u003c\/b\u003e Not known: Headache, restlessness, insomnia, tolerance \u003cb\u003eCardiac diseases\u003c\/b\u003e Not known: Tachycardia, palpitations, myocardial ischemia \u003cb\u003eVascular pathologies\u003c\/b\u003e Not known: Hypertension \u003cb\u003eRespiratory, thoracic and mediastinal disorders\u003c\/b\u003e Not known: Dyspnoea \u003cb\u003eRenal and urinary disorders\u003c\/b\u003e Not known: Nocturia in patients with prostate hyperplasia, urinary retention \u003cb\u003ePathologies of the skin and subcutaneous tissue\u003c\/b\u003e Not known: Hyperhidrosis, rash \u003cb\u003eImmune system disorders\u003c\/b\u003e Not known: Hypersensitivity \u003cb\u003eReporting of suspected adverse reactions \u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: http:\/\/www.agenziafarmaco.gov.it\/content\/come-segnalare-una-sospetti-reazione-avversa.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn case of overdose (e.g. accidental oral intake), central depression and sedation, i.e. episodes of excitement with agitation, hypertensive crisis and facial congestion, may appear in children.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIt is advisable not to use the drug during pregnancy or while breastfeeding. \u003cb\u003ePregnancy\u003c\/b\u003e Ephedrine crosses the placental barrier and has been associated with increased fetal heart rate. \u003cb\u003eBreastfeeding \u003c\/b\u003e Ephedrine is present in breast milk. The effects on infants are unknown: it has been reported that ephedrine can cause irritability and disturbed sleep in infants when used during breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNot known.\u003c\/p\u003e","brand":"Dompé","offers":[{"title":"Default Title","offer_id":51730202755399,"sku":"003950019","price":8.55,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/dompe-farmaceutici-spa-argotone-1-0-9-20-ml-gocce-nasali-soluzione-farmacia-dottor-tili-1213791444.jpg?v=1767138191"},{"product_id":"narhimed-naso-chiuso-1-mg-ml-10-ml-gocce-nasali-soluzione","title":"Narhimed Blocked Nose 1 mg\/ml 10 ml nasal drops solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDecongestant of the nasal mucosa (in case of colds, hay fever or other allergic rhinitis, sinusitis)\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNARHIMED STUFFED NOSE 1 mg\/ml nasal drops, solution 1 ml of solution contains \u003cstrong\u003eActive ingredient\u003c\/strong\u003e: xylometazoline hydrochloride 1 mg. Each drop delivers 0.025 mg of xylometazoline hydrochloride NARHIMED STUD NOSE 1 mg\/ml nasal spray, solution 1 ml of solution contains: \u003cstrong\u003eActive ingredient\u003c\/strong\u003e: xylometazoline hydrochloride 1 mg Each spray nebulization delivers 0.14 mg of xylometazoline hydrochloride. Excipient with known effects: benzalkonium chloride. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eNasal drops, solution - Nasal spray, solution\u003c\/strong\u003e Sodium dihydrogen phosphate dihydrate; disodium phosphate dodecahydrate; sodium edetate; benzalkonium chloride; sorbitol 70%; hypromellose; sodium chloride; purified water.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hypersensitivity to xylometazoline or to any of the excipients listed in section 6.1. - Closed-angle glaucoma. - Chronic rhinitis. - Patients with dry or atrophic rhinitis. - Pregnancy (see section 4.6). - Children under the age of 12. Like other vasoconstrictors, do not use Narhimed stuffy nose in patients undergoing transsphenoidal hypophysectomy or surgery with exposure of the dura mater.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe use of the medicine is limited to adults and adolescents (aged between 12 and 18 years) \u003cstrong\u003eDosage\u003c\/strong\u003e \u003cstrong\u003eNasal drops, solution\u003c\/strong\u003e Instill 2-3 drops of the solution into each nostril 1-3 times a day, as needed. Do not exceed 3 applications in each nostril per day. \u003cstrong\u003eNasal spray, solution\u003c\/strong\u003e 1 spray of Narhimed stuffy nose spray, 1-3 times a day, as needed. Do not exceed 3 applications in each nostril per day. \u003cstrong\u003eMethod of administration\u003c\/strong\u003e \u003cstrong\u003eNarhimed stuffy nose nasal drops, solution\u003c\/strong\u003e 1) Clean your nose. 2) Recline your head backwards in a comfortable position or, if lying in bed, bend your head to the side. 3) Instill the drops into each nostril and keep your head tilted back for a while to allow the drops to spread into the nose. 4) Immediately after use, clean and dry the dropper before placing it in the bottle. To avoid the possible spread of the infection, the bottle must be used by only one person. \u003cstrong\u003eNarhimed stuffy nose nasal spray, solution with vertically activated nebulization\u003c\/strong\u003e Before the initial application, press the pump by operating it 4 times. Once pressed, the pump will normally remain charged throughout the daily treatment period. The pump will need to be refilled by pressing 4 times if, by fully pressing the nozzle, the spray does not come out or if the product has not been used for more than 7 days. For administration, follow the instructions below, being careful not to spray the spray in the eyes. 1) Clean your nose. 2) Hold the bottle in a vertical position with your thumb under the base and the nozzle between your two fingers 3) Lean forward slightly and insert the nozzle into one nostril. 4) Spray and at the same time breathe gently through your nose. 5) Immediately after use, clean and dry the dispenser before replacing the cap. To avoid the possible spread of infections, each pack of spray should be used by only one person. \u003cstrong\u003eNarhimed stuffy nose\u003c\/strong\u003e \u003cstrong\u003enasal spray, solution with nebulization activated by a side button\u003c\/strong\u003e The dosing spray operated with a side button allows for accurate dosing and ensures that the solution is well distributed on the surface of the nasal mucosa by finely nebulising the spray. It's easy to use. The protective cap is childproof and suitable for the elderly. Upon first use, press the side button 5 times, without introducing it into the nostrils. Once activated, the device will remain charged throughout the regular treatment period. The device will need to be recharged by pressing twice if, at the end of the activation phase, the spray does not come out or if the product has not been used for more than 7 days. Be careful not to spray into eyes. To remove the protective cap, press on the two marks and rotate. 1) Clean your nose. 2) Hold the bottle upright with your thumb on the side button. 3) Insert the nozzle into the nostril while remaining in a vertical position to prevent the spray from dripping into the throat. 4) Press the side button to spray and at the same time inhale gently through your nose. Repeat in the other nostril (steps 1 to 4). 5) After each use, clean and dry the nozzle 6) Replace the protective cap until you hear a \"click\". Each metered spray delivers 0.14 ml of solution (0.14 mg xylometazoline hydrochloride). \u003cstrong\u003ePediatric population\u003c\/strong\u003e The medicine must not be used in children under 12 years of age (see also section 4.3).\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eStore below 30°C. Store in the original packaging.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNarhimed stuffy nose, like other sympathomimetic agents, should be used with caution in patients who show a strong reaction to adrenergic substances manifested by signs of insomnia, dizziness, tremor, cardiac arrhythmia, or elevated blood pressure. Like other vasoconstrictors for local use, Narhimed stuffy nose should not be used for more than 7 consecutive days: prolonged or excessive use may cause rebound congestion and\/or atrophy of the nasal mucosa. Do not exceed the indicated doses, especially in the elderly. Caution is recommended in patients with hypertension, cardiovascular disease, hyperthyroidism or diabetes mellitus, pheochromocytoma as well as in patients with prostatic hypertrophy and in patients treated with monoamine oxidase inhibitors (MAOIs) or who have taken them in the last two weeks (see section 4.5). Patients with long QT syndrome treated with xylometazoline may be at increased risk of serious ventricular arrhythmias. \u003cstrong\u003eImportant information about some excipients\u003c\/strong\u003e Narhimed stuffy nose contains benzalkonium chloride (BAC) as a preservative which, especially when used for long periods, may cause swelling of the nasal mucosa. If such a reaction (persistent nasal congestion) is suspected, a medicinal product for nasal use without benzalkonium chloride should be used, if possible. If such medicinal products for nasal use without benzalkonium chloride are not available, another pharmaceutical form should be considered. May cause bronchospasm.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eMonoamine oxidase inhibitors (MAOIs)\u003c\/strong\u003e: xylometazoline can potentiate the action of monoamine oxidase inhibitors and can cause hypertensive crises. Xylometazoline is not recommended in patients who are taking or have taken MAOIs in the last two weeks (see section 4.4). \u003cstrong\u003eTricyclic and tetracyclic antidepressants\u003c\/strong\u003e: Concomitant use of tricyclic and tetracyclic antidepressants and sympathomimetics may reinforce the sympathomimetic effect of xylometazoline and is therefore not recommended.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdverse reactions are listed by system organ class and frequency. Frequencies are defined as: very common (≥1\/10); common (≥1\/100 to \u003c1\/10); uncommon (≥ 1\/1,000 to \u003c 1\/100); rare (≥ 1\/10,000 to \u003c 1\/1,000) or very rare (\u003c 1\/10,000). Within each frequency class, undesirable effects are presented in order of decreasing seriousness.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders.\u003c\/p\u003e\n\u003cp\u003eVery rare: Hypersensitivity reactions (angioedema, rash, pruritus).\u003c\/p\u003e\n\u003cp\u003eNervous system disorders.\u003c\/p\u003e\n\u003cp\u003eCommon: Headache.\u003c\/p\u003e\n\u003cp\u003eEye pathologies.\u003c\/p\u003e\n\u003cp\u003eVery rare: Transient visual disturbances.\u003c\/p\u003e\n\u003cp\u003eCardiac diseases.\u003c\/p\u003e\n\u003cp\u003eVery rare: Irregular heart rate and increased heart rate.\u003c\/p\u003e\n\u003cp\u003eRespiratory, thoracic and mediastinal disorders.\u003c\/p\u003e\n\u003cp\u003eCommon: Nasal dryness or discomfort.\u003c\/p\u003e\n\u003cp\u003eUncommon: Epistaxis.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eCommon: Nausea.\u003c\/p\u003e\n\u003cp\u003eSystemic pathologies and conditions relating to the administration site.\u003c\/p\u003e\n\u003cp\u003eCommon: Burning at the application site.\u003c\/p\u003e\n\u003cp\u003eOther side effects noted: arterial hypertension, reflex bradycardia, urination disorders, insomnia and restlessness. \u003cstrong\u003eReporting of suspected adverse reactions\u003c\/strong\u003e. Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn case of overdose, severe dizziness, sweating, severe drop in body temperature, bradycardia, arterial hypertension, tachycardia, photophobia, intense headache, chest tightness, coma and convulsions may appear and, in children, hypothermia and severe depression of the central nervous system with marked sedation which require the adoption of adequate emergency measures. In case of excessive instillation of the product into the nose and paranasal sinuses, rinse the nasal cavities repeatedly with warm isotonic saline solution, advising the patient not to ingest this solution. If the patient is unconscious, take care that this solution is not ingested during the washing maneuvers. Symptomatic treatment under medical supervision is indicated. This includes observation of the individual for several hours. In the case of a large overdose with cardiac arrest, resuscitation must continue for at least 1 hour.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePregnancy\u003c\/strong\u003e In view of its potential systemic vasoconstrictor effect, it is advisable to take the precaution of not using Narhimed stuffy nose during pregnancy. \u003cstrong\u003eBreastfeeding\u003c\/strong\u003e There is no evidence of adverse effects on the breast-fed infant. However, it is not known whether xylometazoline is excreted in breast milk, therefore caution should be used and Narhimed stuffy nose should be used during breastfeeding only under medical advice. \u003cstrong\u003eFertility\u003c\/strong\u003e There are no adequate data regarding the effects of Narhimed stuffy nose on fertility and no animal studies are available. Since systemic exposure to xylometazoline hydrochloride is very low, effects on fertility are therefore very unlikely.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNarhimed stuffy nose does not alter or negligibly alters the ability to drive vehicles and use machinery. However, patients in whom vision disturbances, dizziness, vertigo, or other central nervous system disorders have occurred with the use of xylometazoline should refrain from driving vehicles or using machinery requiring an intact level of alertness.\u003c\/p\u003e","brand":"Haleon","offers":[{"title":"Default Title","offer_id":51730207080775,"sku":"015598016","price":10.59,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/haleon-italy-srl-narhimed-naso-chiuso-1-mg-ml-10-ml-gocce-nasali-soluzione-farmacia-dottor-tili-1213791101.jpg?v=1767140198"},{"product_id":"aspirina-influenza-e-naso-chiuso-500-mg-30-mg-10-bustine-granulato-per-soluzione-orale","title":"Aspirin flu and stuffy nose 500 mg + 30 mg 10 sachets granules for oral solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of nasal and sinus congestion (rhinosinusitis) with painful and feverish states associated with flu and\/or cold symptoms. Aspirin flu and stuffy nose is indicated for adults and adolescents aged 16 and over.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach sachet contains 500 mg of acetylsalicylic acid and 30 mg of pseudoephedrine hydrochloride \u003cu\u003eExcipients with known effects: \u003c\/u\u003e Each sachet contains 2g of sucrose. Each sachet contains 3.78 mg of benzyl alcohol. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCitric acid Sucrose Hypromellose Saccharin Orange flavor containing benzyl alcohol, acetic acid, alpha tocopherol, modified starch E1450 and maltodextrin\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hypersensitivity to pseudoephedrine, acetylsalicylic acid or other salicylates, or to any of the excipients listed in paragraph 6.1; - History of asthma induced by the administration of salicylates or substances with a similar action, in particular non-steroidal anti-inflammatory drugs; - Acute gastrointestinal ulcers; - Hemorrhagic diathesis; - Pregnancy; - Breastfeeding; - Severe liver failure; - Severe renal failure; - Severe heart failure; - In combination with methotrexate used in doses of 15 mg\/week or higher (see section 4.5); - Severe hypertension; - Severe coronary artery disease; - Treatment with monoamine oxidase inhibitor medicinal products in the previous two weeks. - Narrow angle glaucoma - Urinary retention\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e The contents of 1-2 sachets for adults and adolescents from 16 years. If necessary, the single dose can be repeated after a period of at least 4 hours. Do not exceed the maximum daily dose of 6 sachets. If one of the symptoms prevails, treatment with a single active ingredient is more appropriate. Aspirin flu and stuffy nose should not be taken for more than 3 days without first consulting a doctor. \u003ci\u003ePediatric population\u003c\/i\u003e Aspirin flu and stuffy nose should not be taken by children and adolescents under the age of 16 without consulting your doctor. Given the limited experience of using Aspirin for flu and stuffy nose in children and adolescents, it is not possible to indicate a specific recommended dose. Patients with impaired hepatic function Acetylsalicylic acid should be used with caution in patients with impaired hepatic function (see section 4.4) Patients with impaired renal function Acetylsalicylic acid should be used with caution in patients with impaired renal function or impaired cardiovascular circulation (see section 4.4.) \u003cu\u003eMethod of administration\u003c\/u\u003e Aspirin flu and stuffy nose must be dissolved in a glass of water before taking. The suspension that forms has an orange flavour.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDo not store above 30°C.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Concomitant treatment with anticoagulants (see section 4.5); - History of gastrointestinal ulcers including chronic or relapsing ulcer disease or history of gastrointestinal bleeding; - Patients with impaired renal function or impaired cardiovascular function (e.g. renal vascular disease, congestive heart failure, volume depletion, major surgery, sepsis or major bleeding events), as the medicinal product may further increase the risk of renal damage and acute renal failure; - Impaired liver function; - Renal tubular acidosis due to accumulation of pseudoephedrine and increased risk of side effects - Hypersensitivity to analgesics \/ anti-inflammatory or antirheumatic drugs or other allergens; - Hyperthyroidism, mild to moderate hypertension, diabetes mellitus, ischemic heart disease, elevated intraocular pressure (glaucoma), prostatic hypertrophy, or sensitivity to sympathomimetic agents; - Elderly patients may be particularly sensitive to the effects of pseudoephedrine on the central nervous system. Acetylsalicylic acid may accelerate bronchospasm and induce asthma attacks or other hypersensitivity reactions. The following existing conditions represent risk factors: bronchial asthma, allergic rhinitis (hay fever), nasal polyps or chronic respiratory disease. This also applies to patients who have allergic reactions (e.g. skin reactions, itching, hives) to other substances. Given its inhibitory effect on platelet aggregation which continues for several days after administration, acetylsalicylic acid may lead to an increased tendency for the development of bleeding during and after surgical procedures (including minor procedures such as tooth extractions). In limited doses, acetylsalicylic acid reduces the excretion of uric acid. This can cause gout in patients who already tend to have limited uric acid excretion. Habitual use of analgesics (particularly the combination of several analgesic medicines) can permanently damage the kidneys (analgesic nephropathy). One sachet of Aspirin flu and stuffy nose contains 2 g of sucrose (the equivalent of 0.17 carbohydrate units). This must be taken into consideration in patients with diabetes mellitus. Patients with rare hereditary problems of fructose intolerance, glucose-galactose malabsorption or sucrase-isomaltase insufficiency should not take this medicine. Aspirin flu and stuffy nose contains 3.78 mg of benzyl alcohol in each sachet. Benzyl alcohol can cause allergic reactions. Patients with liver or kidney disease should contact their doctor, since large quantities of benzyl alcohol can cause metabolic acidosis. In patients with severe glucose-6-phosphate dehydrogenase (G6DP) deficiency, acetylsalicylic acid may induce hemolysis or hemolytic anemia. Factors that may increase the risk of hemolysis are, for example, high dosage, influenza or acute infections. \u003cb\u003eSevere skin reactions\u003c\/b\u003e Serious skin reactions such as acute generalized exanthematous pustulosis (AGEP) may occur with products containing pseudoephedrine. This acute pustular eruption may occur within the first 2 days of treatment, with fever and numerous, small, mostly non-follicular pustules resulting from a widespread edematous erythema and localized mainly on the skin folds, trunk and upper limbs. Patients should be carefully monitored. If signs and symptoms such as pyrexia, erythema or numerous small pustules are observed, the administration of Aspirin flu and stuffy nose should be stopped and appropriate measures should be taken if necessary. \u003cb\u003eIschemic colitis\u003c\/b\u003e There have been reports of ischemic colitis with the use of pseudoephedrine. Use of pseudoephedrine should be discontinued immediately and medical advice should be sought if abdominal pain, rectal bleeding or other symptoms of ischemic colitis suddenly occur. Ischemic optic neuropathy Cases of ischemic optic neuropathy have been reported with pseudoephedrine. Pseudoephedrine should be discontinued if sudden loss of vision or reduction in visual acuity occurs, for example in the case of a scotoma. Athletes should be aware that by taking this drug they may test positive for anti-doping.\u003cu\u003ePediatric population\u003c\/u\u003e There is a possible association between acetylsalicylic acid and Reye's syndrome, when administered to children and adolescents for the treatment of viral infections, with or without influenza. For this reason, Aspirin flu and stuffy nose should not be taken by children and adolescents under the age of 16 without consulting your doctor.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eContraindicated combinations (see section 4.3):\u003c\/u\u003e Methotrexate used at doses of 15 mg\/week. or higher: Increased haematological toxicity of methotrexate (decrease in renal clearance of methotrexate by anti-inflammatory agents in general and dislocation of methotrexate from binding sites with plasma proteins caused by salicylates). Monoamine oxidase inhibitors (MAOIs), in the previous 2 weeks, increase the risk of adverse cardiovascular events (e.g. arrhythmia, hypertensive crisis). \u003cu\u003eCombinations that require precautions for use:\u003c\/u\u003e Methotrexate, used at doses lower than 15 mg\/week: Increased haematological toxicity of methotrexate (decrease in renal clearance of methotrexate due to anti-inflammatory agents in general and dislocation of methotrexate from binding sites with plasma proteins caused by salicylates). Anticoagulants, thrombolytics or other inhibitors of platelet aggregation\/haemostasis: Increased risk of haemorrhage. Other non-steroidal anti-inflammatory drugs with salicylates: Increased risk of ulcers and gastrointestinal bleeding due to synergistic effect. Selective serotonin reuptake inhibitors (SSRIs): Increased risk of upper gastrointestinal bleeding due to possible synergistic effect. Digoxin: Plasma concentrations of digoxin are increased due to reduced excretion of this agent by the kidneys. Antidiabetics, e.g. insulin, sulfonylureas: Increased hypoglycemic effect caused by high doses of acetylsalicylic acid through the hypoglycemic action of the latter and the dislocation of the sulfonylurea from the binding sites with plasma proteins. Diuretics in combination with acetylsalicylic acid: Reduction of glomerular filtration due to the limitation of the synthesis of prostaglandins at the kidney level. Systemic glucocorticoids, except hydrocortisone used as replacement therapy in Addison's disease: Reduction in blood levels of salicylates during treatment with corticosteroids and risk of salicylate overdose after discontinuation of this treatment due to increased elimination of salicylates by corticosteroids. Angiotensin converting enzyme (ACE) inhibitors in combination with acetylsalicylic acid: Reduction of glomerular filtration caused by inhibition of vasodilatory prostaglandins. Furthermore, limitation of the antihypertensive effect. Valproic acid: Increased toxicity of valproic acid due to dislocation from protein binding sites. Alcohol: Increased damage to the gastrointestinal mucosa and prolonged bleeding time due to the additive effects of acetylsalicylic acid and alcohol. Uricosurics such as benzbromarone, probenecid: Limitation of the uricosuric effect (antagonism with the elimination of uric acid at the level of the renal tubules). Salbutamol tablets: Increased effects (worsening cardiovascular side effects); this does not preclude the judicious use of an adrenergic bronchodilator aerosol. Antidepressants: Increased effects. Other sympathomimetic medicinal products: Increased effects. Medicines against hypertension, such as guanethidine, methyldopa, beta blockers: Reduction of effects.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFrequencies: not known (cannot be estimated from available data). Possible side effects of acetylsalicylic acid: Immune system disorders Hypersensitivity reactions, with their respective clinical and laboratory manifestations, include respiratory disease exacerbated by acetylsalicylic acid, mild to moderate reactions potentially affecting the skin, respiratory tract, gastrointestinal tract and cardiovascular system, which include symptoms such as rash, urticaria, edema, pruritus, rhinitis, nasal congestion, cardiorespiratory distress and, very rarely, serious reactions, including anaphylactic shock. Gastrointestinal disorders Gastroduodenal disorders (gastralgia, dyspepsia, gastritis); Nausea, vomiting, diarrhea; Gastrointestinal ulcers, which can lead to perforation in isolated cases. Disease of the intestinal diaphragms (especially in long-term treatment). Hepatobiliary disorders Transient hepatic impairment with increased transaminases. Blood and lymphatic system disorders Increased risk of bleeding, haemorrhage such as procedural haemorrhage, haematomas, epistaxis, urogenital haemorrhage and gum bleeding. Hemolysis and hemolytic anemia have been reported in patients with severe forms of glucose-6-phosphate dehydrogenase (G6PD) deficiency; Hemorrhage can cause hemorrhagic anemia\/iron deficiency anemia (e.g. due to occult microbleeds) with related clinical and laboratory signs and symptoms, such as asthenia, pallor, hypoperfusion. Nervous system disorders Overdose may cause dizziness. Ear and labyrinth disorders Overdose may cause tinnitus. Renal and urinary tract disorders Renal damage and acute renal failure have been reported. Possible side effects of pseudoephedrine: Vascular disorders Redness; Increased blood pressure, although not affecting controlled hypertension. Cardiac disorders Cardiac effects (e.g. tachycardia, palpitations, arrhythmias). Nervous system disorders Central nervous system stimulation (e.g. insomnia, rarely hallucinations). Kidney and urinary tract disorders Urinary retention, especially in patients with prostatic hyperplasia. Skin and subcutaneous tissue disorders Effects on the skin (e.g. rash, urticaria, itching). Severe skin reactions, including acute generalized exanthematous pustulosis (AGEP). Gastrointestinal disorders Ischemic colitis. Dry mouth. Eye disorders. Ischemic optic neuropathy. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAcetylsalicylic acid: There is a difference between chronic overdose, which mainly causes central nervous system disorders (\"salicylism\"), and acute intoxication, which essentially manifests itself through a serious imbalance in the acid-base balance. In addition to acid-base and electrolyte imbalances (e.g., potassium loss), hypoglycemia, skin rashes, and gastrointestinal bleeding, symptoms may include hyperventilation, tinnitus, nausea, vomiting, decreased vision and hearing, headache, dizziness, and confusion. In severe poisoning, delirium, tremor, dyspnea, sweating, dehydration, hyperthermia and coma may occur. In poisonings with lethal consequences, death occurs due to respiratory failure. Pseudoephedrine: Abnormal sympathomimetic reactions may occur, e.g. tachycardia, chest pain, agitation, hypertension, breathlessness, shortness of breath, convulsions, hallucinations, following intoxication. The methods used to treat Aspirin poisoning, flu and stuffy nose depend on the extent, stage and clinical symptoms of the poisoning. They correspond to the measures usually adopted to reduce the absorption of an active ingredient: accelerating excretion, monitoring water and electrolyte balance, disturbances in temperature regulation, breathing and cardiovascular and brain functions. Immediate medical intervention is essential, even in the absence of obvious symptoms.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e As no data is available on the combination of the two substances, the use of Aspirin for flu and stuffy nose is contraindicated during pregnancy. Inhibition of prostaglandin synthesis may have adverse effects on pregnancy and\/or embryo-foetal development. Data from epidemiological studies suggest an increased risk of miscarriage and cardiac malformations and gastroschisis following the use of prostaglandin synthesis inhibitors in early pregnancy. The absolute risk of cardiovascular malformation increased from less than 1% to approximately 1.5%. This risk is thought to increase with dose and duration of therapy. In animals, it has been shown that the administration of a prostaglandin synthesis inhibitor causes an increase in pre- and post-implantation embryo loss and embryo-foetal lethality. Furthermore, an increased incidence of various malformations, including cardiovascular ones, has been reported in animals administered a prostaglandin synthesis inhibitor during the organogenetic period. During the first and second trimester of pregnancy, acetylsalicylic acid should not be administered unless absolutely necessary. If acetylsalicylic acid is used by a woman who plans to become pregnant, or during the first and second trimester of pregnancy, the dose should be as low as possible and the duration of treatment as short as possible. During the third trimester of pregnancy, all inhibitors of prostaglandin synthesis can expose the fetus to: - cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension); - renal dysfunction, which can evolve into renal failure with oligohydramniosis. The mother and the newborn, at the end of pregnancy, are exposed to: - possible prolongation of the bleeding time, anti-aggregating effect which can occur even at very low doses; - inhibition of uterine contractions which determines the delay or prolongation of labor. Therefore, the medicine is contraindicated in the third trimester of pregnancy. The limited data available on the use of pseudoephedrine during pregnancy does not show an increased risk of malformations. However, the use of pseudoephedrine during pregnancy is not recommended. In animal studies both active substances showed reproductive toxicity (see section 5.3). \u003cu\u003eBreastfeeding\u003c\/u\u003e Both salicylates and pseudoephedrine pass into breast milk in small quantities. As there is no data available on the combination of the two substances, the use of Aspirin flu and stuffy nose is contraindicated during breastfeeding. \u003cu\u003eFertility\u003c\/u\u003e There is some evidence that drugs that inhibit prostaglandin synthesis may cause impairment of female fertility through an effect on ovulation. This is reversible upon discontinuation of treatment. Animal studies have shown adverse effects on male and female fertility (see section 5.3)\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAspirin flu and stuffy nose causes mild to moderate changes in the ability to drive or use machinery. The risk could increase in case of concomitant alcohol intake.\u003c\/p\u003e","brand":"Bayer","offers":[{"title":"Default Title","offer_id":51730207342919,"sku":"046967016","price":9.26,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/bayer-spa-aspirina-influenza-e-naso-chiuso-500-mg-30-mg-10-bustine-granulato-per-soluzione-orale-farmacia-dottor-tili-1213791096.jpg?v=1767140329"},{"product_id":"tachiflutask-600-mg-10-mg-10-bustine-granulato-per-soluzione-orale","title":"Tachiflutask 600 mg + 10 mg 10 sachets granules for oral solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eShort-term treatment of cold and flu symptoms, including mild\/moderate pain and fever, when associated with nasal congestion.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eEach sachet contains: Active ingredients: paracetamol 600 mg and phenylephrine hydrochloride 10 mg (equal to phenylephrine 8.2 mg). Each sachet contains sorbitol (E 420) 42 mg, aspartame (E 951) 25 mg. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eMannitol (E 421), Xylitab 200 (xylitol, carboxymethylcellulose), lemon flavouring, sorbitol (E 420) ascorbic acid, citric acid, hydrated colloidal silica, aspartame (E 951) sodium saccharin.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Children under the age of 12. - Hypersensitivity to the active substances or to any of the excipients (listed in paragraph 6.1). - Patients taking beta-blockers. - Patients taking tricyclic antidepressants and those taking or have taken in the last 2 weeks monoamine oxidase inhibitors. - Patients with bronchial asthma, pheochromocytoma, narrow-angle glaucoma, or who simultaneously take other sympathetic mimetic medicinal products (such as decongestants, appetite suppressants and amphetamine-like psychostimulants). Patients suffering from liver or kidney failure, diabetes, hyperthyroidism, hypertension and cardiovascular diseases. - Paracetamol-based products are contraindicated in patients with manifest insufficiency of glucose-6-phosphate dehydrogenase and in those suffering from severe hemolytic anemia. - Severe hepatocellular insufficiency.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e \u003ci\u003eAdults and children over 12 years:\u003c\/i\u003e 1 sachet every 4-6 hours and up to a maximum of 3 sachets in 24 hours. The medicine should not be used for more than 3 consecutive days without consulting your doctor. \u003ci\u003ePediatric population\u003c\/i\u003e \u003ci\u003eChildren under 12 years:\u003c\/i\u003e TACHIFLUTASK is contraindicated in children under 12 years of age (see section 4.3). \u003cu\u003eMethod of administration\u003c\/u\u003e Place the granules directly on the tongue and swallow. TACHIFLUTASK dissolves with saliva: this allows it to be used without water. The contents of the sachet can also be dissolved in a glass of hot (not boiling) water, mixing with a teaspoon. If desired, dilute with cold water to cool and sweeten. Once prepared, the solution obtained should be drunk within a few minutes.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicine does not require any particular storage temperature. Store in the original container to protect the medicine from moisture and light.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePatients should be advised not to take other medicines containing paracetamol while taking TACHIFLUTASK as high doses of paracetamol may cause serious adverse reactions. Avoid alcohol consumption during treatment with TACHIFLUTASK. The danger of overdose is in fact greater in patients with liver problems. Invite the patient to contact the doctor before combining warfarin or any other drug (see also section 4.5). The use of the product is not recommended if the patient is being treated with anti-inflammatories. Caution is advised if acetaminophen is administered concurrently with flucloxacillin due to the increased risk of high anion gap metabolic acidosis (HAGMA), particularly in patients with severe renal impairment, sepsis, malnutrition, and other sources of glutathione deficiency (e.g., chronic alcoholism), as well as in those using maximum daily doses of acetaminophen. Close monitoring, including measurement of urinary 5-oxoproline, is recommended. Consult your doctor before using the product in patients with enlarged prostate gland or occlusive vascular disease (e.g. Raynaud's syndrome). Do not exceed the recommended dose and do not administer for more than 3 consecutive days. TACHIFLUTASK contains aspartame: this substance can be harmful to subjects suffering from phenylketonuria. TACHIFLUTASK contains less than 1 mmol (23 mg) sodium per tablet, i.e. it is essentially sodium-free.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eParacetamol\u003c\/i\u003e The hepatotoxic effect of paracetamol can be potentiated by the intake of other drugs active on the liver such as zidovudine and isoniazid which can produce an inhibition of the metabolism of paracetamol. The administration of probenecid before paracetamol decreases the clearance of paracetamol and the urinary elimination of paracetamol sulphate and paracetamol glucuronide, and increases the half-life of paracetamol itself. Use with extreme caution and under strict control during chronic treatment with drugs that can cause the induction of hepatic monooxygenases or in case of exposure to substances that can have this effect (for example rifampicin, cimetidine, antiepileptics such as glutetimide, phenobarbital, carbamazepine). Paracetamol increases the half-life of chloramphenicol. The product taken in high doses can enhance the effect of coumarin anticoagulants (warfarin). Metoclopramide and domperidone can increase the absorption of paracetamol, while it is reduced or delayed by cholestyramine and anticholinergics respectively. Caution should be exercised when paracetamol is used concomitantly with flucloxacillin as concomitant use has been associated with high anion gap metabolic acidosis, especially in patients with risk factors (see section 4.4). \u003ci\u003ePhenylephrine\u003c\/i\u003e Phenylephrine can antagonize the effect of beta-blocking and antihypertensive drugs (including debrisoquine, guanethidine, reserpine and methyldopa) and can potentiate the action of monoamine oxidase inhibitors (see section 4.3). The simultaneous use of phenylephrine with tricyclic antidepressants or sympathomimetic amines may increase the risk of cardiovascular effects. Phenylephrine can interact with digoxin and cardiac glycosides, increasing the risk of arrhythmia or heart attack, and with alkaloids (ergotamine and methylsergide), increasing the risk of ergotism. \u003ci\u003eInterference with some laboratory tests\u003c\/i\u003e The administration of paracetamol can interfere with the determination of uric acid (using the phosphotungstic acid method) and with that of blood sugar (using the glucose-oxidase-peroxidase method).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following are the side effects organized according to the MedDRA System Organ classification. The frequency is defined as follows: very common (≥1\/10), common (≥1\/100 to \u003c1\/10), uncommon (≥1\/1000 to \u003c1\/100), rare (≥1\/10,000 to \u003c1\/1000), very rare (\u003c1\/10,000), not known (the frequency cannot be estimated from the available data).\u003c\/p\u003e\n\u003cp\u003eBlood and lymphatic system disorders - Frequency: Rare. Side effect: Agranulocytosis¹, leukopenia¹, thrombocytopenia¹\u003c\/p\u003e\n\u003cp\u003eBlood and lymphatic system disorders - Frequency: Not known. Side effect: Anemia¹\u003c\/p\u003e\n\u003cp\u003eImmune system disorders - Frequency: Rare. Side effect: Allergic reactions1,2, hypersensitivity reactions1,2, anaphylaxis1,2.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders - Frequency: Not known. Side effect: Anaphylactic shock1,2.\u003c\/p\u003e\n\u003cp\u003eMetabolism and nutrition disorders - Frequency: Common. Side effect: Anorexia²\u003c\/p\u003e\n\u003cp\u003ePsychiatric disorders - Frequency: Very rare. Side effect: Insomnia², nervousness², anxiety², restlessness², confusion², irritability22.\u003c\/p\u003e\n\u003cp\u003eNervous system disorders - Frequency: Very rare. Side effect: Tremor², dizziness², headache²\u003c\/p\u003e\n\u003cp\u003eEye disorders - Frequency: Not known. Side effect: Mydriasis², acute angle-closure glaucoma²\u003c\/p\u003e\n\u003cp\u003eCardiac disorders - Frequency: Rare. Side effect: Tachycardia², palpitations²\u003c\/p\u003e\n\u003cp\u003eVascular disorders - Frequency: Not known. Side effect: Hypertension²\u003c\/p\u003e\n\u003cp\u003eRespiratory, thoracic and mediastinal disorders - Frequency: Rare. Side effect: Bronchospasm1,2.\u003c\/p\u003e\n\u003cp\u003eRespiratory, thoracic and mediastinal disorders - Frequency: Not known. Side effect: Edema of the larynx¹\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Frequency: Common. Side effect: Nausea², vomiting²\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders - Frequency: Not known. Side effect: Diarrhoea¹, gastrointestinal disease¹\u003c\/p\u003e\n\u003cp\u003eHepatobiliary disorders - Frequency: Rare. Side effect: Abnormal liver function¹\u003c\/p\u003e\n\u003cp\u003eHepatobiliary disorders - Frequency: Not known. Side effect: Liver disease¹, hepatitis¹\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders - Frequency: Rare. Side effect: Skin rash1,2, angioedema²\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders - Frequency: Not known. Side effect: Toxic epidermal necrolysis¹, Steven Johnson Syndrome¹, erythema multiforme or polymorph¹\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders - Frequency: Very rare. Side effect: Tubulointerstitial nephritis (after prolonged use of paracetamol at high doses)¹\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders - Frequency: Not known. Side effect: Aggravated renal failure¹, haematuria¹, anuria¹ urine retention.\u003c\/p\u003e\n\u003cp\u003e¹ Side effects associated with paracetamol ² Side effects associated with phenylephrine Very rare cases of serious skin reactions have been reported. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse\u003cu\u003e .\u003c\/u\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eParacetamol\u003c\/i\u003e At the recommended doses, or even if you were to take the entire pack, no symptoms of paracetamol overdose should appear. However, in case of ingestion of very high doses of paracetamol (greater than 10 g), the most commonly encountered complication is liver damage, which generally occurs 12-48 hours after ingestion. \u003cu\u003eRisk factors\u003c\/u\u003e • Long-term treatment with carbamazepine, phenobarbital, phenytoin, primidone, rifampicin, St. John's wort or other liver enzyme-inducing drugs; • Regular consumption of ethanol in quantities higher than recommended; • Glutathione depletion (e.g. eating disorders, cystic fibrosis, HIV infection, starvation, cachexia). \u003cu\u003eSymptoms\u003c\/u\u003e Early symptoms of paracetamol overdose in the first 24 hours are paleness, nausea, vomiting, anorexia and abdominal pain. Abnormalities of glucose metabolism and metabolic acidosis may occur. In severe poisoning, liver failure may progress to encephalopathy, hemorrhage, hypoglycemia, brain edema, and death. Even in the absence of severe liver damage, acute renal failure with acute tubular necrosis, strongly suggested by flank pain, hematuria, and proteinuria can develop, even in the absence of severe liver damage. Cardiac arrhythmias and pancreatitis have been reported. \u003cu\u003eTreatment\u003c\/u\u003e In the management of paracetamol overdose, immediate treatment is essential. Despite a lack of significant initial symptoms, patients should be referred to hospital urgently for immediate medical attention. Symptoms may be limited to nausea or vomiting and may not reflect the severity of the overdose or the risk of organ damage. Management must be in accordance with treatment guidelines. If overdose has occurred within 1 hour, treatment with activated charcoal should be considered. Paracetamol plasma concentration should be measured 4 or more hours after ingestion (initial concentrations are not reliable). Treatment with N-acetylcysteine ​​can be used up to 24 hours after ingestion of paracetamol, however, the maximum protective effect is achieved up to 8 hours after ingestion. The effectiveness of the antidote declines sharply after this period. If necessary, the patient should be administered N-acetylcysteine ​​intravenously, in line with the established dosing regimen. If vomiting is not a problem, oral methionine may be a suitable alternative in more remote areas, outside of hospital. Management of patients who present with severe hepatic dysfunction more than 24 hours after ingestion should be discussed with the National Poison Control Center or liver unit. \u003ci\u003ePhenylephrine\u003c\/i\u003e \u003cu\u003eSymptoms\u003c\/u\u003e Symptoms of overdose caused by phenylephrine are irritability, headache and increased blood pressure. In more serious cases, confusion, hallucinations, convulsions and arrhythmias may occur. However, the amount needed to produce severe phenylephrine toxicity would be greater than that related to acetaminophen. \u003cu\u003eTreatment\u003c\/u\u003e Treatment must be clinically appropriate. Severe hypertension should be treated with alpha blocker drugs such as phentolamine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e \u003ci\u003eParacetamol\u003c\/i\u003e A large amount of data on pregnant women indicates neither malformation nor fetal\/neonatal toxicity. Epidemiological studies on neurodevelopment in children exposed to paracetamol in utero show inconclusive results. If clinically necessary, paracetamol can be used during pregnancy, however it should be used at the lowest effective dose for the shortest possible time and with the lowest possible frequency. The administration of the preparation during pregnancy and breastfeeding must take place under the direct supervision of a doctor. \u003ci\u003ePhenylephrine\u003c\/i\u003e Data regarding the use of phenylephrine in pregnancy are limited. Vasoconstriction of the uterine vessels and reduction of blood flow to the uterus associated with the use of phenylephrine may result in fetal hypoxia. The use of phenylephrine during pregnancy should be avoided as further information is needed. \u003cu\u003eBreastfeeding\u003c\/u\u003e \u003ci\u003eParacetamol\u003c\/i\u003e Paracetamol is excreted in breast milk but in clinically insignificant quantities. The available published data do not contraindicate its use during breastfeeding. \u003ci\u003ePhenylephrine\u003c\/i\u003e No data are available regarding the excretion of phenylephrine in breast milk, nor is there information regarding the effects of phenylephrine on breast-fed infants. In the absence of available data, the use of phenylephrine should be avoided during breastfeeding. \u003cu\u003eFertility\u003c\/u\u003e There is no evidence in non-clinical studies indicating effects of paracetamol on male and female fertility at doses commonly used in clinic. The effect of phenylephrine on male and female fertility has not been studied.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTACHIFLUTASK does not affect the ability to drive or use machines. However, patients should be advised not to drive or operate machines if they feel dizzy.\u003c\/p\u003e","brand":"Angelini Pharma","offers":[{"title":"Default Title","offer_id":51730208194887,"sku":"047430018","price":9.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/angelini-pharma-italia-spa-tachiflutask-600-mg-10-mg-10-bustine-granulato-per-soluzione-orale-farmacia-dottor-tili-1213791080.jpg?v=1767154212"},{"product_id":"reactine-5-mg-120-mg-6-compresse-rilascio-prolungato","title":"Reactine 5 mg + 120 mg 6 prolonged release tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eREACTINE is indicated in the short-term symptomatic treatment of seasonal and\/or perennial allergic rhinitis with nasal congestion and hypersecretion, nasal and\/or ocular itching, sneezing and tearing.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOne tablet contains: • active ingredient: - cetirizine dihydrochloride 5 mg; - pseudoephedrine hydrochloride 120 mg. • excipient with known effects: lactose, sodium. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eFirst layer excipients\u003c\/i\u003e Hypromellose, microcrystalline cellulose, anhydrous colloidal silica, magnesium stearate. \u003ci\u003eSecond layer excipients \u003c\/i\u003e Lactose, microcrystalline cellulose, crosscaramellose sodium, colloidal anhydrous silica, magnesium stearate. \u003ci\u003eCoating excipients \u003c\/i\u003e Opadry Y-1-7000 white (methocel E5, premium (hypromellose) (E 464), titanium dioxide (E 171), macrogol 400).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eREACTINE is contraindicated in the following cases: • hypersensitivity to the active ingredients, to any of the excipients listed in paragraph 6.1, to hydroxyzine or piperazine derivatives; • severe renal insufficiency (patients with creatinine clearance less than 10 ml\/min); • severe hypertension; • severe coronary heart disease; • pheochromocytoma; • history of stroke; • high risk of developing hemorrhagic stroke; • serious arrhythmia; • uncontrolled hyperthyroidism; • patients who are being treated or who have been treated in the previous two weeks with monoamine oxidase inhibitors (see section 4.5); • patients who are being treated with dihydroergotamine; • increased intraocular pressure; • urinary retention; • children under 12 years old; • pregnancy and breastfeeding (see section 4.6).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e \u003cb\u003eAdults and children aged 12 and over\u003c\/b\u003e: one tablet 2 times a day, one in the morning and one in the evening, to be taken without chewing during or between meals. The duration of treatment should not exceed the period of acute symptoms and in any case should not be continued beyond 7 days. After 7 days of therapy, continue treatment with cetirizine alone. \u003cu\u003eSpecial populations\u003c\/u\u003e \u003ci\u003eElderly patients\u003c\/i\u003e The dose should be halved in elderly patients. \u003ci\u003ePatients with renal impairment\u003c\/i\u003e The dose should be halved in patients with renal insufficiency. \u003ci\u003ePatients with hepatic impairment\u003c\/i\u003e The dose should be halved in patients with hepatic impairment. \u003ci\u003ePediatric population \u003c\/i\u003e REACTINE is contraindicated in children under 12 years of age (see section 4.3). \u003cu\u003eMethod of administration\u003c\/u\u003e Oral use. The tablets should be taken with a little water and should not be divided, chewed or crushed.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo special precautions for storage.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eREACTINE is intended for short-term treatments only. Reactine must be used under medical supervision in diabetic patients and in subjects with thyroid problems, prostatic hypertrophy, hepatic insufficiency or reduced renal function, positive history of bronchospasm, as well as in elderly subjects. This medicine should be used under medical supervision in patients with pre-existing cardiovascular problems, including those with a history of myocardial infarction, coronary artery disease, hypertension, tachycardia and arrhythmia. Caution must also be exercised in subjects treated with sympathomimetics (decongestants, anorectics, psychostimulants) such as amphetamines, antihypertensive medicines, tricyclic antidepressants and digitalis or following the intake of higher quantities of alcohol or other substances with a depressant action on the central nervous system (CNS). Although at therapeutic doses of cetirizine, no clinically significant interactions with alcohol have been demonstrated (for a blood alcohol level of 0.5 g\/l), caution is recommended if alcohol is taken simultaneously. Caution should also be exercised in patients with risk factors that may increase the risk of haemorrhagic stroke (such as concomitant use of vasoconstrictors such as bromocriptine, pergolide, lisuride, cabergoline, ergotamine) or any other drug with decongestant activity (for example phenylpropanolamine, phenylephrine, ephedrine), used orally or nasally, due to the risk of vasoconstriction and increase in blood pressure (see paragraph 4.5). Increased ectopic pacemaker activity may occur when pseudoephedrine is used concomitantly with cardiac glycosides, such as digoxin or digitoxin; the use of the combination of cetirizine and pseudoephedrine should therefore be avoided in patients treated with cardiac glycosides (see section 4.5). Pseudoephedrine is associated with the risk of abuse. High doses may eventually induce toxicity. Prolonged use may induce habituation with an increased risk of overdose. Rapid discontinuation can induce depression. Use caution in patients with predisposing factors for urinary retention (e.g., spinal cord injury, prostatic hyperplasia), as cetirizine may increase the risk of urinary retention. Caution is recommended in patients at risk of hypercoagulation such as in inflammatory bowel disease, due to the vasoconstrictor effect of pseudoephedrine. Isolated cases of ischemic colitis have been reported in association with pseudoephedrine. The product should be discontinued in case of sudden abdominal pain, rectal bleeding or other symptoms of ischemic colitis. Caution is required in hypertensive patients receiving concomitant treatment with non-steroidal anti-inflammatory drugs (NSAIDs) as both pseudoephedrine and NSAIDs can increase blood pressure (see section 4.5). Severe skin reactions such as acute generalized exanthematous pustulosis (AGEP) may occur with medicines containing pseudoephedrine. This acute pustular eruption can occur within the first 2 days of treatment, with fever, and numerous small pustules, mostly non-follicular, resulting from a widespread edematous erythema and localized mainly on the skin folds, trunk and upper limbs. Patients should be carefully monitored. If signs and symptoms such as pyrexia, erythema or numerous small pustules are observed, the administration of Reactine should be stopped and appropriate measures taken if necessary. The medicine can act as a brain stimulant and give rise to episodes of insomnia, nervousness, hyperpyrexia, tremor and epileptic-type convulsions. During treatment with indirect sympathomimetic agents, acute postoperative hypertension may occur if they are used halogenated volatile anesthetics. Therefore, if surgery is planned, it is advisable to stop treatment 24 hours before anesthesia. Ischemic optic neuropathy Cases of ischemic optic neuropathy have been reported with pseudoephedrine. Pseudoephedrine should be discontinued if sudden loss of vision or reduction in visual acuity occurs, for example in the case of a scotoma. Allergy skin tests are inhibited by antihistamines therefore a washout period (3 days) is required before performing them. Athletes should be informed that treatment with pseudoephedrine could lead to a positive doping test result. If symptoms persist or worsen, or if new symptoms occur, discontinue use and consult a doctor. \u003cu\u003ePediatric population\u003c\/u\u003e \u003cu\u003eThe combination of cetirizine and pseudoephedrine is contraindicated in children under 12 years of age (see sections 4.2 and 4.3) due to the presence of pseudoephedrine and because this combination has not been studied in this age group\u003c\/u\u003e. \u003cu\u003eExcipient with known effects\u003c\/u\u003e The medicine contains lactose: patients suffering from rare hereditary problems of galactose intolerance, lactase deficiency, or glucose-galactose malabsorption should not take this medicine. This medicinal product contains less than 1 mmol (23 mg) sodium per single dose and can therefore be considered essentially sodium-free.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDue to the pharmacokinetic, pharmacodynamic and tolerability profile of cetirizine, no interactions are expected with this antihistamine. In reality, no significant pharmacodynamic or pharmacokinetic interactions were reported in drug-drug interaction studies carried out, in particular, with pseudoephedrine or theophylline (400 mg\/day). The activity of sympathomimetic amines such as pseudoephedrine contained in this medicinal product is increased by the concomitant administration of monoamine oxidase inhibitors and β-blockers. Due to the long duration of action of monoamine oxidase inhibitors, the activity of sympathomimetic amines can be observed even 15 days after discontinuation of administration (see section 4.3). Sympathomimetic amines reduce the antihypertensive effects of β-blockers, methyldopa, guanethidine, and reserpine. Antacids increase the absorption of pseudoephedrine while it is reduced by the simultaneous intake of kaolin. Concomitant administration of linezolid and pseudoephedrine may cause an increase in blood pressure in normotensive patients. Caution is also required in patients taking: - sympathomimetic drugs such as decongestants (e.g. phenylpropanolamine, phenylephrine, ephedrine), anorectics, psychostimulants such as amphetamines (combined effects on the cardiovascular system), - antihypertensive drugs (reduction of antihypertensive effects), - bromocriptine, pergolide, lisuride, cabergoline, ergotamine (risk of vasoconstriction and increase in blood pressure (see section 4.4), - tricyclic antidepressants, - alcohol or other substances with depressant action on the central nervous system (CNS) (possible intensification of the depressant action on the CNS and deterioration of performance), - cardiac glycosides such as digoxin or digitoxin (risk of cardiac arrhythmia) (see section 4.4), - non-steroidal anti-inflammatories (NSAIDs) (both pseudoephedrine and NSAIDs can increase blood pressure) (see section 4.4). The degree of absorption of cetirizine is not reduced by food intake, although the percentage of absorption is decreased.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eClinical studies have shown that cetirizine at a dose of 10 mg has minor side effects on the central nervous system, including drowsiness, fatigue, dizziness and headache. In some cases, paradoxical CNS stimulation has been reported. The following adverse reactions were reported by ≥ 1% of adult subjects in randomized, placebo-controlled trials with cetirizine alone: ​​drowsiness, nervousness, fatigue, dry mouth, dizziness, headache, nausea, pharyngitis, abdominal pain. Drowsiness was mild to moderate in the majority of cases, although statistically more common than with placebo. Further studies in which objective tests were carried out have shown that usual daily activities are not compromised at the recommended daily dose in healthy young volunteers. Although cetirizine is a selective H\u003csub\u003e1\u003c\/sub\u003e-peripheral and is relatively devoid of anticholinergic activity, cases of dysuria, accommodation disorder and dry mouth have been reported. Cases of abnormal liver function with elevations in liver enzymes accompanied by elevated bilirubin have been reported. This mainly resolves with discontinuation of treatment with cetirizine dihydrochloride. Isolated cases of stroke and ischemic colitis associated with the use of pseudoephedrine have been described in the literature. The following adverse reactions were reported by ≥ 1% of subjects in randomized, placebo-controlled trials with pseudoephedrine alone: ​​dry mouth, nausea, dizziness, insomnia, and nervousness. \u003cb\u003eClinical studies \u003c\/b\u003e The safety of the combination of cetirizine and pseudoephedrine from clinical studies is based on data from 3 randomized double-blind placebo-controlled studies for the treatment of seasonal allergic rhinitis. Table 1 includes adverse reactions that occurred in patients in whom more than one event was reported, and the incidence was higher than placebo and in 1% or more of patients. \u003cb\u003eTable 1: Side effects reported by \u003e 1% of adult subjects treated with the combination of cetirizine and pseudoephedrine in 3 randomized placebo-controlled clinical trials.\u003c\/b\u003e\u003c\/p\u003e\n\u003cp\u003eSystem Organ Classification: Cetirizine 5 mg\/Pseudoephedrine 120 mg Multi-dose (N =840) Placebo (N =831).\u003c\/p\u003e\n\u003cp\u003ePreferred Term: % (frequency) % (frequency).\u003c\/p\u003e\n\u003cp\u003eSystemic pathologies and conditions relating to the administration site.\u003c\/p\u003e\n\u003cp\u003eAsthenia: 2.0 (Common) 0.7 (Uncommon).\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders.\u003c\/p\u003e\n\u003cp\u003eDry mouth: 3.3 (Common) 0.4 (Uncommon).\u003c\/p\u003e\n\u003cp\u003eNervous system disorders.\u003c\/p\u003e\n\u003cp\u003eDizziness: 1.1 (Common) 0.1 (Uncommon).\u003c\/p\u003e\n\u003cp\u003eInsomnia: 3.8 (Common) 0.5 (Uncommon).\u003c\/p\u003e\n\u003cp\u003eDrowsiness: 2.5 (Common) 0.2 (Uncommon).\u003c\/p\u003e\n\u003cp\u003eSide effects observed and reported during treatment with REACTINE are reported according to system organ class according to MedDRA. Frequencies are defined as follows: • Very common (≥ 1\/10); • Common (≥ 1\/100, \u003c 1\/10); • Uncommon (≥ 1\/1,000, \u003c 1\/100); • Rare (≥ 1\/10,000, \u003c1\/1,000); • Very rare (\u003c1\/10,000); • Not known (frequency cannot be estimated from the available data).\u003c\/p\u003e\n\u003cp\u003eTable 2. Adverse reactions identified during post-marketing experience with cetirizine, pseudoephedrine or the combination of cetirizine and pseudoephedrine by frequency category estimated from spontaneous reporting *.\u003c\/p\u003e\n\u003cp\u003eSOCFrequency: Adverse reaction.\u003c\/p\u003e\n\u003cp\u003ePathologies of the blood and lymphatic system:\u003c\/p\u003e\n\u003cp\u003eVery rare: thrombocytopenia.\u003c\/p\u003e\n\u003cp\u003eImmune system disorders:\u003c\/p\u003e\n\u003cp\u003eRare: Hypersensitivity (including anaphylactic shock).\u003c\/p\u003e\n\u003cp\u003eMetabolism and nutrition disorders:\u003c\/p\u003e\n\u003cp\u003eNot known: increased appetite.\u003c\/p\u003e\n\u003cp\u003ePsychiatric disorders:\u003c\/p\u003e\n\u003cp\u003eCommon: nervousness.\u003c\/p\u003e\n\u003cp\u003eUncommon: anxiety.\u003c\/p\u003e\n\u003cp\u003eUncommon: agitation.\u003c\/p\u003e\n\u003cp\u003eRare: hallucinations.\u003c\/p\u003e\n\u003cp\u003eRare: psychotic disorder.\u003c\/p\u003e\n\u003cp\u003eRare: assault.\u003c\/p\u003e\n\u003cp\u003eRare: confusional state.\u003c\/p\u003e\n\u003cp\u003eRare: depression.\u003c\/p\u003e\n\u003cp\u003eRare: insomnia.\u003c\/p\u003e\n\u003cp\u003eVery rare: tic.\u003c\/p\u003e\n\u003cp\u003eNot known: euphoric behavior.\u003c\/p\u003e\n\u003cp\u003eVery rare: visual hallucination.\u003c\/p\u003e\n\u003cp\u003eNot known: suicidal behavior.\u003c\/p\u003e\n\u003cp\u003eNervous system disorders:\u003c\/p\u003e\n\u003cp\u003eCommon: dizziness.\u003c\/p\u003e\n\u003cp\u003eCommon: headache.\u003c\/p\u003e\n\u003cp\u003eCommon: drowsiness.\u003c\/p\u003e\n\u003cp\u003eUncommon: restlessness.\u003c\/p\u003e\n\u003cp\u003eUncommon: paraesthesia.\u003c\/p\u003e\n\u003cp\u003eRare: convulsion.\u003c\/p\u003e\n\u003cp\u003eVery rare: dysgeusia.\u003c\/p\u003e\n\u003cp\u003eVery rare: syncope.\u003c\/p\u003e\n\u003cp\u003eVery rare: tremor.\u003c\/p\u003e\n\u003cp\u003eVery rare: dystonia.\u003c\/p\u003e\n\u003cp\u003eVery rare: dyskinesia.\u003c\/p\u003e\n\u003cp\u003eVery rare: cerebrovascular accidents (stroke)†\u003c\/p\u003e\n\u003cp\u003eNot known: amnesia.\u003c\/p\u003e\n\u003cp\u003eNot known: memory impairment.\u003c\/p\u003e\n\u003cp\u003eEye disorders:\u003c\/p\u003e\n\u003cp\u003eVery rare: accommodation disorder.\u003c\/p\u003e\n\u003cp\u003eVery rare: blurred vision.\u003c\/p\u003e\n\u003cp\u003eVery rare: oculogyric crisis.\u003c\/p\u003e\n\u003cp\u003eVery rare: swelling of the eyes.\u003c\/p\u003e\n\u003cp\u003eNot known: mydriasis.\u003c\/p\u003e\n\u003cp\u003eNot known: eye pain.\u003c\/p\u003e\n\u003cp\u003eNot known: vision impairment.\u003c\/p\u003e\n\u003cp\u003eNot known: photophobia.\u003c\/p\u003e\n\u003cp\u003eNot known: Ischemic optic neuropathy.\u003c\/p\u003e\n\u003cp\u003eEar and labyrinth disorders:\u003c\/p\u003e\n\u003cp\u003eNot known: dizziness.\u003c\/p\u003e\n\u003cp\u003eCardiac disorders:\u003c\/p\u003e\n\u003cp\u003eUncommon: palpitations.\u003c\/p\u003e\n\u003cp\u003eRare: arrhythmia.\u003c\/p\u003e\n\u003cp\u003eRare: tachycardia.\u003c\/p\u003e\n\u003cp\u003eNot known: myocardial infarction†\u003c\/p\u003e\n\u003cp\u003eVascular pathologies:\u003c\/p\u003e\n\u003cp\u003eRare: paleness.\u003c\/p\u003e\n\u003cp\u003eRare: hypertension.\u003c\/p\u003e\n\u003cp\u003eVery rare: circulatory collapse.\u003c\/p\u003e\n\u003cp\u003eVery rare: hypotension.\u003c\/p\u003e\n\u003cp\u003eRespiratory, thoracic and mediastinal disorders:\u003c\/p\u003e\n\u003cp\u003eVery rare: cough.\u003c\/p\u003e\n\u003cp\u003eUncommon: dyspnoea.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders:\u003c\/p\u003e\n\u003cp\u003eCommon: dry mouth.\u003c\/p\u003e\n\u003cp\u003eCommon: nausea.\u003c\/p\u003e\n\u003cp\u003eUncommon: diarrhoea.\u003c\/p\u003e\n\u003cp\u003eRare: vomiting.\u003c\/p\u003e\n\u003cp\u003eVery rare: ischemic colitis; Abdominal discomfort.\u003c\/p\u003e\n\u003cp\u003eHepatobiliary disorders:\u003c\/p\u003e\n\u003cp\u003eRare: Abnormal liver function (transaminases increased, alkaline phosphatase increased, gamma GT increased, blood bilirubin increased).\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders:\u003c\/p\u003e\n\u003cp\u003eUncommon: pruritus.\u003c\/p\u003e\n\u003cp\u003eUncommon: skin rash.\u003c\/p\u003e\n\u003cp\u003eRare: dry skin.\u003c\/p\u003e\n\u003cp\u003eRare: hyperhidrosis.\u003c\/p\u003e\n\u003cp\u003eRare: urticaria.\u003c\/p\u003e\n\u003cp\u003eVery rare: fixed drug eruption.\u003c\/p\u003e\n\u003cp\u003eVery rare: angioedema.\u003c\/p\u003e\n\u003cp\u003eVery rare: skin disease.\u003c\/p\u003e\n\u003cp\u003eVery rare: acute generalized exanthematous pustulosis.\u003c\/p\u003e\n\u003cp\u003ePathologies of the musculoskeletal system and connective tissue.\u003c\/p\u003e\n\u003cp\u003eNot known: arthralgia.\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders:\u003c\/p\u003e\n\u003cp\u003eVery rare: enuresis.\u003c\/p\u003e\n\u003cp\u003eVery rare: dysuria.\u003c\/p\u003e\n\u003cp\u003eNot known: urinary retention.\u003c\/p\u003e\n\u003cp\u003eSystemic disorders and conditions relating to the administration site:\u003c\/p\u003e\n\u003cp\u003eCommon: weakness.\u003c\/p\u003e\n\u003cp\u003eUncommon: asthenia.\u003c\/p\u003e\n\u003cp\u003eUncommon: malaise.\u003c\/p\u003e\n\u003cp\u003eRare: edema.\u003c\/p\u003e\n\u003cp\u003eNot known: itching after withdrawal.\u003c\/p\u003e\n\u003cp\u003eMetabolism and nutrition disorders:\u003c\/p\u003e\n\u003cp\u003eRare: weight gain.\u003c\/p\u003e\n\u003cp\u003eReproductive system and breast disorders:\u003c\/p\u003e\n\u003cp\u003eNot known: erectile dysfunction.\u003c\/p\u003e\n\u003cp\u003e* Patient exposure was estimated from the calculation of sales data from IMS MIDAS. \u003csup\u003e†\u003c\/sup\u003eThese adverse reactions have been reported very rarely in post-marketing safety studies. A recent post-authorisation safety study (PASS) provided no evidence of an increased risk of myocardial infarction or cerebrovascular accident associated with the use of vasoconstrictors, including pseudoephedrine, for nasal decongestion. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSymptoms\u003c\/u\u003e In case of overdose the following may be observed: tachycardia, arrhythmias, hypertension, depressant or stimulant effects on the CNS. (sedation, apnea, collapse, insomnia, hallucinations, tremors, convulsions). These effects can be fatal. Symptoms observed after overdose of cetirizine are mainly associated with CNS effects or effects that might suggest an anticholinergic effect. Adverse events reported after taking at least 5 times the 10 mg dose of cetirizine are: confusion, diarrhea, dizziness, fatigue, headache, malaise, mydriasis, itching, restlessness, sedation, drowsiness, stupor, tachycardia, tremor and urinary retention. In case of overdose of pseudoephedrine, nausea, vomiting, mydriasis, anxiety, agitation, palpitations and reflex bradycardia may occur. Other possible effects are dysrhythmia, hypertensive crisis, intracerebral hemorrhage, myocardial infarction, psychosis, rhabbomyolysis, hypokalemia, and ischemic infarction of the intestine. In the case of overdose in children, drowsiness has been reported. Keep out of reach of children. In case of overdose, seek medical help or contact a poison control center immediately. \u003cu\u003eTreatment\u003c\/u\u003e Treatment, which should preferably take place in a hospital environment, must be symptomatic. If vomiting does not occur spontaneously it must be induced. Gastric lavage is recommended. There are no known antidotes. It is important to avoid the use of sympathomimetics. Hypertension can be controlled with α-blockers, possible tachycardia with β-blockers, convulsions with iv diazepam (or with diazepam administered rectally in the case of children). There is no specific antidote for cetirizine. Should overdose occur, symptomatic or supportive treatment is recommended. Following recent ingestion, gastric lavage is recommended. Cetirizine is not effectively eliminated by dialysis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eREACTINE is contraindicated during pregnancy and breastfeeding. \u003cu\u003ePregnancy\u003c\/u\u003e Very little clinical data on pregnancies exposed to treatment are available for cetirizine. Animal studies do not indicate direct or indirect harmful effects with respect to pregnancy, embryonic\/foetal development, parturition or postnatal development. \u003cu\u003eBreastfeeding\u003c\/u\u003e Both cetirizine and pseudoephedrine are excreted in breast milk, therefore REACTINE should not be taken during breastfeeding. Cetirizine is excreted in breast milk at concentrations representing 25% to 90% of those measured in plasma, depending on the sampling time after administration.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eCetirizine at recommended doses does not influence cognitive and motor functions; no effect on these abilities has been demonstrated with pseudoephedrine. However, due to its potential sedative action, caution should be exercised when driving or operating machinery. Objective measurements of driving ability, sleep latency and assembly line performance demonstrated no clinically relevant effects at the 10 mg dose of cetirizine. Patients intending to drive, engage in potentially dangerous activities or operate machinery should not exceed the dose of 10 mg of cetirizine and consider their response to the medicine. Patients should not drive, engage in potentially hazardous activities, or operate machinery if they feel drowsy or dizzy. In sensitive patients, concomitant use with alcohol or other CNS depressants may cause further reductions in alertness and impaired performance.\u003c\/p\u003e","brand":"Johnson \u0026 Johnson","offers":[{"title":"Default Title","offer_id":51730208719175,"sku":"032800043","price":8.78,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/johnson-johnson-spa-reactine-5-mg-120-mg-6-compresse-rilascio-prolungato-farmacia-dottor-tili-1213791071.jpg?v=1767154391"},{"product_id":"rinoclenil-100-µg-30-ml-spray-nasale-sospensione-200-erogazioni","title":"Rinoclenil 100 µg 30 ml nasal spray suspension (200 sprays)","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProphylaxis and treatment of seasonal and perennial allergic rhinitis and vasomotor rhinitis.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e100 ml of suspension contains: Active ingredient: Beclomethasone dipropionate 77 mg. Each spray delivers 100 micrograms of beclomethasone dipropionate. Excipients \u003cu\u003ewith known effects\u003c\/u\u003e: Benzalkonium chloride 27 mg. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePolysorbate 20, microcrystalline cellulose and sodium carboxymethylcellulose, benzalkonium chloride, phenylethyl alcohol, dextrose (glucose) monohydrate, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients listed in paragraph 6.1; Local viral and tuberculosis infections; Contraindicated in children under 6 years of age.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eRhinoclenil should be administered exclusively via the nasal route. \u003cu\u003eDosage\u003c\/u\u003e \u003cu\u003eAdults and children over 6 years old\u003c\/u\u003e: two sprays in each nostril once a day. In children, if deemed appropriate, a divided dose administration schedule can be maintained, carrying out a single delivery into each nostril twice a day. The onset of the effect is not immediate and for complete therapeutic benefit it is advisable to use the product regularly and for several days. \u003cu\u003eChildren under 6 years old\u003c\/u\u003e: the product must not be administered to children under 6 years of age. \u003cb\u003e \u003cu\u003eMethod of administration\u003c\/u\u003e \u003c\/b\u003e Shake the bottle vigorously before each administration. Furthermore, before starting the therapy it is advisable to remove the protective cap and the protection ring and activate the dosing pump several times to start the nebulization mechanism. \u003cu\u003eProceed with dispensing as follows\u003c\/u\u003e: 1) Carry out a thorough cleaning of the nose. 2) Remove the protective cap. 3) Remove the protection ring that blocks the pump from the side. 4) Hold the bottle between your fingers. To put the nebulization mechanism into operation, operate the dosing pump several times until you obtain a visible spray. 5) Place the nasal nozzle on one nostril, closing the other nostril with a finger. Inhale and press the base of the nasal nozzle at the same time. In this way, a precisely metered single dose of the active ingredient is delivered. Repeat the same operation on the other nostril. 6) After use, replace the protective cap and the protective ring. If the dispenser becomes blocked, wash it carefully with warm water, without touching the hole with sharp objects.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSystemic effects may occur with intranasal corticosteroids, particularly when prescribed in high doses for prolonged periods. In any case, treatment must be suspended and appropriate therapy instituted. Such effects are less likely to occur than with treatment with oral corticosteroids and may vary in individual patients and between different corticosteroid preparations. Possible systemic effects include Cushing's syndrome, Cushingoid features, adrenal suppression, growth retardation in children and adolescents, decreased bone mineral density, cataracts, glaucoma and, more rarely, a range of psychological or behavioral effects including, sleep disturbances, anxiety, depression or aggression (particularly in children) or neurological effects such as psychomotor hyperactivity. It is recommended to regularly monitor the height of children receiving prolonged treatment with intranasal corticosteroids (see section 4.8). Although RINOCLENIL controls the symptoms of allergic rhinitis in most cases, an abnormally high stimulus of allergens may in certain cases require appropriate additional therapy, in particular to control ocular symptoms. The replacement of systemic corticosteroid therapy with topical corticosteroid therapy (Rinoclenil) requires caution, especially where there is reason to believe that a certain degree of impairment of adrenal function is present. In particularly sensitive or predisposed subjects due to recent therapies with systemic steroids, or if doses of nasal beclomethasone are taken in excess of what is recommended, systemic effects may occur (osteoporosis, peptic ulcer, signs of secondary adrenal insufficiency). Visual disturbances Visual disturbances may be reported with the use of systemic and topical corticosteroids. If a patient presents with symptoms such as blurred vision or other visual disturbances, referral to an ophthalmologist should be considered for evaluation of possible causes which may include cataracts, glaucoma, or rare diseases such as central serous chorioretinopathy (CSCR), which have been reported after the use of systemic and topical corticosteroids. Rhinoclenil should not be used after trauma or surgery to the nose (until healing) and in the presence of nasal ulcerations, unless prescribed by a doctor. In patients being treated with systemic corticosteroids, the product must be administered under medical supervision. Do not use for more than a month without consulting your doctor. Excessively prolonged use of topical corticosteroids can cause temporary suppression of the hypothalamic-pituitary-adrenal axis, causing secondary adrenal insufficiency. Infections of the nasal passages and paranasal sinuses must be treated appropriately, however they do not constitute a specific contraindication to the use of Rinoclenil. \u003ci\u003e \u003cu\u003eWarnings relating to excipients\u003c\/u\u003e \u003c\/i\u003e The product contains benzalkonium chloride, an irritant that may cause local reactions. Benzalkonium chloride (BAC) contained as a preservative in Rinoclenil, especially when used for long periods, can cause swelling of the nasal mucosa. If such a reaction (persistent nasal congestion) is suspected, a medicinal product for nasal use without BAC should be used, if possible. If such medicinal products for nasal use without BAC are not available, another pharmaceutical form should be considered. May cause bronchospasm.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBeclomethasone is less dependent on CYP3A metabolism than other corticosteroids and, in general, interactions are unlikely; however, since the possibility of systemic effects cannot be excluded with the concomitant use of strong CYP3A inhibitors (e.g. ritonavir, cobicistat), caution and appropriate monitoring of the use of such agents is recommended.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSystemic side effects are extremely unlikely due to the low doses used. Systemic effects may occur with intranasal corticosteroids, particularly if prescribed in high doses for prolonged periods. These can include growth retardation in children and adolescents. However, particular caution must be exercised in prolonged use of the product, keeping the patient under observation in order to promptly reveal possible systemic effects (osteoporosis, peptic ulcer, signs of secondary adrenal insufficiency). As with other nasal preparations, burning sensation, irritation, dryness and, more rarely, epistaxis may occur locally. Rare cases of nasal septal perforation have been reported following nasal applications of corticosteroids. Rare cases of increased intraocular pressure or glaucoma have been associated with formulations of beclomethasone dipropionate for nasal application. Cases of blurred vision have been observed with unknown frequency (see also section 4.4). In case of infection, institute appropriate therapy. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at: www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse..\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdministration of large quantities of beclomethasone dipropionate over a short period of time may result in suppression of hypothalamic-pituitary-adrenal function. In this case, the dose of RINOCLENIL should be reduced immediately to the recommended dose.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e In pregnant women, the product should be administered in cases of actual need, under the direct supervision of a doctor. There are no or limited data on the use of beclomethasone in pregnant women. Administration of drugs during pregnancy should only be considered if the foreseeable benefits to the mother are greater than the potential risks to the fetus. In reproductive studies on animals, the typical side effects of potent corticosteroids were observed only following high systemic exposures; nasal administration ensures minimal systemic exposure. \u003cu\u003eBreastfeeding\u003c\/u\u003e There is insufficient information on the excretion of beclomethasone\/metabolites in breast milk. It is reasonable to assume that beclometasone dipropionate is excreted in milk but, at doses used via the nasal route, the presence of significant levels in breast milk is unlikely. However, the use of beclomethasone dipropionate during breastfeeding requires careful evaluation by the doctor of the risk-benefit ratio for both mother and child.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eRhinoclenil does not alter the ability to drive and use machines.\u003c\/p\u003e","brand":"Chiesi","offers":[{"title":"Default Title","offer_id":51730209669447,"sku":"035799028","price":22.79,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/chiesi-rinoclenil-100-g-30-ml-spray-nasale-sospensione-200-erogazioni-farmacia-dottor-tili-1258975864.jpg?v=1789560279"},{"product_id":"vivinduo-febbre-e-congestione-nasale-500-mg-60-mg-10-bustine-granulo-per-soluzione-orale","title":"Vivinduo fever and nasal congestion 500 mg + 60 mg 10 sachets granule for oral solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eTreatment of cold and flu symptoms.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eA 1.5 g sachet contains: \u003ci\u003eActive ingredients:\u003c\/i\u003e Paracetamol 500 mg; Pseudoephedrine hydrochloride 60 mg (equivalent to 49.15 mg of pseudoephedrine). \u003ci\u003eExcipients with known effects:\u003c\/i\u003e Sorbitol (E420): 95.2 mg; Sucrose: 418.7 mg. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSucrose, lemon flavouring, anhydrous citric acid, sorbitol, sucralose, polysorbate 20, beetroot red colouring, riboflavin sodium phosphate colouring.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1. - Pregnancy and breastfeeding. - Children under the age of 12. - Patients with manifest insufficiency of glucose-6-phosphate dehydrogenase. - Subjects suffering from a severe form of the following diseases: • coronary heart disease (angina, previous heart attack); • hypertension; • arrhythmias; • liver failure; • renal failure; • hyperthyroidism; • asthma; • diabetes; • urination disorders caused by prostatic hypertrophy or other pathologies; • glaucoma; • hemolytic anemia. Subjects who are being treated with dihydroergotamine or monoamine oxidase inhibitors (MAOIs) or who have discontinued this treatment less than two weeks ago (see section 4.5).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e Adults and children over 12 years of age: 2-3 sachets per day, dissolved in a glass of water. Children: It is not recommended in children under 12 years (see section 4.3). Use the lowest effective dose. That is, start treatment at the minimum intended dosage by increasing the dose only if the symptoms are not sufficiently controlled. The maximum dose (both for single administration and for total daily dose) must never be exceeded. In adolescents, the elderly or in subjects with impaired hepatic or renal function it may be necessary to reduce the dosage in relation to the patient's clinical condition; in these cases the patient must be advised to consult the doctor before using VIVINDUO FEVER AND NASAL CONGESTION. The medicine must be used: maximum 5 days of therapy for the adult population; 3 days maximum therapy for the pediatric population (12-18 years). \u003cu\u003eMethod of administration\u003c\/u\u003e Dissolve the granules in a glass of water and immediately drink the solution obtained. You can also use hot water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDuring treatment with paracetamol, before taking any other medicine, check that it does not contain the same active ingredient, since if paracetamol is taken in high doses, serious adverse reactions may occur. This medicine must be used correctly, respecting the instructions for use and in particular the authorized dosage. Hepatotoxicity may occur with paracetamol even at therapeutic doses, after short-term treatment and in patients without pre-existing liver dysfunction (see section 4.8). Caution is recommended in patients with a history of sensitivity to aspirin and\/or nonsteroidal anti-inflammatory drugs (NSAIDs). Caution is advised if acetaminophen is administered concurrently with flucloxacillin due to the increased risk of high anion gap metabolic acidosis (HAGMA), particularly in patients with severe renal impairment, sepsis, malnutrition, and other sources of glutathione deficiency (e.g., chronic alcoholism), as well as in those using maximum daily doses of acetaminophen. Close monitoring, including measurement of urinary 5-oxoproline, is recommended. The risk of serious side effects is also increased when paracetamol is taken together with other antipyretic analgesics; the simultaneous use of this type of medicines must therefore be avoided. This medicine can cause even serious side effects (see section 4.8); the patient must be advised to discontinue the medicine and to immediately consult a doctor if he suspects the onset of a serious side effect. Serious skin reactions: Potentially fatal reactions such as Stevens-Johnson syndrome (SSJ), toxic epidermal necrolysis (TEN) and acute generalized exanthematous pustulosis have been reported with the use of paracetamol. Patients should be informed about the signs and symptoms and monitored carefully for skin reactions. If symptoms or signs of Stevens-Johnson syndrome, toxic epidermal necrolysis or acute generalized exanthematous pustulosis occur (e.g. progressive skin rash associated with blistering or mucosal lesions), the patient should immediately discontinue treatment with paracetamol and consult a doctor. The use of the medicine requires an accurate evaluation of the risk\/benefit ratio in the elderly and in subjects suffering from a mild\/moderate form of the following diseases: - coronary heart disease (angina, previous heart attack); - hypertension; - arrhythmias; - liver failure; - renal failure; - hyperthyroidism; - asthma; - diabetes; - urination disorders caused by prostatic hypertrophy or other pathologies; - glaucoma; - hemolytic anemia; - glucose-6-phosphate dehydrogenase deficiency. Patients taking acetaminophen should avoid using alcoholic beverages because alcohol increases the risk of liver damage. Heavy consumers of alcoholic beverages should consult their doctor before taking a medicine containing paracetamol. During the use of VIVINDUO FEVER AND NASAL CONGESTION it is necessary to avoid drinking bitter orange juice (see paragraph 4.5). During therapy with oral anticoagulants, the administration of paracetamol can increase the effect of anticoagulants, making it necessary to monitor the anticoagulant therapy more closely; furthermore, potentially harmful interactions are also possible with several other drugs (see section 4.5). In these cases VIVINDUO FEVER AND NASAL CONGESTION can only be used under strict medical supervision. The patient must be advised of the need to consult the doctor if he is already being treated with other drugs. \u003cu\u003eIschemic colitis\u003c\/u\u003e Some cases of ischemic colitis have been reported with medicines containing pseudoephedrine. The use of pseudoephedrine should be discontinued and it is recommended to consult a doctor if abdominal pain, rectal bleeding or other symptoms of ischemic colitis suddenly occur. \u003cu\u003eIschemic optic neuropathy\u003c\/u\u003e Cases of ischemic optic neuropathy have been reported with pseudoephedrine. Pseudoephedrine should be discontinued if sudden loss of vision or reduction in visual acuity occurs, for example in the case of a scotoma. \u003ci\u003eImportant information about some excipients \u003c\/i\u003e This medicine contains: \u003cb\u003eSorbitol:\u003c\/b\u003e The additive effect of co-administration of medicinal products containing sorbitol (or fructose) and daily dietary intake of sorbitol (or fructose) should be considered. The sorbitol content in oral medicinal products may modify the bioavailability of other co-administered oral medicinal products. Patients with hereditary fructose intolerance should not be given this medicine. \u003cb\u003eSucrose\u003c\/b\u003e: Patients suffering from rare hereditary problems of fructose intolerance, glucose-galactose malabsorption, or sucrase isomaltase insufficiency should not take this medicine. \u003cb\u003eSodium:\u003c\/b\u003e This medicinal product contains less than 1 mmol (23 mg) sodium per sachet, i.e. it is essentially 'sodium-free'.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003e \u003cu\u003eInteractions related to paracetamol\u003c\/u\u003e \u003c\/i\u003e Use with extreme caution and under strict control during chronic treatment with drugs that can cause the induction of hepatic monooxygenases or in case of exposure to substances that can have this effect (for example cimetidine and ranitidine). The risk of paracetamol toxicity may be increased in patients taking other potentially hepatotoxic drugs or drugs that induce hepatic microsomal enzymes, such as some antiepileptics (such as glutethimide, phenobarbital, phenytoin, carbamazepine, topiramate), rifampin and alcohol. The administration of paracetamol can interfere with the determination of uric acid (using the phosphotungstic acid method) and with that of blood sugar (using the glucose-oxidase-peroxidase method). \u003ci\u003eAnticoagulants\u003c\/i\u003e: Paracetamol may increase the risk of bleeding in patients taking warfarin and other vitamin K antagonists. Patients taking paracetamol and vitamin K antagonists should be monitored for appropriate clotting and bleeding. \u003ci\u003eFlucloxacillin\u003c\/i\u003e: Caution should be exercised when paracetamol is used concomitantly with flucloxacillin as concomitant use has been associated with high anion gap metabolic acidosis, especially in patients with risk factors (see section 4.4). \u003ci\u003eCytotoxic\u003c\/i\u003e: possible inhibition of the metabolism of intravenous busulfan (caution is recommended in the 72 hours following the use of paracetamol). \u003ci\u003eDomperidone\u003c\/i\u003e: increased absorption of paracetamol. \u003ci\u003eHypolipidemic drugs\u003c\/i\u003e: reduction of paracetamol absorption with cholestyramine. \u003ci\u003eMetoclopramide\u003c\/i\u003e: increased absorption of paracetamol (increased effect). \u003ci\u003e \u003cu\u003eInteractions related to pseudoephedrine\u003c\/u\u003e \u003c\/i\u003e Due to the possibility of serious reactions, the simultaneous administration of pseudoephedrine and: \u003ci\u003emonoamine oxidase inhibitors \u003c\/i\u003e(MAOI) (see section 4.3). Monoamine oxidase inhibitors are used in therapy as: - antiparkinsonians (such as selegiline or rasagiline); - antidepressants (such as isocarboxazid, nialamide, phenelzine, tranylcypromine, iproniazid, iproclozide, moclobemide and toloxatone); - antineoplastics (such as procarbazine). Concomitant use of pseudoephedrine and MAOIs can trigger a severe hypertensive crisis (hypertension, hyperpyrexia, headache). The use of pseudoephedrine is contraindicated even in patients who have stopped treatment with MAOIs for less than two weeks. - \u003ci\u003edihydroergotamine:\u003c\/i\u003e the combination of the two drugs can cause a dangerous increase in blood pressure. Due to the possible effects caused by their interaction, the association of pseudoephedrine with some medicines is only possible under the strict supervision of a doctor who will evaluate the risk\/benefit ratio in the individual case. Use VIVINDUO FEVER AND NASAL CONGESTION only under strict medical supervision when you are already being treated with one of these drugs: - \u003ci\u003elinezolid\u003c\/i\u003e: the association of the two drugs can cause an increase in blood pressure; - \u003ci\u003emethyldopa\u003c\/i\u003e: reduction of the antihypertensive effect of methyldopa; - \u003ci\u003emidodrine\u003c\/i\u003e: increase in the hypertensive effect of midodrine. Due to the presence of pseudoephedrine, avoid association with other sympathomimetics (risk of hypertensive episodes) or with guanethidine (cancellation of the antihypertensive effect). \u003ci\u003eBitter orange\u003c\/i\u003e: bitter orange (also called melangolo) can trigger a serious hypertensive crisis (hypertension, hyperpyrexia, headache) in patients taking pseudoephedrine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eSide effects due to paracetamol\u003c\/i\u003e - \u003cu\u003ePathologies of the blood and lymphatic system:\u003c\/u\u003e thrombocytopenia, neutropenia, leukopenia; agranulocytosis, haemolytic anemia in patients with basic glucose-6-phosphate dehydrogenase deficiency. - \u003cu\u003eNervous system disorders:\u003c\/u\u003e dizziness. - \u003cu\u003eImmune system disorders: \u003c\/u\u003ehypersensitivity reactions such as angioedema, laryngeal edema, anaphylactic shock. - \u003cu\u003eCardiac disorders:\u003c\/u\u003e Kounis syndrome. - \u003cu\u003eRespiratory, thoracic and mediastinal disorders:\u003c\/u\u003e bronchospasm, pneumonia. - \u003cu\u003eGastrointestinal disorders:\u003c\/u\u003e gastrointestinal hemorrhage; gastrointestinal reactions. - \u003cu\u003eRenal and urinary disorders:\u003c\/u\u003e nephrotoxicity; alterations affecting the kidney (acute renal failure, interstitial nephritis, hematuria, anuria). - \u003cu\u003eSkin and subcutaneous tissue disorders:\u003c\/u\u003e erythema, urticaria, rash, fixed drug eruption. Very rare cases of serious skin reactions such as erythema multiforme, toxic epidermal necrolysis (TEN), Stevens-Johnson syndrome (SSJ) and acute generalized exanthematous pustulosis have been reported (see section 4.4). - \u003cu\u003eHepatobiliary disorders:\u003c\/u\u003e hepatotoxicity; alteration of liver function and hepatitis; cytolytic hepatitis which can lead to acute liver failure. In case of overdose, paracetamol can cause hepatic cytolysis which can evolve towards massive and irreversible necrosis. \u003ci\u003eSide effects due to pseudoephedrine\u003c\/i\u003e - \u003cu\u003eCardiac disorders:\u003c\/u\u003e myocardial infarction, atrial fibrillation, tachyarrhythmia, hypertension, hypotension, ventricular extrasystoles, precordial pain, palpitations. - \u003cu\u003eNervous system disorders:\u003c\/u\u003e convulsions, insomnia, tremors, ataxia, dizziness, headache. - \u003cu\u003eEye disorders:\u003c\/u\u003e mydriasis, ischemic optic neuropathy (frequency not known). - \u003cu\u003eGastrointestinal disorders:\u003c\/u\u003e ischemic colitis (frequency not known), taste changes, nausea, vomiting, dry mouth. - \u003cu\u003eSkin and subcutaneous tissue disorders:\u003c\/u\u003e eczema, fixed erythema, pseudo-scarlet fever. - \u003cu\u003eMetabolism and nutrition disorders: \u003c\/u\u003ehyperthermia, thirst, sweating. - \u003cu\u003ePsychiatric disorders:\u003c\/u\u003e anxiety, agitation, nervousness, irritability, confusion, hallucinations. - \u003cu\u003eDifficulty urinating:\u003c\/u\u003e cases of urinary retention may occur in patients with prostatic hypertrophy. \u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at \u003cu\u003ewww.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/u\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eParacetamol\u003c\/i\u003e In case of accidental intake of very high doses of paracetamol, acute intoxication manifests itself with pallor, nausea, vomiting, anorexia and abdominal pain which generally appear within the first 24 hours after overdose with paracetamol. In adults, the maximum daily dosage of paracetamol is 3 g; above this limit there is a risk of dose-dependent hepatotoxicity. Nausea and vomiting, the only early signs of poisoning, usually disappear within 24 hours. Persistence beyond this time, often associated with subcostal pain on the right side or hyperesthesia, may indicate the development of hepatic necrosis. Liver damage is maximum 3-4 days after ingestion and paracetamol overdose can cause hepatic cytolysis which can lead to hepatocellular failure, metabolic acidosis, encephalopathy, hemorrhage, hypoglycemia, cerebral edema, coma and death. Therefore, despite the lack of significant early symptoms, patients who have taken an overdose of paracetamol should be urgently transferred to hospital. Increased levels of hepatic transaminases, lactate dehydrogenase and bilirubin with decreased prothrombin levels may occur 12 to 48 hours after acute overdose. Overdose can also lead to pancreatitis, acute renal failure and pancytopenia. A dose of 10-15 g (20-30 tablets) or 150 mg\/kg of paracetamol taken over 24 hours can cause severe hepatocellular necrosis and, much less frequently, renal tubular necrosis. The administration of activated charcoal should be taken into consideration if it is thought that paracetamol has been taken within the last hour in quantities greater than 150 mg\/kg or 12 g (however consider the lower limit). Acetylcysteine ​​protects the liver if administered by infusion within 24 hours of ingesting paracetamol. \u003ci\u003ePseudoephedrine\u003c\/i\u003e The most common signs\/symptoms of pseudoephedrine overdose include: mydriasis, tachycardia, hypertension, agitation\/anxiety, sinus arrhythmia, hallucinations, tremors\/hyperreflexia, vomiting; less frequently the following are observed: hyperglycemia, rhabdomyolysis, acute renal failure. Most patients require only a short period of observation in hospital; pharmacological treatment is required in the most serious cases (e.g. arrhythmias, hypertensive crisis, convulsions).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVIVINDUO FEVER AND NASAL CONGESTION is contraindicated during confirmed or presumed pregnancy and during breastfeeding.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVIVINDUO FEVER AND NASAL CONGESTION does not alter the ability to drive and use machinery.\u003c\/p\u003e","brand":"Menarini","offers":[{"title":"Default Title","offer_id":51730210783559,"sku":"044921029","price":10.42,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/a-menarini-ind-farm-riun-srl-vivinduo-febbre-e-congestione-nasale-500-mg-60-mg-10-bustine-granulo-per-soluzione-orale-farmacia-dottor-tili-1213791040.jpg?v=1767155050"},{"product_id":"fexallegra-nasale-1-mg-ml-3-55-mg-ml-10-ml-spray-nasale-soluzione","title":"Fexallegra Nasal 1 mg\/ml + 3.55 mg\/ml 10 ml nasal spray solution","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic treatment of allergic rhinitis, such as hay fever.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e1 ml of solution contains: tramazoline hydrochloride 1.18 mg equal to tramazolin 1.01 mg, chlorpheniramine maleate 5.05 mg equal to chlorpheniramine 3.55 mg (10 ml contains: tramazolin hydrochloride 11.8 mg, chlorpheniramine maleate 50.5 mg). Excipients with known effect: benzalkonium chloride. For the full list of excipients, see section 6.1\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cb\u003ebenzalkonium chloride\u003c\/b\u003e, liquid sorbitol, citric acid, disodium phosphate dihydrate, sodium chloride, purified water.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eFexallegra nasal is contraindicated in the following cases: • Hypersensitivity to the active substances or to any of the excipients listed in paragraph 6.1. • Rhinitis sicca. • Heart disease and severe arterial hypertension. • Acute angle glaucoma. • Hyperthyroidism, prostatic hypertrophy. • Pregnancy and breastfeeding. • After cranial surgery performed nasally. • Children under the age of 12.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAdults and children over 12 years: 1-2 sprays per nostril every 8-12 hours. Do not exceed the recommended doses. Duration of treatment: advise the patient that, in the absence of a complete therapeutic response within a few days, he must consult his doctor; in any case the treatment must not be continued for more than 4 days. Pediatric population: the medicine is contraindicated in children under 12 years of age (see section 4.3). \u003cu\u003eMethod of administration\u003c\/u\u003e The bottle must be used by holding it vertically, to obtain spray nebulisations. For correct use of the nebulizer, follow the instructions below: Remove the protective cap after blowing your nose, keeping your head in a normal position, introduce the olive into the nostril and spray by pressing the bottle evenly once or twice with quick, forceful strokes. After nebulization, inhale deeply with your mouth closed, pressing lightly with your index finger on the other nostril, in order to ensure distribution of the solution over the entire nasal mucosa. Then repeat the application in the other nostril. The empty space above the liquid is necessary for the bottle to function perfectly as a nebulizer. After use it is recommended to clean the olive and put the protective cap on.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProlonged use of topical nasal vasoconstrictors can alter the normal function of the nasal mucosa and paranasal sinuses, causing chronic inflammation and atrophy; furthermore, it can also induce addiction to the medicine. The use, especially if prolonged, of topical products can give rise to sensitization phenomena. When the vasoconstrictor effect of the drug ceases, edema of the nasal mucosa may occur due to reactive hyperemia. \u003cu\u003eMild and moderate arterial hypertension\u003c\/u\u003e Due to the potential risk of systemic absorption, Fexallegra nasal should be used with caution in patients suffering from mild-moderate arterial hypertension; in these patients the use of nasal decongestants must however be subjected to clinical evaluation from time to time. \u003cu\u003eDiabetes Mellitus\u003c\/u\u003e During treatment with sympathetic mimetic medicinal products, an alteration of glucose regulation may occur caused by pharmacological interaction with antidiabetic medicinal products or by the effect on glucose metabolism. Due to the potential risk of systemic absorption, Fexallegra nasal should be used with caution in patients with diabetes mellitus. \u003cu\u003ePheochromocytoma and porphyria\u003c\/u\u003e Due to the potential risk of systemic absorption, Fexallegra nasal should be used with caution in patients suffering from pheochromocytoma and porphyria. \u003cu\u003eElderly people\u003c\/u\u003e In the elderly the medicine should be used with caution. Dizziness, sedation, confusion and hypotension may be more likely in elderly patients taking antihistamines. Elderly patients are particularly sensitive to the anticholinergic side effects of antihistamines, such as dry mouth and urinary retention (especially in male patients). \u003cu\u003eImproper use \/ Drug administration error\u003c\/u\u003e The medicine must not be used orally. If accidentally ingested or if used for a long period in excessive doses, it can cause toxic phenomena. Accidental ingestion in children may cause severe central nervous system depression with marked sedation (see section 4.9). Contact of the liquid with the eyes may cause irritation. \u003cu\u003eImportant information about some excipients\u003c\/u\u003e Fexallegra nasal contains the preservative benzalkonium chloride which can cause irritation and, especially if used for long periods, persistent nasal congestion; in this case, a medicinal product for nasal use without benzalkonium chloride or, alternatively, another pharmaceutical form must be used.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eAntidepressant drugs and vasopressor drugs\u003c\/u\u003e Due to the presence of the sympathomimetic agent tramazoline hydrochloride, Fexallegra nasal must not be administered together with antidepressant drugs and in the two weeks following the administration of the latter. The administration of Fexallegra nasal concomitantly with antidepressant drugs (MAO inhibitors or tricyclic antidepressants) or vasopressor drugs may cause an increase in blood pressure. Use in combination with tricyclic antidepressants can also cause arrhythmias. MAO inhibitors and tricyclic antidepressants may prolong and intensify the anticholinergic and central nervous system (CNS) depressant effects of chlorpheniramine maleate. \u003cu\u003eDrugs with depressant action on the CNS\u003c\/u\u003e Alcohols, sedatives, opioid analgesics, hypnotics can cause an increase in the sedation effects due to the antihistamine chlorpheniramine maleate. \u003cu\u003ePhenytoin\u003c\/u\u003e If taken concomitantly with phenytoin, chlorpheniramine maleate may result in decreased elimination of phenytoin with an increased risk of phenytoin toxicity. \u003cu\u003eAntihypertensive drugs\u003c\/u\u003e Interactions with antihypertensive drugs, especially those whose action involves the sympathetic nervous system, can be complex and lead to various cardiovascular effects.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe following convention has been used for the classification of undesirable effects: very common (≥1\/10), common (≥1\/100, \u003c1\/10), uncommon (≥1\/1000 and \u003c1\/100), rare (≥1\/10,000 and \u003c1\/1000), very rare (\u003c1\/10,000), not known (cannot be estimated from the available data). The following side effects may occur following the use of Fexallegra nasal: \u003cu\u003eImmune system disorders.\u003c\/u\u003e Not known: hypersensitivity (skin edema, mucosal edema). \u003cu\u003ePsychiatric disorders.\u003c\/u\u003e Not known: hallucinations, insomnia, restlessness. \u003cu\u003eNervous system disorders.\u003c\/u\u003e Not known: drowsiness, sedation, headache, dizziness, dysgeusia. \u003cu\u003eCardiac diseases.\u003c\/u\u003e Not known: arrhythmias, tachycardia, palpitations. \u003cu\u003eRespiratory, thoracic and mediastinal disorders.\u003c\/u\u003e Not known: epistaxis, nasal edema, burning nose, nasal dryness, rhinorrhea, sneezing. \u003cu\u003eGastrointestinal disorders.\u003c\/u\u003e Not known: nausea. \u003cu\u003ePathologies of the skin and subcutaneous tissue.\u003c\/u\u003e Not known: rash, itching. \u003cu\u003eSystemic pathologies and conditions relating to the administration site.\u003c\/u\u003e Not known: fatigue. \u003cu\u003eDiagnostic tests.\u003c\/u\u003e Not known: increased blood pressure. \u003cb\u003eReporting of suspected adverse reactions\u003c\/b\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system at www.agenziafarmaco.gov.it\/it\/responsabili.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSymptoms\u003c\/u\u003e An increase in blood pressure and tachycardia can, especially in children, be followed by a drop in blood pressure, subnormal temperatures, shock and reflex bradycardia. Similarly to other alpha-sympathomimetic drugs, the clinical picture of intoxication with nasal Fexallegra can be confusing, since phases of stimulation and depression of the Central Nervous System and the cardiovascular system can alternate. Especially in children, intoxications produce effects on the Central Nervous System such as convulsions and coma, bradycardia, respiratory depression. Symptoms of stimulation of the Central Nervous System are anxiety, agitation, hallucinations and convulsions. Symptoms of Central Nervous System depression are hypothermia, lethargy, drowsiness and coma. Furthermore, the following symptoms may occur: mydriasis, miosis, sweating, fever, pallor, cyanosis of the lips, cardiovascular dysfunction, including cardiac arrest, respiratory dysfunction, including respiratory failure and respiratory arrest, psychological alterations. Similarly to other H1 antagonist drugs, in case of acute intoxication with chlorpheniramine maleate, the greatest danger is represented by excitatory effects at a central level. The syndrome includes hallucinations, excitation, ataxia, athetosis, and convulsions. Dilated and fixed pupils with a flushed face may be found, along with sinus tachycardia, urinary retention, dry mouth, and fever. \u003cu\u003eTherapy\u003c\/u\u003e In case of overdose via the nasal route, immediately wash or carefully clean the nasal mucous membranes. Symptomatic treatment may be necessary.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003ePregnancy\u003c\/i\u003e The medicine is contraindicated during pregnancy (see section 4.3). \u003ci\u003eBreastfeeding\u003c\/i\u003e The medicine is contraindicated during breastfeeding (see section 4.3). \u003ci\u003eFertility\u003c\/i\u003e No studies have been conducted to investigate the effects on human fertility.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNo studies have been performed to investigate the effects of Fexallegra nasal on the ability to drive or use machines. However, patients are advised that side effects such as hallucinations, drowsiness, sedation, dizziness and tiredness may occur during treatment with Fexallegra nasal. Chlorpheniramine maleate may cause drowsiness which may persist the following day. The simultaneous ingestion of alcohol or other CNS depressant drugs produces an additive effect that compromises motor skills. Consumption of alcohol should be avoided during treatment. Therefore, caution is recommended when driving vehicles or using machinery. If patients experience the aforementioned side effects they should avoid activities in which loss of attention can be potentially dangerous, such as driving vehicles or using machinery.\u003c\/p\u003e","brand":"Opella Healthcare","offers":[{"title":"Default Title","offer_id":51730210849095,"sku":"027910013","price":13.86,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/opella-healthcare-italy-srl-fexallegra-nasale-1-mg-ml-3-55-mg-ml-10-ml-spray-nasale-soluzione-farmacia-dottor-tili-1213791038.jpg?v=1767164469"},{"product_id":"argento-proteinato-marco-viti-0-5-10-ml-gocce-nasali-e-auricolari","title":"Marco Viti protein silver 0.5% 10 ml nasal and ear drops","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDecongestant and antiseptic of the nasal mucosa and antiseptic of the ear canal.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProtein silver Marco Viti Bambini 0.5% nasal and ear drops, solution 100 g of solution contain: \u003ci\u003eActive ingredient\u003c\/i\u003e: protein silver 0.5 g. Excipients with known effects: sodium methylparahydroxybenzoate. Protein silver Marco Viti Adults 1% nasal and ear drops, solution 100 g of solution contain: \u003ci\u003eActive ingredient\u003c\/i\u003e: protein silver 1 g. Excipients with known effects: sodium methylparahydroxybenzoate. Protein silver Marco Viti Adults 2% nasal and ear drops, solution 100 g of solution contain: \u003ci\u003eActive ingredient\u003c\/i\u003e: protein silver 2 g. Excipients with known effects: sodium methylparahydroxybenzoate. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePurified water, disodium phosphate dodecahydrate, potassium monobasic phosphate, sodium methyl parahydroxybenzoate.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eAdults and children\u003c\/i\u003e Administer 1-2 drops into each nostril or ear canal 2-3 times a day.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eKeep the bottle tightly closed in the original package to protect the medicine from light.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAvoid concomitant use with papain-based products (see section 4.5). Follow the recommended doses and methods of use. Protein silver, if accidentally ingested or if used for a long period in excessive doses, can cause toxic phenomena (see paragraph 4.9). \u003ci\u003eImportant information about some excipients\u003c\/i\u003e: Marco Viti protein silver contains sodium methylparahydroxybenzoate which may cause allergic reactions (even delayed).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProteinated silver solution may interact with papain-based products. Papain is a proteolytic enzyme, belonging to the hydrolase class, which is extracted from the immature papaya fruit (Carica papaya). The concomitant use of protein silver and papain could inhibit the enzymatic action of papain.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of protein silver, organized according to the MedDRA system organ classification. There is insufficient data to establish the frequency of the individual effects listed. \u003ci\u003ePathologies of the skin and subcutaneous tissue\u003c\/i\u003e: Dermatitis, Rash, Burning, Skin irritations, Skin discoloration, Hypersensitivity reactions, Argyria (see section 4.9).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn case of overdose, high concentrations of silver in the plasma and skin discoloration may occur. Additionally, systemic symptoms such as hepatotoxicity, cardiomyopathy, amnesia, and slurred speech may occur. Prolonged daily ingestion of protein silver can cause irreversible neurotoxicity, with myoclonic status epilepticus, leading to coma and, finally, death. An accumulation of silver in the skin, mucous membranes, membranes and eyes, due to ingestion or absorption of even small quantities, can lead to the appearance of argyria. Argyria is characterized by a gray to dark blue coloration of the skin, due to the binding of silver with various proteins and the consequent production of pigments.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003ePregnancy\u003c\/i\u003e There are no adequate data regarding the use of protein silver in pregnant women. Protein silver should not be used during pregnancy unless absolutely necessary. \u003ci\u003eBreastfeeding\u003c\/i\u003e There are no adequate data regarding the use of protein silver during breastfeeding. Protein silver should not be used during breastfeeding unless absolutely necessary.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProteinated silver does not affect the ability to drive or use machines.\u003c\/p\u003e","brand":"Marco Viti","offers":[{"title":"Default Title","offer_id":51730213208391,"sku":"030322010","price":4.19,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/marco-viti-farmaceutici-spa-argento-proteinato-marco-viti-0-5-10-ml-gocce-nasali-e-auricolari-farmacia-dottor-tili-1213791004.jpg?v=1767155988"},{"product_id":"argento-proteinato-marco-viti-1-10-ml-gocce-nasali-e-auricolari","title":"Marco Viti protein silver 1% 10 ml nasal and ear drops","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eDecongestant and antiseptic of the nasal mucosa and antiseptic of the ear canal.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProtein silver Marco Viti Bambini 0.5% nasal and ear drops, solution 100 g of solution contain: \u003ci\u003eActive ingredient\u003c\/i\u003e: protein silver 0.5 g. Excipients with known effects: sodium methylparahydroxybenzoate. Protein silver Marco Viti Adults 1% nasal and ear drops, solution 100 g of solution contain: \u003ci\u003eActive ingredient\u003c\/i\u003e: protein silver 1 g. Excipients with known effects: sodium methylparahydroxybenzoate. Protein silver Marco Viti Adults 2% nasal and ear drops, solution 100 g of solution contain: \u003ci\u003eActive ingredient\u003c\/i\u003e: protein silver 2 g. Excipients with known effects: sodium methylparahydroxybenzoate. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003ePurified water, disodium phosphate dodecahydrate, potassium monobasic phosphate, sodium methyl parahydroxybenzoate.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eHypersensitivity to the active substance or to any of the excipients.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003eAdults and children\u003c\/i\u003e Administer 1-2 drops into each nostril or ear canal 2-3 times a day.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eKeep the bottle tightly closed in the original package to protect the medicine from light.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eAvoid concomitant use with papain-based products (see section 4.5). Follow the recommended doses and methods of use. Protein silver, if accidentally ingested or if used for a long period in excessive doses, can cause toxic phenomena (see paragraph 4.9). \u003ci\u003eImportant information about some excipients\u003c\/i\u003e: Marco Viti protein silver contains sodium methylparahydroxybenzoate which may cause allergic reactions (even delayed).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProteinated silver solution may interact with papain-based products. Papain is a proteolytic enzyme, belonging to the hydrolase class, which is extracted from the immature papaya fruit (Carica papaya). The concomitant use of protein silver and papain could inhibit the enzymatic action of papain.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eBelow are the side effects of protein silver, organized according to the MedDRA system organ classification. There is insufficient data to establish the frequency of the individual effects listed. \u003ci\u003ePathologies of the skin and subcutaneous tissue\u003c\/i\u003e: Dermatitis, Rash, Burning, Skin irritations, Skin discoloration, Hypersensitivity reactions, Argyria (see section 4.9).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eIn case of overdose, high concentrations of silver in the plasma and skin discoloration may occur. Additionally, systemic symptoms such as hepatotoxicity, cardiomyopathy, amnesia, and slurred speech may occur. Prolonged daily ingestion of protein silver can cause irreversible neurotoxicity, with myoclonic status epilepticus, leading to coma and, finally, death. An accumulation of silver in the skin, mucous membranes, membranes and eyes, due to ingestion or absorption of even small quantities, can lead to the appearance of argyria. Argyria is characterized by a gray to dark blue coloration of the skin, due to the binding of silver with various proteins and the consequent production of pigments.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003ci\u003ePregnancy\u003c\/i\u003e There are no adequate data regarding the use of protein silver in pregnant women. Protein silver should not be used during pregnancy unless absolutely necessary. \u003ci\u003eBreastfeeding\u003c\/i\u003e There are no adequate data regarding the use of protein silver during breastfeeding. Protein silver should not be used during breastfeeding unless absolutely necessary.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eProteinated silver does not affect the ability to drive or use machines.\u003c\/p\u003e","brand":"Marco Viti","offers":[{"title":"Default Title","offer_id":51730213339463,"sku":"030322022","price":4.28,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/marco-viti-farmaceutici-spa-argento-proteinato-marco-viti-1-10-ml-gocce-nasali-e-auricolari-farmacia-dottor-tili-1213791001.jpg?v=1767156046"},{"product_id":"vicks-flu-action-200-30-mg-12-compresse-rivestite","title":"Vicks Flu Action 200 + 30 mg 12 coated tablets","description":"\u003cp\u003e\u003cstrong\u003eINDICATIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eSymptomatic relief of nasal\/sinus congestion with headache, fever and pain associated with colds and flu. Vicks Flu Action is indicated in adults and adolescents aged 15 years and older.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eACTIVE INGREDIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eOne tablet contains 200 mg of ibuprofen and 30 mg of pseudoephedrine hydrochloride equivalent to 24.6 mg of pseudoephedrine. For the full list of excipients, see section 6.1.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEXCIPIENTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eTablet core\u003c\/u\u003e: Microcrystalline cellulose, Pregelatinized corn starch, Povidone K-30, Colloidal anhydrous silica, Stearic acid 95, Croscarmellose sodium, Sodium lauryl sulfate. \u003cu\u003eCoating film\u003c\/u\u003e: Polyvinyl alcohol - Parz. hydrolysate, Talc (E553b), Macrogol 3350, Pearlescent pigment based on MICA (Mixture of potassium aluminum silicate (E555)-[mica], titanium dioxide (E171)), Polysorbate 80 (E433), Hypromellose, Titanium dioxide (E 171), Macrogol 400, Yellow iron oxide (E 172), Red iron oxide (E 172), Black iron oxide (E 172).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e- Hypersensitivity to ibuprofen, pseudoephedrine or to any of the excipients listed in section 6.1. - Patients under the age of 15. - Pregnancy and breastfeeding (see section 4.6). - A history of hypersensitivity reactions (e.g. bronchospasm, asthma, nasal polyposis, rhinitis or urticaria) associated with aspirin, other analgesics, antipyretics or other non-steroidal anti-inflammatory drugs (NSAIDs). - Active peptic ulcer or history of recurrent ulcer\/hemorrhage (two or more distinct episodes of proven ulcer or bleeding). - History of gastrointestinal bleeding or perforation, including cases associated with NSAIDs. - Cerebrovascular hemorrhage or other type of hemorrhage. - Unexplained hematopoietic abnormalities. - Severe renal insufficiency (eGFR \u003c30 mL\/minute\/1.73 m²). - Severe hepatic impairment such as cirrhosis or end-stage liver disease - Severe heart failure (NYHA Class IV). - Severe cardiovascular disorders such as coronary artery disease (e.g. angina pectoris), severe or uncontrolled hypertension, tachycardia and other serious cardiac and\/or vascular disorders. - History of myocardial infarction. - History of stroke or presence of risk factors for stroke (due to the α-sympathomimetic activity of pseudoephedrine hydrochloride). - Hyperthyroidism, diabetes, pheochromocytoma. - Closed-angle glaucoma. - Urinary retention related to urethro-prostatic disorders. - History of seizures. - Disseminated systemic lupus erythematosus and mixed connective tissue disease (increased risk of aseptic meningitis, see section 4.8). - Concomitant use of other vasoconstrictor drugs used as nasal decongestants, administered orally or nasally (e.g. phenylpropanolamine, phenylephrine and ephedrine), and methylphenidate (see section 4.5). - Concomitant use of NSAIDs or aspirin with a daily dose exceeding 75 mg, analgesics and selective COX 2 inhibitors \u003cb\u003e(see paragraph 4.5).\u003c\/b\u003e - Concomitant or previous use of monoamine oxidase inhibitors (MAOIs) in the previous 2 weeks (see section 4.5). This medicine should generally not be used in combination with: - oral anticoagulants, - corticosteroids, - heparins at curative doses or in the elderly, - anti-platelet agents, - lithium, - selective serotonin reuptake inhibitors (SSRIs), - methotrexate (used at doses higher than 20 mg\/week)\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDOSAGE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eDosage\u003c\/u\u003e Adults and adolescents aged 15 years and older: 1 tablet (equivalent to 200 mg of ibuprofen and 30 mg of pseudoephedrine hydrochloride) every 4-6 hours as needed. For more severe symptoms, 2 tablets (equivalent to 400 mg of ibuprofen and 60 mg of pseudoephedrine hydrochloride) every 6-8 hours as needed, up to the maximum total daily dose. The lowest effective dose should be used for the shortest period necessary to relieve symptoms (see section 4.4). The maximum total daily dose of 6 tablets (equivalent to 1200 mg ibuprofen and 180 mg pseudoephedrine hydrochloride) should not be exceeded. Do not exceed 5 days of therapy for the adult population. Do not exceed 3 days of therapy for adolescents (15-18 years). This combination product must be used when both the decongestant action of pseudoephedrine hydrochloride and the analgesic and\/or anti-inflammatory action of ibuprofen are necessary. If one symptom is predominant (nasal congestion or headache and\/or fever), therapy with a single active ingredient is preferable. In older patients, start therapy with the lowest possible dose because the risk of gastrointestinal bleeding, ulcer or perforation is greater with increasing doses of NSAIDs. In these patients, or in patients taking other drugs capable of increasing the risk of gastrointestinal events (see below and in section 4.5), the concomitant use of protective agents (misoprostol or proton pump inhibitors) should be considered. In patients with chronic kidney disease with eGFR \u003e30 mL\/min\/1.73m² \u003c 90 mL\/min\/1.73m² or stage 1 or 2 hepatocellular disease (hepatic inflammation or liver fibrosis) it is necessary to adapt the dosage to the individual patient. Undesirable effects can be reduced by using the lowest effective dose for the minimum duration needed to relieve symptoms (see section 4.4). \u003ci\u003ePediatric population\u003c\/i\u003e Vicks Flu Action is contraindicated in children under 15 years of age (see section 4.3). \u003cu\u003eMethod of administration\u003c\/u\u003e For oral use. The tablets should be swallowed with water, preferably on a full stomach. Do not break or crush the tablets.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eCONSERVATION\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThis medicinal product does not require any special storage conditions.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eWARNINGS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe concomitant use of Vicks Flu Action and other NSAIDs containing COX-2 inhibitors should be avoided (see section 4.3). Patients with chronic kidney disease or stage 1 or 2 hepatocellular disease (hepatic inflammation or hepatic fibrosis) require dose adjustment on an individual basis (see section 4.2). \u003cb\u003e \u003ci\u003eSevere skin reactions\u003c\/i\u003e \u003c\/b\u003e Severe skin reactions, such as acute generalized exanthematous pustulosis (PEAG), may occur with medicines containing ibuprofen and pseudoephedrine. This acute pustular eruption can occur within the first 2 days of treatment, with fever and numerous small pustules, mostly non-follicular, appearing on a very widespread edematous erythema and localized mainly on the skin folds, trunk and upper limbs. Patients should be carefully monitored. If signs and symptoms such as pyrexia, erythema or numerous small pustules are observed, the administration of Vicks Flu Action should be stopped and appropriate measures taken if necessary. Other skin manifestations potentially associated with this medicine and requiring urgent medical attention are: Stevens-Johnson syndrome, erythema multiforme and toxic epidermal necrolysis (Lyell's syndrome), Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS syndrome). These serious conditions present with additional involvement of mucous membranes and skin erosion, or systemic reactions, such as lymphadenopathy, arthritis or general malaise, facial and acral edema, involvement of multiple organs, particularly liver and kidneys, and hematological abnormalities. The first symptoms develop within a few hours\/days up to two to six weeks, in case of DRESS syndrome, after exposure. \u003cb\u003eMasking of symptoms of underlying infections\u003c\/b\u003e Vicks Flu Action can mask the symptoms of infection, which could delay the initiation of appropriate treatment and therefore worsen the outcome of the infection. This has been observed in community-acquired bacterial pneumonia and bacterial complications of chickenpox. When Vicks flu Action is given for the relief of fever or pain related to infection, monitoring of the infection is advised. In non-hospital settings, the patient should seek medical attention if symptoms persist or worsen. \u003cb\u003e \u003ci\u003eSpecial warnings regarding pseudoephedrine hydrochloride\u003c\/i\u003e \u003c\/b\u003e: • The dosage, maximum recommended duration of treatment (see section 4.2) and contraindications must be strictly respected (see section 4.8). • Patients should be informed that treatment should be discontinued if hypertension, tachycardia, palpitations, cardiac arrhythmias, nausea or any neurological signs such as onset or worsening headache appear. Before using this product, patients should consult their doctor in case of: • Well-controlled mild to moderate hypertension and heart disease (see section 4.3) • Psychosis • Concomitant administration of anti-migraine drugs, in particular ergot alkaloid vasoconstrictors (due to the a-sympathomimetic activity of pseudoephedrine). Neurological symptoms such as convulsions, hallucinations, behavioral disturbances, agitation and insomnia have been described following the systemic administration of vasoconstrictors, especially during feverish episodes or in case of overdose. These symptoms have been commonly reported in the pediatric population. The following is therefore advisable: • avoid the administration of Vicks Flu Action both in association with medicines capable of lowering the epileptogenic threshold, such as terpene derivatives, clobutinol, atropine-like substances and local anaesthetics, and where there is a history of convulsions; • strictly respect the recommended dosage in all cases and inform patients about the risk of overdose if Vicks Flu Action is taken in combination with other medicinal products containing vasoconstrictors. Patients with urethro-prostatic disorders are more susceptible to the development of symptoms such as dysuria and urinary retention (see section 4.3). Elderly patients may be more sensitive to effects on the central nervous system (CNS). \u003cu\u003eIschemic colitis\u003c\/u\u003e Some cases of ischemic colitis have been reported with pseudoephedrine. If sudden abdominal pain, rectal bleeding, or other symptoms of ischemic colitis develop, pseudoephedrine should be discontinued and a physician should be consulted. \u003cb\u003e \u003ci\u003ePrecautions for use relating to pseudoephedrine hydrochloride\u003c\/i\u003e \u003c\/b\u003e: • In patients undergoing elective surgery during which volatile halogenated anesthetics will be used, it is preferable to suspend therapy with Vicks Flu Action several days before surgery due to the risk of acute hypertension (see section 4.5). • Athletes should be informed that treatment with pseudoephedrine hydrochloride may cause positive doping test results. \u003cb\u003eIschemic optic neuropathy\u003c\/b\u003e Cases of ischemic optic neuropathy have been reported with pseudoephedrine. Pseudoephedrine should be discontinued if sudden loss of vision or reduction in visual acuity occurs, for example in the case of a scotoma. \u003cu\u003eInterference with serological tests\u003c\/u\u003e Pseudoephedrine may potentially reduce iobenguane I-131 reuptake in neuroendocrine tumors, thereby interfering with scintigraphy. \u003cb\u003e \u003ci\u003eSpecial warnings regarding ibuprofen\u003c\/i\u003e \u003c\/b\u003e: In patients suffering from, or with a history of bronchial asthma or allergies, ibuprofen may trigger bronchospasm. The product must not be administered in case of asthma without prior medical consultation (see section 4.3). Patients suffering from asthma associated with chronic rhinitis, chronic sinusitis and\/or nasal polyposis are at greater risk of allergic reactions when taking acetylsalicylic acid and\/or NSAIDs. The administration of Vicks Flu Action can trigger an acute asthma attack, particularly in some patients allergic to acetylsalicylic acid or an NSAID (see section 4.3). In dehydrated adolescents there is a risk of kidney failure. \u003ci\u003eGastrointestinal effects\u003c\/i\u003e: With all NSAIDs, cases of gastrointestinal bleeding, ulceration or perforation, which may be fatal, have been reported at any time during treatment, with or without warnings or previous history of gastrointestinal events. The risk of gastrointestinal bleeding, ulceration or perforation, which may be fatal, is greater with increasing doses of NSAIDs, in patients with a history of ulcer (particularly if complicated by haemorrhage or perforation - see section 4.3) and in patients over 60 years of age. These older patients should start treatment at the lowest available dose (see section 4.2). For these patients and for those taking concomitant treatment with low-dose acetylsalicylic acid or other drugs that may increase gastrointestinal risk, combination therapy with gastroprotectors (e.g. misoprostol or proton pump inhibitors) should be considered (see below and sections 4.3 and 4.5). Patients with a history of gastrointestinal disorders, particularly if elderly, may experience unusual abdominal symptoms (particularly gastrointestinal bleeding) in the initial stages of treatment. The administration of NSAIDs must be carefully evaluated in patients with coagulation disorders, since a reduction in coagulation capacity is possible. Particular caution is advised in patients receiving concomitant therapy. Some drugs may increase the risk of ulcer or bleeding such as oral corticosteroids, anticoagulants such as warfarin, SSRIs or antiplatelets such as acetylsalicylic acid (see sections 4.3 and 4.5). Treatment with Vicks Flu Action must be stopped immediately if bleeding or gastrointestinal ulceration occurs. NSAIDs should be administered with caution to patients with a history of gastrointestinal disorders (ulcerative colitis, Crohn's disease) as these conditions may worsen (see section 4.8). The concomitant use of alcohol and NSAIDs may increase side effects related to the active ingredient, in particular those relating to the gastrointestinal tract or central nervous system. \u003ci\u003eCardiovascular and cerebrovascular effects\u003c\/i\u003e: Clinical studies suggest that the use of ibuprofen, particularly at high doses (2400 mg\/day), may be associated with a small increased risk of arterial thrombotic events (such as myocardial infarction or stroke). Overall, epidemiological studies do not suggest that low-dose ibuprofen (e.g., ≤1200 mg\/day) is associated with an increased risk of arterial thrombotic events. Patients with uncontrolled hypertension, congestive heart failure (NYHA II-III), demonstrated ischemic heart disease, peripheral arterial disease and\/or cerebrovascular disease should be treated with ibuprofen, after careful examination and at high doses (2400 mg\/day) its administration should be avoided. \u003cb\u003e \u003ci\u003ePrecautions for use relating to ibuprofen\u003c\/i\u003e \u003c\/b\u003e: • Elderly patients: The pharmacokinetics of ibuprofen are not modified by age, therefore dosage adjustments are not necessary in the elderly. However, elderly patients must be kept under close medical supervision as they are more sensitive to side effects from NSAIDs, and in particular to gastrointestinal bleeding and perforation, which can be fatal. • Particular caution and medical supervision are required when administering ibuprofen to patients with a history of gastrointestinal disease. The use of Vicks Flu Action is contraindicated in some gastrointestinal pathologies (see section 4.3). • During the initial phases of treatment, careful monitoring of urinary excretion and renal function is required in patients with heart failure, chronic impairment of renal or hepatic function, in patients on diuretic therapy, in those hypovolemic due to major surgery and, in particular, in elderly patients. The renal function of these patients may be adversely affected by treatment with NSAIDs. • If visual disturbances occur during treatment, the patient will need to undergo a complete ophthalmological examination. If symptoms persist or worsen, the patient should consult his doctor. Vicks Flu Action contains 1.65 mg sodium per tablet.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eINTERACTIONS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eNon-selective monoamine oxidase inhibitors (MAOIs) - Possible reactions: Vicks Flu Action must not be taken by patients on current or past (last two weeks) therapy with monoamine oxidase inhibitors (MAOIs), as there is a risk of hypertensive episodes such as paroxysmal hypertension and hyperthermia, which can be fatal (see section 4.3).\u003c\/p\u003e\n\u003cp\u003eOther sympathomimetics or vasoconstrictors with indirect action, administered orally or nasally, α-sympathomimetic drugs, phenylpropanolamine, phenylephrine, ephedrine, methylphenidate - Possible reactions: Pseudoephedrine may potentiate the effect of other sympathomimetics (vasoconstrictors) and cause a risk of vasoconstriction and\/or hypertensive crisis.\u003c\/p\u003e\n\u003cp\u003eReversible monoamine oxidase A inhibitors (RIMA), Linezolid, ergot alkaloids with dopaminergic action, ergot alkaloid vasoconstrictors - Possible reactions: Risk of vasoconstriction and\/or hypertensive crisis.\u003c\/p\u003e\n\u003cp\u003eHalogenated volatile anesthetics - Possible reactions: Acute perioperative hypertension. In scheduled surgical interventions, suspend treatment with Vicks Flu Action several days before the operation.\u003c\/p\u003e\n\u003cp\u003eGuanethidine, reserpine and methyldopa - Possible reactions: The effect of pseudoephedrine may be reduced.\u003c\/p\u003e\n\u003cp\u003eTricyclic antidepressants - Possible reactions: The effect of pseudoephedrine may be reduced or increased.\u003c\/p\u003e\n\u003cp\u003eDigitalis, quinidine or tricyclic antidepressants - Possible reactions: Increased frequency of arrhythmia.\u003c\/p\u003e\n\u003cp\u003eTerpene derivatives, clobutinol, atropine-like substances and local anesthetics - Possible reactions: Reduction of the epileptogenic threshold.\u003c\/p\u003e\n\u003cp\u003eOther NSAIDs, salicylates, analgesics, antipyretics and COX 2 inhibitors - Possible reactions: The concomitant administration of various NSAIDs, analgesics, antipyretics and selective COX 2 inhibitors may increase the risk of adverse reactions such as ulcers and gastrointestinal bleeding due to a synergistic effect. The concomitant use of Vicks Flu Action with these drugs should therefore be avoided (see sections 4.3 and 4.4).\u003c\/p\u003e\n\u003cp\u003eCardiac glycosides (such as digoxin) - Possible reactions: Concomitant use with digoxin preparations may increase serum levels of cardiac glycosides (digoxin). With correct use (a maximum of 5 days), monitoring of serum digoxin levels is usually not necessary.\u003c\/p\u003e\n\u003cp\u003eCorticosteroids - Possible reactions: Corticosteroids may increase the risk of adverse reactions, particularly of the gastrointestinal tract (ulcer or gastrointestinal bleeding) (see section 4.3).\u003c\/p\u003e\n\u003cp\u003eAntiplatelets - Possible reactions: Increased risk of gastrointestinal bleeding (see section 4.3).\u003c\/p\u003e\n\u003cp\u003eAcetylsalicylic acid (low dose) - Possible reactions: Concomitant administration of acetylsalicylic acid should be avoided (see section 4.3). Coadministration of ibuprofen and acetylsalicylic acid (aspirin) is generally not recommended due to the potential for increased adverse effects. Experimental data indicate that ibuprofen can competitively inhibit the effect of low doses of acetylsalicylic acid on platelet aggregation, when they are administered simultaneously. Although there are uncertainties regarding the extrapolation of these data from the clinical situation, the possibility cannot be excluded that regular and long-term use of ibuprofen may reduce the cardioprotective effect of low doses of acetylsalicylic acid. No clinically relevant effect is considered likely for occasional use of ibuprofen (see section 5.1).\u003c\/p\u003e\n\u003cp\u003eAnticoagulants (e.g. warfarin, ticlopidine, clopidogrel, Tirofiban, eptifibatide, abciximab, iloprost) - Possible reactions: Increased risk of gastrointestinal bleeding, because NSAIDs such as ibuprofen can increase the effect of anticoagulants (see sections 4.3 and 4.4).\u003c\/p\u003e\n\u003cp\u003ePhenytoin - Possible reactions: The concomitant use of Vicks Flu Action and phenytoin preparations could increase the serum levels of these medicinal products. With correct use (a maximum of 5 days), monitoring of phenytoin serum levels is usually not necessary.\u003c\/p\u003e\n\u003cp\u003eSelective serotonin reuptake inhibitors (SSRIs) - Possible reactions: Increased risk of gastrointestinal bleeding (see section 4.3).\u003c\/p\u003e\n\u003cp\u003eLithium - Possible reactions: The concomitant use of Vicks Flu Action and lithium preparations may increase the serum levels of these medicinal products (see section 4.3).\u003c\/p\u003e\n\u003cp\u003eProbenecid and sulfinpyrazone - Possible reactions: Medicinal products containing probenecid or sulfinpyrazone may delay the excretion of ibuprofen.\u003c\/p\u003e\n\u003cp\u003eDiuretics, ACE inhibitors, beta blockers and angiotensin-II antagonists - Possible reactions: NSAIDs can reduce the effect of diuretics and other antihypertensive drugs. In some patients with impaired renal function (e.g. dehydrated patients or elderly patients with impaired renal function) the concomitant administration of an ACE inhibitor, a beta blocker or an angiotensin-II antagonist and drugs that inhibit cyclo-oxygenase may cause further deterioration of renal function, including possible acute renal failure, which is usually reversible. Therefore, the administration of these drugs in combination must be carried out with caution, especially in elderly patients. Patients should be adequately hydrated and consideration should be given to monitoring renal function after initiation of treatment and on a periodic basis thereafter.\u003c\/p\u003e\n\u003cp\u003ePotassium-sparing diuretics - Possible reactions: Concomitant administration of Vicks Flu Action and potassium-sparing diuretics may cause hyperkalemia (monitoring of serum potassium levels is recommended).\u003c\/p\u003e\n\u003cp\u003eMethotrexate - Possible reactions: Administration of Vicks Flu Action within 24 hours before or after administration of methotrexate may cause high concentrations of methotrexate and an increase in its toxic effects (see section 4.3).\u003c\/p\u003e\n\u003cp\u003eCiclosporin - Possible reactions: The risk of a harmful effect on the kidneys due to ciclosporin increases with concomitant administration of some non-steroidal anti-inflammatory drugs. This effect cannot be excluded even for the association between ciclosporin and ibuprofen.\u003c\/p\u003e\n\u003cp\u003eTacrolimus - Possible reactions: The risk of nephrotoxicity increases if the two medicinal products are administered in combination.\u003c\/p\u003e\n\u003cp\u003eZidovudine - Possible reactions: Cases of an increased risk of hemarthrosis and hematoma have been reported in HIV (+) hemophiliac patients receiving concomitant therapy with zidovudine and ibuprofen.\u003c\/p\u003e\n\u003cp\u003eSulfonylureas - Possible reactions: Clinical studies have demonstrated interactions between nonsteroidal anti-inflammatory drugs and antidiabetics (sulfonylureas). Although no interactions have been described between sulphonylureas and ibuprofen, as a precaution during concomitant use it is recommended to monitor blood glucose values.\u003c\/p\u003e\n\u003cp\u003eQuinolone antibiotics - Possible reactions: Animal data indicate that NSAIDs may increase the risk of seizures associated with quinolone antibiotics. Patients treated with NSAIDs and quinolones may have an increased risk of developing seizures.\u003c\/p\u003e\n\u003cp\u003eHeparins; Gingko biloba - Possible reactions: Increased risk of bleeding (see section 4.3).\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eSIDE EFFECTS\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eThe most commonly observed adverse events related to ibuprofen are gastrointestinal in nature. In general, the risk of presenting adverse events (in particular the risk of presenting serious gastrointestinal complications) increases with increasing dose and duration of treatment. Cases of hypersensitivity reactions have been reported following treatment with ibuprofen. These may consist of: (a) Nonspecific allergic reactions and anaphylaxis; (b) Respiratory tract reactivity, including asthma, worsening of asthma, bronchospasm, or dyspnea; (c) Skin disorders of various nature, including rash of various types, pruritus, urticaria, purpura, angioedema and, more rarely, exfoliative dermatitis and bullous dermatitis (including epidermal necrolysis and erythema multiforme). In patients with pre-existing autoimmune disease (such as systemic lupus erythematosus, mixed connective tissue disease), single cases of symptoms of aseptic meningitis, such as neck stiffness, headache, nausea, vomiting, fever or disorientation have been reported during treatment with ibuprofen. Edema, hypertension and heart failure have been reported in association with treatment with NSAIDs. Clinical studies and epidemiological data suggest that the use of ibuprofen (particularly at high doses 2400 mg\/day) and in long-term therapy may be associated with a slight increase in the risk of arterial thrombotic events (e.g. myocardial infarction or stroke), (see section 4.4). The following list of adverse events relates to those occurring with ibuprofen and pseudoephedrine hydrochloride at normal over-the-counter doses, for short-term use. In the treatment of chronic pathologies and long-term treatment, further adverse events may occur. Patients should be informed of the need to immediately stop taking Vicks Flu Action and consult their doctor if a serious adverse drug reaction occurs. The frequency of adverse reactions is defined using the following convention: Very common (≥1\/10); common (≥1\/100 to \u003c1\/10); uncommon (≥1\/1,000 to \u003c1\/100); rare (≥1\/10,000 to \u003c1\/1,000); very rare (\u003c1\/10,000), frequency not known (frequency cannot be estimated from the available data).\u003c\/p\u003e\n\u003cp\u003eInfections and infestations: Ibuprofen Very rare Exacerbation of infectious inflammations (e.g. necrotizing fasciitis), Aseptic meningitis (neck stiffness, headache, nausea, vomiting, fever or disorientation in patients with pre-existing autoimmune diseases (SLE, mixed connective tissue disease).\u003c\/p\u003e\n\u003cp\u003eBlood and lymphatic system disorders: Ibuprofen Very rare Hematopoietic disorders (anaemia, leukopenia, thrombocytopenia, pancytopenia, agranulocytosis, neutropenia).\u003c\/p\u003e\n\u003cp\u003eImmune system disorders: Ibuprofen and pseudoephedrine hydrochloride Very rare Severe generalized hypersensitivity reactions: signs may be facial edema, angioedema, dyspnoea, bronchospasm, tachycardia, sharp drop in blood pressure, anaphylactic shock.\u003c\/p\u003e\n\u003cp\u003ePsychiatric disorders: Ibuprofen Very rare Psychotic reactions, depression.\u003c\/p\u003e\n\u003cp\u003ePsychiatric disorders: Pseudoephedrine hydrochloride Frequency not known Hallucinations, behavioral anomalies.\u003c\/p\u003e\n\u003cp\u003eNervous system disorders: Ibuprofen Uncommon Central nervous system disorders such as headache, dizziness, insomnia, agitation, irritability or tiredness.\u003c\/p\u003e\n\u003cp\u003eNervous system disorders: Pseudoephedrine hydrochloride Rare Insomnia, nervousness, anxiety, agitation, restlessness, tremors.\u003c\/p\u003e\n\u003cp\u003eNervous system disorders: Pseudoephedrine hydrochloride Frequency not known Haemorrhagic stroke, ischemic stroke, convulsions, headache.\u003c\/p\u003e\n\u003cp\u003eEye disorders: Ibuprofen Uncommon Visual disturbances.\u003c\/p\u003e\n\u003cp\u003eEye disorders: Pseudoephedrine hydrochloride Not Known Ischemic optic neuropathy.\u003c\/p\u003e\n\u003cp\u003eEar and labyrinth disorders: Ibuprofen Rare Tinnitus.\u003c\/p\u003e\n\u003cp\u003eCardiac disorders: Ibuprofen Rare Edema, hypertension, palpitations, heart failure, myocardial infarction Clinical studies suggest that the use of ibuprofen, particularly at high doses (2400 mg\/day), may be associated with a small increase in the risk of arterial thrombotic events (such as myocardial infarction or stroke) (see section 4.4).\u003c\/p\u003e\n\u003cp\u003eCardiac disorders: Pseudoephedrine hydrochloride Rare Palpitations, tachycardia, chest pain, arrhythmia.\u003c\/p\u003e\n\u003cp\u003eVascular disorders: Ibuprofen Rare Arterial hypertension.\u003c\/p\u003e\n\u003cp\u003eVascular disorders: Pseudoephedrine hydrochloride Frequency not known Hypertension.\u003c\/p\u003e\n\u003cp\u003eRespiratory, thoracic and mediastinal disorders: Pseudoephedrine hydrochloride Rare Asthma exacerbation or hypersensitivity reactions with bronchospasm.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders: Ibuprofen Uncommon Gastrointestinal discomfort, dyspepsia, nausea, vomiting, diarrhea, anorexia.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders: Ibuprofen Rare Abdominal pain, flatulence, constipation.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders: Ibuprofen Very rare Peptic ulcer, perforation or gastrointestinal haemorrhage (with melena or haematemesis, gastritis, ulcerative stomatitis). Exacerbation of colitis and Crohn's disease (see section 4.4).\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders: Ibuprofen Very rare Esophagitis, pancreatitis, intestinal diaphragm stenosis.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders: Pseudoephedrine hydrochloride Uncommon Dry mouth, thirst, nausea, vomiting.\u003c\/p\u003e\n\u003cp\u003eGastrointestinal disorders: Peudoephedrine hydrochloride Frequency not known Ischemic colitis.\u003c\/p\u003e\n\u003cp\u003eHepatobiliary disorders: Ibuprofen Very rare Liver dysfunction, liver damage, particularly in long-term therapy, liver failure, acute hepatitis.\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders: Ibuprofen Rare Various skin rashes.\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders: Ibuprofen Very rare Severe forms of skin reactions such as exfoliative dermatitis or bullous rash such as Stevens-Johnson syndrome, erythema multiforme and toxic epidermal necrolysis (Lyell's syndrome), alopecia, severe skin infections, soft tissue complications in a chickenpox infection.\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders: Ibuprofen Not known Drug reaction with eosinophilia and systemic symptoms (DRESS syndrome).\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders: Pseudoephedrine hydrochloride Rare Skin rash, urticaria, pruritus, erythema, hyperhidrosis.\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders: Ibuprofen Not known Serious skin reactions, including acute generalized exanthematous pustulosis (PEAG).\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders: Pseudoephedrine hydrochloride Not known Serious skin reactions, including acute generalized exanthematous pustulosis (PEAG).\u003c\/p\u003e\n\u003cp\u003eSkin and subcutaneous tissue disorders: Ibuprofen Not Known Photosensitivity Reaction\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders: Ibuprofen Rare Damage to renal tissue (papillary necrosis) and high blood concentrations of uric acids.\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders: Ibuprofen Very rare Increased serum creatinine, edema (particularly in patients with arterial hypertension or renal failure) edema, nephrotic syndrome, interstitial nephritis, acute renal failure.\u003c\/p\u003e\n\u003cp\u003eRenal and urinary disorders: Pseudoephedrine hydrochloride Frequency not known Urinary retention in men with prostatic hypertrophy.\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eReporting of suspected adverse reactions\u003c\/u\u003e Reporting suspected adverse reactions that occur after authorization of the medicine is important, as it allows continuous monitoring of the benefit\/risk balance of the medicine. Healthcare professionals are asked to report any suspected adverse reactions via the national reporting system https:\/\/www.aifa.gov.it\/content\/segnalazioni-reazioni-avverse.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eOVERDOSE\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003eSymptoms\u003c\/u\u003e The most frequent manifestations of ibuprofen overdose are abdominal pain, nausea, vomiting, lethargy, thirst, muscle weakness, drowsiness, blurred vision and dizziness. Other side effects may occur, including headache, tinnitus, CNS depression, seizures, hypotension, bradycardia, tachycardia, supraventricular and ventricular arrhythmia, and atrial fibrillation. Coma, acute renal failure, hyperkalemia, apnea (especially in young children), respiratory depression and respiratory failure have been reported rarely. In asthmatics, worsening of asthma is possible. \u003cb\u003eIn cases of severe poisoning, metabolic acidosis may occur\u003c\/b\u003e. Signs and symptoms of pseudoephedrine overdose include irritability, insomnia, fever, sweating, anxiety, restlessness, tremors, seizures, palpitations (sinus arrhythmia), high blood pressure, dry mouth, and difficulty urinating. Hallucinations (more likely in children) have been reported. \u003cu\u003eTreatment\u003c\/u\u003e Treatment of overdose is supportive. Within 1 hour of ingesting a potentially toxic amount you may benefit from gastric lavage and activated charcoal and, if necessary, correction of serum electrolytes. Symptomatic and supportive treatment should be undertaken, particularly regarding the cardiovascular and respiratory systems. For example, severe hypertension may need to be treated with an alpha-blocker drug, while the use of a beta blocker may be necessary to control cardiac arrhythmias. Seizures can be controlled with intravenous diazepam, while for extreme excitability and hallucinations chlorpromazine can be used.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003ePREGNANCY AND BREASTFEEDING\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e\u003cu\u003ePregnancy\u003c\/u\u003e: \u003cb\u003eVicks Flu Action is contraindicated during pregnancy\u003c\/b\u003e (see paragraph 4.3). Inhibition of prostaglandin synthesis can negatively affect pregnancy and\/or embryonic\/fetal development. Data from epidemiological studies suggest an increased risk of spontaneous abortion, cardiac malformation and gastroschisis following the use of a prostaglandin synthesis inhibitor during the first months of pregnancy. The absolute risk of cardiovascular malformation increased from less than 1% to approximately 1.5%. The risk is thought to increase with the dose and duration of therapy. In animals it has been demonstrated that the administration of a prostaglandin synthesis inhibitor causes an increase in the rate of pre- and post-implantation spontaneous abortion and embryo-foetal lethality. Furthermore, increased incidences of various malformations, including cardiovascular ones, have been reported in animals to which an inhibitor of prostaglandin synthesis was administered during the organogenetic period. During the third trimester of pregnancy all prostaglandin synthesis inhibitors can expose the fetus to: - cardiopulmonary toxicity (with premature closure of the ductus arteriosus and pulmonary hypertension); - renal dysfunction, which may progress to renal failure with oligohydramnios; They can expose mother and newborn, at the end of pregnancy, to: - possible prolongation of bleeding time, an anti-aggregating effect which can occur even at very low doses; - inhibition of uterine contractions resulting in delay or prolongation of labor. There is the possibility of an association between the appearance of fetal anomalies and the intake of pseudoephedrine during the first trimester of pregnancy. \u003cu\u003eBreastfeeding\u003c\/u\u003e \u003cb\u003eVicks Flu Action is contraindicated during breastfeeding\u003c\/b\u003e (see paragraph 4.3). Ibuprofen\/pseudoephedrine has been identified in breastfed newborns\/infants of treated patients. There is limited data on the effects of ibuprofen\/pseudoephedrine on infants\/children. \u003cu\u003eFertility\u003c\/u\u003e The effects of this drug on fertility have not been studied. The use of ibuprofen may impair fertility and is not recommended in women who are trying to conceive. Women with difficulty conceiving or undergoing fertility tests should consider discontinuing ibuprofen. There are no adequate reproductive toxicology studies on pseudoephedrine.\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eEFFECTS ON DRIVING ABILITY\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003eVicks Flu Action has no known effects on the ability to drive or use machinery. However, given that dizziness or hallucinations may occur due to the presence of pseudoephedrine, this possibility must be taken into account if you intend to drive a vehicle or use machinery.\u003c\/p\u003e","brand":"Procter \u0026 Gamble","offers":[{"title":"Default Title","offer_id":51730213994823,"sku":"042499032","price":9.2,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/procter-gamble-srl-vicks-flu-action-200-30-mg-12-compresse-rivestite-farmacia-dottor-tili-1213791348.jpg?v=1767156347"},{"product_id":"isomar-occhi-0-2-10ml-soluzione-oftalmica","title":"Isomar eyes 0.2% 10ml ophthalmic solution","description":"\u003cp\u003e\u003cstrong\u003eIsomar eyes 0.2% 10ml ophthalmic solution\u003c\/strong\u003e it's one \u003cstrong\u003eophthalmic solution\u003c\/strong\u003e in drops, ideal for the treatment of \u003cstrong\u003ered, dry and irritated eyes\u003c\/strong\u003e. Thanks to its formulation based on \u003cstrong\u003ehyaluronic acid\u003c\/strong\u003e e \u003cstrong\u003eisotonic sea water\u003c\/strong\u003e, offers an action \u003cstrong\u003ehydrating, soothing and refreshing\u003c\/strong\u003e, giving quick relief in case of \u003cstrong\u003eredness, burning, itching and foreign body sensation\u003c\/strong\u003e. It is particularly suitable for those who suffer from \u003cstrong\u003eeye irritation\u003c\/strong\u003e due to environmental factors such as wind, sun, dust, smog, smoke, air-conditioned environments or prolonged use of digital screens.\u003c\/p\u003e\n\n\u003cp\u003eThe presence of \u003cstrong\u003enatural extracts of Jacobaea maritima, Marigold, Cornflower, Helichrysum and Euphrasia\u003c\/strong\u003e helps to increase the soothing effectiveness and reduce allergic symptoms caused by contact with pollen. \u003cstrong\u003eIsomar eyes\u003c\/strong\u003e it is also suitable for those who carry \u003cstrong\u003econtact lenses\u003c\/strong\u003e and can be used daily to maintain ocular well-being. His formula \u003cstrong\u003ewithout preservatives\u003c\/strong\u003e guarantees maximum tolerability and safety, making it a \u003cstrong\u003emedical device\u003c\/strong\u003e ideal for home use and for those looking for a reliable product for the \u003cstrong\u003eeye care and hydration\u003c\/strong\u003e.\u003c\/p\u003e\n\n\u003cp\u003eThe practical bottle \u003cstrong\u003e10ml\u003c\/strong\u003e ensures simple and hygienic use, maintaining the \u003cstrong\u003esterility of the solution\u003c\/strong\u003e throughout the entire period of employment. Choose \u003cstrong\u003eIsomar eyes 0.2% ophthalmic solution\u003c\/strong\u003e for a \u003cstrong\u003eimmediate and lasting relief\u003c\/strong\u003e from dryness, redness and ocular discomfort, with the safety of a quality product, designed for \u003cstrong\u003edaily well-being of your eyes\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Isomar eyes 0.2% 10ml ophthalmic solution used? What is it for?\u003c\/h3\u003e\u003cp\u003eOphthalmic solution based on hyaluronic acid and isotonic sea water, indicated for the treatment of red, dry and irritated eyes; offers a hydrating, soothing and refreshing action in case of redness, burning, itching and foreign body sensation, even for those who wear contact lenses.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Isomar eyes 0.2% 10ml ophthalmic solution contain?\u003c\/h3\u003e\u003cp\u003ePurified Water, *Sea Water (28-30%), Jacobaea Maritima Extract (0.01%), Calendula Officinalis Flower Water (0.1%), Centaurea Cyanus Flower Water (0.1%), Helichrysum Italicum Flower Water (0.1%), Euphrasia Officinalis Flower\/Leaf\/Stem Water (0.1%), Hydroxypropylmethylcellulose (0.2%), Sodium Hyaluronate (0.2%).\u003cbr\u003e*Isotonic\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Isomar eyes 0.2% 10ml ophthalmic solution?\u003c\/h3\u003e\u003cp\u003eFor correct use of the product it is necessary to follow the following instructions:\u003cbr\u003e- open the package and upon first administration remove the protective seal and the cap;\u003cbr\u003e- raise your head and hold the vial upside down over your eye;\u003cbr\u003e- gently lower the lower eyelid with a finger and gradually increase the force of pressing the fingers on the bottle until a drop is obtained;\u003cbr\u003e- instill 1-2 drops into the conjunctival sac every 4-5 hours;\u003cbr\u003e- close your eye for a few seconds;\u003cbr\u003e- immediately after use, close the bottle. The solution can be reused within 6 months of first opening. If necessary, the operation can be repeated in the other eye.\u003cbr\u003eThe cap used for Isomar Occhi is specifically designed to guarantee the sterility of the product during use and optimal dispensing. It is advisable not to forcefully press the closed vial to prevent a few drops from coming out of the cap grid. It is possible that as the solution contained in the bottle gradually runs out, it will be necessary to apply greater force.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Isomar eyes 0.2% 10ml ophthalmic solution?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eThe medical device is not indicated for subjects with known hypersensitivity to the components present in the formulation. Before use, carefully read the information provided by the manufacturer. Do not exceed the recommended dose. Discontinue treatment if any side effects occur. Do not use in conjunction with other topical treatments. Do not ingest. The product is intended for ophthalmic use only. Do not puncture or tamper with the packaging. Do not use the product if the packaging is open or damaged. Do not use after the expiry date. The expiry date refers to the product in intact packaging and stored correctly. The product is intended for adult patients. There are no specific data relating to the use of the product on children and pregnant women. Keep out of the sight and reach of children. It is recommended to wash your hands thoroughly before applying the solution and not to touch the tip of the dispenser with your hands. During administration of the solution, it is recommended not to touch the conjunctival membrane with the end of the vial.\u003cbr\u003eThe solution is free of preservatives, therefore it must be used within 12 hours of first opening. For correct storage it is recommended to close the bottle correctly at the end of each use. Do not dispose of the bottle in the environment after use. In the event of a serious incident occurring in relation to the medical device, immediately report it to the manufacturer and to the Competent Authority of the member state where the incident occurred.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Isomar eyes 0.2% 10ml ophthalmic solution stored?\u003c\/h3\u003e\u003cp\u003eStore inside the case, in a dry place, away from light and heat, at a temperature between 5°C and 25°.\u003cbr\u003eValidity with intact packaging: 36 months.\u003cbr\u003ePost-opening validity: 6 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Isomar eyes 0.2% 10ml ophthalmic solution?\u003c\/h3\u003e\u003cp\u003e10 ml bottle.\u003c\/p\u003e","brand":"Euritalia Pharma","offers":[{"title":"Default Title","offer_id":51776455508295,"sku":"989409115","price":13.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/euritalia-pharma-div-coswell-isomar-occhi-0-2-10ml-soluzione-oftalmica-farmacia-dottor-tili-1213790670.jpg?v=1767163348"},{"product_id":"argotone-gocce-nasali-0-12-mesi","title":"Argotone nasal drops 0–12 months","description":"\u003cp\u003e\n\u003cstrong\u003eArgotone nasal drops 0–12 months\u003c\/strong\u003e it's a \u003cstrong\u003emedical device\u003c\/strong\u003e specifically formulated for newborns and children from 0 to 12 months, ideal for promoting development \u003cstrong\u003efluidization and cleansing of nasal secretions\u003c\/strong\u003e. Thanks to his action \u003cstrong\u003edecongestant and fluidifying\u003c\/strong\u003e, this product helps to clear a stuffy nose, improving the \u003cstrong\u003ebreathing\u003c\/strong\u003e and the \u003cstrong\u003etubal ventilation\u003c\/strong\u003e in the little ones, even in the presence of \u003cstrong\u003ecold\u003c\/strong\u003e or \u003cstrong\u003eflu states\u003c\/strong\u003e. \n\u003c\/p\u003e\n\u003cp\u003e\nIts formula contains \u003cstrong\u003ecarboxymethyl-betaglucan\u003c\/strong\u003e e \u003cstrong\u003ecolloidal silver\u003c\/strong\u003e, ingredients known for their soothing and protective properties, as well as being enriched with a delicate \u003cstrong\u003estrawberry flavour\u003c\/strong\u003e to make the application more pleasant. Argotone 0-12 is devoid of \u003cstrong\u003egluten\u003c\/strong\u003e e \u003cstrong\u003elactose\u003c\/strong\u003e, guaranteeing maximum safety even for the most sensitive children. \n\u003c\/p\u003e\n\u003cp\u003e\nIndicated for \u003cstrong\u003etreatment of symptoms associated with cold-related inflammatory states\u003c\/strong\u003e, even of bacterial origin, of the nasal cavities, Argotone nasal drops 0-12 months is ideal for\u003cstrong\u003edaily pediatric use\u003c\/strong\u003e and can also be used in the presence of small lesions of the skin around the nostrils or of the nasal mucosa. The practical \u003cstrong\u003e20 ml bottle with dropper\u003c\/strong\u003e It allows precise and hygienic dosing, facilitating administration and ensuring quick and long-lasting relief for your child.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Argotone nasal drops used 0-12 months? What is it for?\u003c\/h3\u003e\u003cp\u003eMedical device based on carboxymethyl-betaglucan and colloidal silver, indicated for newborns and children from 0 to 12 months for the fluidification and cleansing of nasal secretions; promotes the relief of stuffy nose in case of colds and flu.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Argotone nasal drops 0-12 months contain?\u003c\/h3\u003e\u003cp\u003eCarboxymethyl-betaglucan, colloidal silver, potassium sorbate, sorbic acid, sodium benzoate, sodium N-hydroxymethylglycinate, strawberry flavor, monobasic sodium phosphate, dibasic sodium phosphate, purified water.\u003c\/p\u003e\u003cp\u003eWithout \u003cstrong\u003egluten\u003c\/strong\u003e, without \u003cstrong\u003elactose\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Argotone nasal drops 0-12 months?\u003c\/h3\u003e\u003cp\u003eTo prepare the bottle, remove the cap from the dropper and without placing it on any surface to avoid contamination, insert it into the bottle.\u003cbr\u003eInstill 2-3 drops 3-4 times a day up to a maximum of 7 days. The product can also be used in the presence of small lesions of the skin around the nostrils or of the nasal mucosa.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Argotone nasal drops 0-12 months?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eIn case of adverse reactions, discontinue use of the product and consult your doctor. Close the container tightly after use. Do not use the product after the expiry date indicated on the package. Do not use the product if the packaging or bottle is not intact. Keep out of reach of children. Avoid contact with eyes. Do not inject. Do not ingest. Do not dispose of the bottle in the environment after use. Avoid promiscuous use of the product.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow to store Argotone nasal drops 0-12 months?\u003c\/h3\u003e\u003cp\u003eStore at a temperature not exceeding 30°C and keep away from heat sources.\u003cbr\u003eValidity with intact packaging: 24 months.\u003cbr\u003ePost-opening validity: 90 days.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Argotone nasal drops 0-12 months?\u003c\/h3\u003e\u003cp\u003e20 ml bottle with dropper.\u003c\/p\u003e","brand":"Dompé","offers":[{"title":"Default Title","offer_id":51821890339143,"sku":"981995956","price":11.5,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/dompe-farmaceutici-spa-argotone-gocce-nasali-0-12-mesi-farmacia-dottor-tili-1213790652.jpg?v=1767163709"},{"product_id":"breathe-right-cerotti-nasali-trasparenti-30-pezzi","title":"Breathe Right transparent nasal plasters 30 pieces","description":"\u003cp\u003e\u003cstrong\u003eBreathe Right transparent nasal plasters 30 pieces\u003c\/strong\u003e I'm a \u003cstrong\u003emedical device\u003c\/strong\u003e innovative, designed to deliver \u003cstrong\u003eImmediate relief from nasal congestion\u003c\/strong\u003e caused by \u003cstrong\u003eallergies, colds or deviated septum\u003c\/strong\u003e. These \u003cstrong\u003etransparent nasal patches\u003c\/strong\u003e they are ideal for those looking for a discreet and effective solution against \u003cstrong\u003estuffy nose\u003c\/strong\u003e and the \u003cstrong\u003esnore\u003c\/strong\u003e, improving the quality of \u003cstrong\u003enight breathing\u003c\/strong\u003e and well-being during the day.\u003c\/p\u003e\n\n\u003cp\u003eThanks to \u003cstrong\u003eelastic strips\u003c\/strong\u003e integrated, i \u003cstrong\u003eBreathe Right adhesive plasters\u003c\/strong\u003e they gently lift the nasal passages, promoting greater \u003cstrong\u003eair flow\u003c\/strong\u003e without the use of medicines. Their formulation \u003cstrong\u003ewithout drugs\u003c\/strong\u003e It also makes them suitable for those who have the \u003cstrong\u003esensitive skin\u003c\/strong\u003e and wants a product \u003cstrong\u003edisposable\u003c\/strong\u003e practical and safe. Each package contains \u003cstrong\u003e30 pieces\u003c\/strong\u003e, perfect for a \u003cstrong\u003edaily use\u003c\/strong\u003e both day and night, for adults and for those who need constant support against nasal congestion.\u003c\/p\u003e\n\n\u003cp\u003eThe version \u003cstrong\u003etransparent\u003c\/strong\u003e of the Breathe Right patches guarantee discretion and comfort, easily adapting to any skin type. Ideal for those who suffer from \u003cstrong\u003eseasonal allergies\u003c\/strong\u003e, \u003cstrong\u003ecold\u003c\/strong\u003e or simply want to improve breathing during sleep, these patches represent an effective and immediate solution to clear a stuffy nose and promote peaceful rest.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy do I use Breathe Right transparent nasal plasters 30 pieces? What is it for?\u003c\/h3\u003e\u003cp\u003eNasal patches medical device, indicated to offer relief from nasal congestion caused by allergies, colds or deviated nasal septum. The integrated elastic strips gently lift the nasal passages promoting airflow and reducing snoring, without the use of medications.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Breathe Right transparent nasal plasters 30 pieces?\u003c\/h3\u003e\u003cp\u003eUse each patch only once. Disposable. They can be used day or night.\u003cbr\u003eBe careful not to place the patch too high or too low.\u003cbr\u003e1. Wash and dry the skin of your nose to remove dirt and grease (use an astringent to clean oily skin).\u003cbr\u003e2. Remove the protective film and place the patch on your nose.\u003cbr\u003e3. Gently press and rub the patch into your skin to secure it.\u003cbr\u003eRemoval\u003cbr\u003eRemove the patch while washing your face with warm water or when you are in the shower. Always remove the patch slowly. Loosen the ends, then gently lift the patch from both sides. Proper removal of the patches, with warm water, reduces the likelihood of skin reactions or lesions.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Breathe Right transparent nasal plasters 30 pieces?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eFor external use only.\u003cbr\u003eDo not use on wounded, burned or irritated skin.\u003cbr\u003eIf you experience a rash or skin irritation, discontinue use.\u003cbr\u003eDo not use for more than 12 hours a day.\u003cbr\u003eThe patches are for single use only.\u003cbr\u003eAfter removal, the adhesive loses its tack and the patch does not stay in place.\u003cbr\u003eKeep out of the sight and reach of children.\u003cbr\u003eNot suitable for children under 5 years of age.\u003cbr\u003eThe paper wrapper in which the patches are packaged may contain natural rubber latex which may cause allergenic reactions.\u003cbr\u003eIf you have any doubts about the use of this product, consult your doctor.\u003cbr\u003eSleep Apnea: These are not intended to treat sleep apnea.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow do you store Breathe Right transparent nasal plasters 30 pieces?\u003c\/h3\u003e\u003cp\u003eDo not store above 30°C. Store in the original packaging.\u003cbr\u003eDo not use after the indicated expiry date.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Breathe Right transparent nasal plasters 30 pieces?\u003c\/h3\u003e\u003cp\u003e30 pieces.\u003c\/p\u003e","brand":"Efas","offers":[{"title":"Default Title","offer_id":51821893353799,"sku":"985832753","price":23.28,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/e-fa-s-spa-breathe-right-cerotti-nasali-trasparenti-30-pezzi-farmacia-dottor-tili-1213790874.jpg?v=1767165191"},{"product_id":"clenny-a-soluzione-fisiologica-25-flaconcini-2-ml","title":"Clenny A physiological solution 25 vials of 2 ml","description":"\u003cp\u003e\n\u003cstrong\u003eClenny A saline solution 25 vials 2 ml\u003c\/strong\u003e it's one \u003cstrong\u003esterile physiological solution\u003c\/strong\u003e in practical single-dose vials, ideal for daily use in both adults and children. Each vial contains \u003cstrong\u003e2 ml of physiological solution\u003c\/strong\u003e based on \u003cstrong\u003esodium chloride 0.9%\u003c\/strong\u003e, free of preservatives, guaranteeing maximum safety and tolerability even for prolonged use. \n\u003c\/p\u003e\n\u003cp\u003e\nThis solution is particularly suitable for\u003cstrong\u003eaerosol therapy\u003c\/strong\u003e, thanks to its optimal composition for \u003cstrong\u003edilution of drugs to be nebulized\u003c\/strong\u003e. The disposable vials allow precise and hygienic dosing, reducing the risk of contamination. Clenny A is also perfect for\u003cstrong\u003ehydration of the nasal mucosa\u003c\/strong\u003e, helping to \u003cstrong\u003efree the nasal passages\u003c\/strong\u003e from mucus, dust and allergens, promoting freer and more natural breathing.\n\u003c\/p\u003e\n\u003cp\u003e\nThe package contains \u003cstrong\u003e25 single-dose vials\u003c\/strong\u003e 2 ml each, practical to always carry with you and simple to use in any situation. Clenny A saline solution is suitable for both\u003cstrong\u003enasal use\u003c\/strong\u003e and for the preparation of solutions to be nebulized, making it an indispensable ally for the daily care of the respiratory tract of the whole family.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Clenny A saline solution 25 vials 2 ml used? What is it for?\u003c\/h3\u003e\u003cp\u003eSterile single-dose physiological solution (sodium chloride 0.9%), preservative-free, indicated for the dilution of drugs to be nebulized in aerosol therapy and for the daily hydration and cleaning of the nasal mucosa in adults and children.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Clenny A saline solution 25 vials 2 ml contain?\u003c\/h3\u003e\u003cp\u003eSodium chloride E.Ph. 18 mg, water for injections 2 ml.\u003cbr\u003eIt does not contain preservatives.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Clenny A saline solution 25 vials 2 ml contain?\u003c\/h3\u003e\u003cp\u003e\nSodium chloride E.Ph. 18 mg, water for injections 2 ml.\u003cbr\u003e\nIt does not contain preservatives.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Clenny A saline solution 25 vials 2 ml?\u003c\/h3\u003e\u003cp\u003eOpen the Clenny A vial by twisting the top.\u003cbr\u003ePress the Clenny A vial on the sides and let out the necessary amount of liquid.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Clenny A saline solution 25 vials 2 ml?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eFollow the instructions given by the aerosol manufacturer and those on the packaging of the medicine to be diluted.\u003cbr\u003eNot injectable.\u003cbr\u003eFor use in aerosol therapy, do not use in patients suffering from serious respiratory or cardiovascular diseases.\u003cbr\u003eIt does not contain preservatives and therefore can also be used for long periods.\u003cbr\u003eDo not dispose of the container in the environment after use.\u003cbr\u003eDo not use after the expiry date shown on the package.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Clenny A saline solution 25 vials 2 ml stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool place, away from heat sources and in intact packaging.\u003cbr\u003eLast shelf life from the date of production, in unopened packaging: 36 months.\u003cbr\u003eOnce opened, the vial must be used immediately.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Clenny A saline solution 25 vials 2 ml?\u003c\/h3\u003e\u003cp\u003ePack of 25 single-dose vials of 2 ml.\u003c\/p\u003e","brand":"Chiesi","offers":[{"title":"Default Title","offer_id":51821895188807,"sku":"927170492","price":8.23,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/chiesi-italia-spa-clenny-a-soluzione-fisiologica-25-flaconcini-2-ml-farmacia-dottor-tili-1213790842.jpg?v=1767155327"},{"product_id":"euphorbium-comp-spray-nasale-20ml","title":"Euphorbium comp nasal spray 20ml","description":"\u003cp\u003e\u003cstrong\u003eEuphorbium compositum nasal spray\u003c\/strong\u003e is a homeopathic medicine used for the symptomatic treatment of colds, allergic rhinitis, sinusitis and nasal congestion. Thanks to its natural composition, it exerts an anti-inflammatory, decongestant and mucolytic action, improving breathing without causing dryness of the mucosa or rebound effect.\u003c\/p\u003e\n\u003cp\u003eThe bottle gives \u003cstrong\u003e20ml\u003c\/strong\u003e with spray dispenser it is practical to use and also ideal for prolonged treatments. Euphorbium is indicated for both adults and children and can also be used during pregnancy, subject to medical advice.\u003c\/p\u003e\n\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Euphorbium comp nasal spray 20ml used? What is it for?\u003c\/h3\u003e\u003cp\u003eThe product is indicated in case of:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eAcute and chronic rhinitis\u003c\/li\u003e\n\u003cli\u003eSinusitis\u003c\/li\u003e\n\u003cli\u003eAllergic rhinitis\u003c\/li\u003e\n\u003cli\u003eNasal obstruction and congestion\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eDOSAGE\u003c\/h2\u003e\n\u003ch3\u003eHow to take Euphorbium comp nasal spray 20ml?\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eAdults and children over 12 years: 1-2 sprays per nostril, 3-5 times a day\u003c\/li\u003e\n\u003cli\u003eChildren over 6 years: 1 spray per nostril, 2-3 times a day\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003eShake the bottle before use. Blow your nose before application and keep the bottle in an upright position during use.\u003c\/p\u003e\n\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Euphorbium comp nasal spray 20ml?\u003c\/h3\u003e\u003cul\u003e\n  \u003cli\u003eAdults and children over 12 years: 1-2 sprays per nostril, 3-5 times a day\u003c\/li\u003e\n  \u003cli\u003eChildren over 6 years: 1 spray per nostril, 2-3 times a day\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003eShake the bottle before use. Blow your nose before application and keep the bottle in an upright position during use.\u003c\/p\u003e\n\u003ch2\u003eCONTRAINDICATIONS AND SIDE EFFECTS\u003c\/h2\u003e\n\u003ch3\u003eWhen should Euphorbium comp nasal spray 20ml not be used and what side effects can it cause?\u003c\/h3\u003e\u003cp\u003eDo not use in case of hypersensitivity to one of the components.\u003c\/p\u003e\u003cbr\u003e\u003cbr\u003e\u003cp\u003eRarely, the following may occur:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eMild nasal burning\u003c\/li\u003e\n\u003cli\u003eSneezing\u003c\/li\u003e\n\u003cli\u003eAllergic reactions in sensitive individuals\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003ePREGNANCY AND BREASTFEEDING\u003c\/h2\u003e\n\u003ch3\u003eCan Euphorbium comp nasal spray 20ml be used during pregnancy and breastfeeding?\u003c\/h3\u003e\u003cp\u003eConsult your doctor if pregnant or breastfeeding.\u003c\/p\u003e\n\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Euphorbium comp nasal spray 20ml?\u003c\/h3\u003e\u003cul\u003e\n\u003cli\u003eKeep out of reach of children\u003c\/li\u003e\n\u003cli\u003eDo not exceed the recommended dosage\u003c\/li\u003e\n\u003cli\u003eDo not use beyond 30 consecutive days without consulting a doctor\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Euphorbium comp nasal spray 20ml stored?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place, away from heat sources. Do not use after the expiry date indicated on the bottle.\u003c\/p\u003e\n\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Euphorbium comp nasal spray 20ml?\u003c\/h3\u003e\u003cp\u003eSpray bottle from \u003cstrong\u003e20ml\u003c\/strong\u003e with nasal nebulizer.\u003c\/p\u003e\n\u003ch2\u003eDRUG LEGAL TEXT\u003c\/h2\u003e\n\u003cp\u003eContent responsibility\u003c\/p\u003e\u003cp\u003eThis sheet contains information that is not intended to replace a doctor's diagnosis or advice, as only the doctor can draw up any prescription and give therapeutic indications. All contents must be understood and are of an exclusively informative nature and aimed exclusively at bringing to the attention of customers or potential customers in the pre-purchase phase of the products sold through this site. In case of pathologies, disorders or allergies it is always best to consult your doctor first.\u003c\/p\u003e\u003cp\u003ePlease note\u003c\/p\u003e\u003cp\u003eThe product names, ingredients and percentages indicated in the descriptions are purely indicative and may be subject to changes or updates by the manufacturing companies. Due to the impossibility of adapting to these updates in real time, the photos and technical information of the products included on Dottortili.com may differ from those shown on the label or otherwise disseminated by the manufacturing companies. The only identification element appears to be the ministerial code MINSAN. The online pharmacy Dottortili.com does not guarantee the truthfulness and timeliness of the information published and declines any responsibility for any errors, omissions or failure to update the same. Dottortili.com assumes no responsibility for damages of any nature that may arise from access to the information published.\u003c\/p\u003e\u003cp\u003eData source: Farmadati Italia\u003c\/p\u003e\u003cp\u003eWebsite: www.farmadati.it\u003c\/p\u003e\u003cp\u003eThe Farmadati Italia database is used by almost all pharmacies, parapharmacies, herbalist shops, health shops, large-scale retail trade, computerized doctors, etc. thanks to the guarantee of historical reliability, seriousness and professionalism of the company on the national territory.\u003c\/p\u003e\u003cp\u003eThe Farmadati Italia S.r.l management system complies with the requirements of the UNI EN ISO 9001:2015 standards for quality management systems and UNI CEI ISO\/IEC 27001:2017 for information security management systems.\u003c\/p\u003e","brand":"Guna","offers":[{"title":"Default Title","offer_id":51821897515335,"sku":"909468365","price":16.44,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/guna-spa-euphorbium-comp-spray-nasale-20ml-farmacia-dottor-tili-1213790789.jpg?v=1767165670"},{"product_id":"filme-nasale-olio-20-ml-secchezza-nasale","title":"Nasal Film Oil 20 ml nasal dryness","description":"\u003cp\u003e\u003cstrong\u003eNasal film Oil 20 ml nasal dryness\u003c\/strong\u003e is a medical device specifically formulated to deliver \u003cstrong\u003ehydration and protection of the nasal mucosa\u003c\/strong\u003e in case of \u003cstrong\u003edryness, burning, itching, redness and nasal irritation\u003c\/strong\u003e. Its composition based on \u003cstrong\u003etocopherol acetate (vitamin E)\u003c\/strong\u003e guarantees an action \u003cstrong\u003esoothing and nourishing\u003c\/strong\u003e, helping to restore the natural balance of the mucosa and strengthen the \u003cstrong\u003enasal protective barrier\u003c\/strong\u003e against external agents and allergens.\u003c\/p\u003e\n\n\u003cp\u003eThanks to his \u003cstrong\u003eformula free of gas, flavourings, colourants, preservatives and essential oils\u003c\/strong\u003e, Nasal Film Oil is particularly suitable even for the most sensitive subjects and for those who suffer from \u003cstrong\u003erhinitis or nasal allergies\u003c\/strong\u003e. The\u003cstrong\u003ejet dispenser\u003c\/strong\u003e allows precise and uniform application, promoting immediate relief from \u003cstrong\u003enasal discomfort\u003c\/strong\u003e and improving the quality of breathing. The product is \u003cstrong\u003enickel and gluten tested\u003c\/strong\u003e, ensuring maximum safety and tolerability.\u003c\/p\u003e\n\n\u003cp\u003eIdeal for presenters \u003cstrong\u003epoor nasal secretion\u003c\/strong\u003e or needs a \u003cstrong\u003eoil for the nasal mucosa\u003c\/strong\u003e which offers a prolonged hydrating and protective action, Nasal Filme Oil 20 ml represents the effective solution for \u003cstrong\u003edaily well-being of the respiratory tract\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Filme Nasal Oil 20 ml used for nasal dryness? What is it for?\u003c\/h3\u003e\u003cp\u003eNasal oil based on tocopherol acetate (vitamin E), medical device indicated in case of dryness, burning, itching, redness and irritation of the nasal mucosa; It has a soothing and nourishing action that helps strengthen the nasal protective barrier, also suitable for those suffering from rhinitis or allergies.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Filme Nasal Oil 20 ml for nasal dryness contain?\u003c\/h3\u003e\u003cp\u003eTocopherol acetate.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Filme Nasal Oil 20 ml for nasal dryness contain?\u003c\/h3\u003e\u003cp\u003eTested for nickel (less than 1 ppm) and gluten (less than 10 ppm). Without gas and without flavourings, colourants, preservatives and essential oils.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Filme Nasal Oil 20 ml for nasal dryness?\u003c\/h3\u003e\u003cp\u003eTocopheryl acetate based oil with jet dispenser.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Filme Nasal Oil 20 ml Nasal Dryness?\u003c\/h3\u003e\u003cp\u003e20ml\u003c\/p\u003e","brand":"Hulka","offers":[{"title":"Default Title","offer_id":51821897777479,"sku":"934975133","price":15.6,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/hulka-srl-filme-nasale-olio-20-ml-secchezza-nasale-farmacia-dottor-tili-1213790781.jpg?v=1767115869"},{"product_id":"fitonasal-spray-concentrato-decongestionante-nasale","title":"Fitonasal concentrated nasal decongestant spray","description":"\u003cp\u003e\n\u003cstrong\u003eFitonasal concentrated nasal decongestant spray\u003c\/strong\u003e it is one \u003cstrong\u003enasal spray\u003c\/strong\u003e innovative, ideal for offering a \u003cstrong\u003eQuick relief from stuffy nose\u003c\/strong\u003e and from \u003cstrong\u003enasal congestion\u003c\/strong\u003e caused by \u003cstrong\u003ecold\u003c\/strong\u003e, \u003cstrong\u003eseasonal and perennial allergies\u003c\/strong\u003e, \u003cstrong\u003erhinosinusitis\u003c\/strong\u003e e \u003cstrong\u003erhinitis\u003c\/strong\u003e of viral, bacterial or mechanical-obstructive origin. Thanks to his \u003cstrong\u003enatural action\u003c\/strong\u003e and the formulation based on \u003cstrong\u003eplant and mineral complexes\u003c\/strong\u003e (Tannisal-FL, with witch hazel and thyme extracts, rock salt, water, vegetable glycerin, natural eucalyptus and mint flavours), Fitonasal concentrated spray protects and promotes \u003cstrong\u003eregeneration of the nasal mucosa\u003c\/strong\u003e without irritating or drying the respiratory tract.\n\u003c\/p\u003e\n\u003cp\u003e\nThis \u003cstrong\u003enasal decongestant\u003c\/strong\u003e it's a \u003cstrong\u003emedical device\u003c\/strong\u003e 100% natural, free of vasoconstrictors, synthetic, semi-synthetic or GMO substances, and can be used \u003cstrong\u003efrequently and for prolonged periods\u003c\/strong\u003e without risk of addiction. Fitonasal concentrated spray is suitable for both \u003cstrong\u003echildren aged 6 and over\u003c\/strong\u003e and for adults, making it perfect for\u003cstrong\u003edaily use\u003c\/strong\u003e throughout the family. His action \u003cstrong\u003efluidifying and protective\u003c\/strong\u003e helps to release \u003cstrong\u003erespiratory tract\u003c\/strong\u003e and to reduce the\u003cstrong\u003enasal irritation\u003c\/strong\u003e, ensuring a \u003cstrong\u003eimmediate well-being\u003c\/strong\u003e and long-lasting.\n\u003c\/p\u003e\n\u003cp\u003e\nChoose Aboca Fitonasal concentrated nasal decongestant spray for a \u003cstrong\u003eeffective, safe and natural treatment\u003c\/strong\u003e against congestion and nasal irritation, with the guarantee of a product \u003cstrong\u003ebiodegradable\u003c\/strong\u003e and respectful of the mucosa. Ideal for those looking for a natural and delicate solution for \u003cstrong\u003ewell-being of the nose\u003c\/strong\u003e every day.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Fitonasal concentrated nasal decongestant spray used? What is it for?\u003c\/h3\u003e\u003cp\u003eNasal spray based on plant and mineral complexes, medical device indicated for the relief of stuffy nose and nasal congestion caused by colds, seasonal and perennial allergies, rhinosinusitis and rhinitis; protects and promotes the regeneration of the nasal mucosa, without vasoconstrictors or risk of addiction.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Fitonasal concentrated nasal decongestant spray contain?\u003c\/h3\u003e\u003cp\u003eFitonasal concentrated spray is a 100% natural and biodegradable product with Tannisal-FL, a plant and mineral complex.\u003cbr\u003eIt does not contain synthetic, semi-synthetic or genetically modified substances and the manufacturing processes with which it is obtained do not use either solvents or chemically synthesized substances.\u003cbr\u003e1 ml of product contains: Tannisal-FL natural complex 3.2 mg, based on tannins and flavonoids (Lpme extractive fractions of witch hazel and thyme - 3 mg) and minerals (chemically untreated mineral extraction rock salt - 0.2 mg); waterfall; vegetable glycerin; natural aromas of eucalyptus and mint.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Fitonasal concentrated nasal decongestant spray contain?\u003c\/h3\u003e\u003cp\u003e\nFitonasal concentrated spray is a 100% natural and biodegradable product with Tannisal-FL, a plant and mineral complex.\u003cbr\u003e\nIt does not contain synthetic, semi-synthetic or genetically modified substances and the manufacturing processes with which it is obtained do not use either solvents or chemically synthesized substances.\u003cbr\u003e\n1 ml of product contains: Tannisal-FL natural complex 3.2 mg, based on tannins and flavonoids (LPME extraction fractions of witch hazel and thyme - 3 mg) and minerals (chemically untreated mineral extraction rock salt - 0.2 mg); waterfall; vegetable glycerin; natural aromas of eucalyptus and mint.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Fitonasal concentrated nasal decongestant spray?\u003c\/h3\u003e\u003cp\u003eDosage for adults and children over 12 years of age: deliver 2 sprays per nostril, blow your nose and repeat the application.\u003cbr\u003eDosage for children aged 6 to 12 years: deliver 1 spray per nostril, blow your nose and repeat the application.\u003cbr\u003eIt is advisable to apply Fitonasal Spray concentrate several times during the day even at close range and to repeat the application before going to bed.\u003cbr\u003eUse exclusively nasally.\u003cbr\u003eAfter each use, clean the dispenser with a clean, damp cloth and dry carefully.\u003cbr\u003eFitonasal concentrated spray can be used frequently and for prolonged periods because it does not contain vasoconstrictor decongestants, is not habit-forming, does not irritate or dry the mucosa.\u003cbr\u003eIf Fitonasal Spray concentrate is used together with nasally applied drugs, it is advisable to space the application of the two products by at least 1 hour.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Fitonasal concentrated nasal decongestant spray?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not use if there is individual hypersensitivity or allergy to one or more components.\u003cbr\u003eUse exclusively nasally.\u003cbr\u003eAvoid contact with eyes, if necessary wash them with water.\u003cbr\u003eHowever, if symptoms persist, consult your doctor or pharmacist.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Fitonasal concentrated nasal decongestant spray stored?\u003c\/h3\u003e\u003cp\u003eStore at room temperature.\u003cbr\u003eValidity with intact packaging: 30 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Fitonasal concentrated nasal decongestant spray?\u003c\/h3\u003e\u003cp\u003e30 ml bottle.\u003c\/p\u003e","brand":"Aboca","offers":[{"title":"Default Title","offer_id":51821897843015,"sku":"977545591","price":13.86,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/aboca-spa-societa-agricola-fitonasal-spray-concentrato-decongestionante-nasale-farmacia-dottor-tili-1213790780.jpg?v=1767165868"},{"product_id":"freetouch-irrigatore-nasale-2-pezzi","title":"FreeTouch nasal irrigator 2 pieces","description":"\u003cp\u003e\n\u003cstrong\u003eFreeTouch nasal irrigator 2 pieces\u003c\/strong\u003e it's a \u003cstrong\u003emedical device\u003c\/strong\u003e designed to ensure a \u003cstrong\u003eeffective and gentle nasal cleaning\u003c\/strong\u003e, ideal for children's daily hygiene. Thanks to his \u003cstrong\u003esoft silicone tip\u003c\/strong\u003e, this irrigator ensures comfortable and safe nasal washing, helping to remove mucus, impurities and allergens from the nasal cavities. Regular use of FreeTouch promotes \u003cstrong\u003eclearing of the airways\u003c\/strong\u003e, helping to prevent and relieve the symptoms of \u003cstrong\u003enasal congestion\u003c\/strong\u003e e \u003cstrong\u003ecold\u003c\/strong\u003e.\n\u003c\/p\u003e\n\u003cp\u003e\nThe package contains \u003cstrong\u003e2 pieces\u003c\/strong\u003e, perfect for prolonged use and to always guarantee maximum hygiene. FreeTouch nasal irrigator is particularly suitable for children, thanks to its \u003cstrong\u003eease of use\u003c\/strong\u003e and the ergonomic structure that allows for simple and quick nasal washing. Can be used with \u003cstrong\u003ephysiological solution\u003c\/strong\u003e or specific saline solutions, making it ideal for \u003cstrong\u003enasal shower\u003c\/strong\u003e daily and for the treatment of stuffy or irritated noses.\n\u003c\/p\u003e\n\u003cp\u003e\nChoosing FreeTouch means relying on a product designed for \u003cstrong\u003ecare and health of the respiratory tract of the little ones\u003c\/strong\u003e, guaranteeing a \u003cstrong\u003edeep nasal cleansing\u003c\/strong\u003e and delicate every day. Perfect for\u003cstrong\u003edaily use\u003c\/strong\u003e and to support children's well-being during periods of colds or allergies.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy use FreeTouch nasal irrigator 2 pieces? What is it for?\u003c\/h3\u003e\u003cp\u003eNasal irrigator with soft silicone tip, medical device indicated for daily nasal cleaning, especially for children; regular use promotes clearing of the airways, helping to prevent and relieve the symptoms of nasal congestion and colds.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use FreeTouch nasal irrigator 2 pieces?\u003c\/h3\u003e\u003cp\u003e1. Open the package and take out the irrigator and silicone tip.\u003cbr\u003e2. Remove the irrigator tip and aspirate the physiological solution or serum.\u003cbr\u003e3. Attach the silicone tip to the irrigator. Position the child sitting, tilting his head forward. Insert the solution into the nasal cavity by pressing the irrigator. The solution will come out of the other nostril. Repeat the step in the other nostril.\u003cbr\u003e4. Gently clean and dry the baby's nose.\u003cbr\u003e5. After each use, clean the irrigator and plunger with water.\u003cbr\u003e6. After cleaning, dry with a tissue or cloth.\u003cbr\u003eAfter use, rinse the irrigator with warm water and dry it to prevent deterioration.\u003cbr\u003eBefore using it again, wash the nasal irrigator with boiling water for at least 2\/3 minutes.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of FreeTouch nasal irrigator 2 pieces?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003e- It is forbidden to use the device with pure water or edible salt instead of specific products.\u003cbr\u003e- Children under the age of 12 must use the device with the help of an adult (parent) or a doctor.\u003cbr\u003e- Do not speak or breathe while using the device to avoid coughing.\u003cbr\u003e- It is strictly forbidden to use the device in case of blocked nostril or otitis media.\u003cbr\u003e- The reusable silicone plunger is a nasal hygiene product therefore it is advisable to avoid exchanging it with others.\u003cbr\u003e- Before using the silicone plunger again, boil water for 3 minutes and disinfect it.\u003cbr\u003e- Check the device before use, in case of enlargements or alterations, use a new plunger.\u003cbr\u003e- The use of this product is prohibited for children under 4 months of age, for people with nasal bleeding or ear inflammation, and for people who are unable to understand or want to.\u003cbr\u003e- In case of serious accidents, contact the manufacturer and the competent authorities.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow do you store FreeTouch nasal irrigator 2 pieces?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place, away from heat and direct sunlight.\u003cbr\u003eValidity with intact packaging: 36 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the size of FreeTouch nasal irrigator 2 pieces?\u003c\/h3\u003e\u003cp\u003ePack containing 2 pieces.\u003c\/p\u003e","brand":"Logiter One","offers":[{"title":"Default Title","offer_id":51821898563911,"sku":"988052217","price":7.35,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/logiter-one-freetouch-irrigatore-nasale-2-pezzi-farmacia-dottor-tili-1258975987.jpg?v=1789559110"},{"product_id":"isomar-occhi-rossi-0-2-10-fiale-monodose","title":"Isomar red eyes 0.2% 10 single-dose vials","description":"\u003cp\u003e\u003cstrong\u003eIsomar red eyes 0.2% 10 single-dose vials\u003c\/strong\u003e is an ophthalmic solution specifically formulated to deliver \u003cstrong\u003equick and long-lasting relief in case of red, irritated, burning, itching or foreign body sensation eyes\u003c\/strong\u003e. Thanks to the presence of \u003cstrong\u003e0.2% hyaluronic acid\u003c\/strong\u003e e \u003cstrong\u003eisotonic sea water\u003c\/strong\u003e, these eye drops favor a \u003cstrong\u003edeep hydration and lubrication of the ocular surface\u003c\/strong\u003e, helping to restore the natural balance of the tear film and reduce eye dryness. The formula is enriched with natural extracts of \u003cstrong\u003eMarigold, Euphrasia, Centaurea, Helichrysum and Jacobaea maritima\u003c\/strong\u003e, known for their properties \u003cstrong\u003esoothing, refreshing and decongestant\u003c\/strong\u003e, ideal for combating allergic symptoms and visual fatigue due to environmental factors such as wind, sun, smog, smoke, dust, air-conditioned environments or prolonged use of digital screens.\u003c\/p\u003e\n\n\u003cp\u003eLe \u003cstrong\u003esingle-dose vials\u003c\/strong\u003e they guarantee maximum hygiene and practicality of use, making the product perfect also for those who use it \u003cstrong\u003econtact lenses\u003c\/strong\u003e of any kind. The absence of preservatives and colorings makes it \u003cstrong\u003eIsomar red eyes\u003c\/strong\u003e suitable even for the most sensitive eyes, ensuring a delicate but effective action. Regular use of Isomar eye drops helps \u003cstrong\u003eprevent and relieve eye discomfort\u003c\/strong\u003e linked to dryness, redness and irritation, favoring a sensation of \u003cstrong\u003ewell-being, freshness and visual comfort\u003c\/strong\u003e throughout the day.\u003c\/p\u003e\n\n\u003cp\u003eThe package contains \u003cstrong\u003e10 single-dose vials\u003c\/strong\u003e, practical to always carry with you for immediate relief in every situation. Choose Isomar red eye 0.2% for one \u003cstrong\u003ecomplete and natural protection of your eye health\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Isomar red eyes 0.2% 10 single-dose vials used? What is it for?\u003c\/h3\u003e\u003cp\u003eOphthalmic solution based on 0.2% hyaluronic acid and isotonic sea water, indicated for the relief of red, irritated, burning, itching or foreign body sensation eyes, even in cases of visual fatigue or exposure to environmental factors.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Isomar red eyes 0.2% 10 single-dose vials contain?\u003c\/h3\u003e\u003cp\u003ePurified Water, *Sea Water (28-30%), Jacobaea Maritima Extract (0.01%), Calendula Officinalis Flower Water (0.1%), Centaurea Cyanus Flower Water (0.1%), Helichrysum Italicum Flower Water (0.1%), Euphrasia Officinalis Flower\/Leaf\/Stem Water (0.1%), Hydroxypropylmethylcellulose (0.2%), Sodium Hyaluronate (0.2%).\u003cbr\u003e*Isotonic\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Isomar red eyes 0.2% 10 single-dose vials?\u003c\/h3\u003e\u003cp\u003e1-2 drops per eye every 4\/5 hours. It is recommended to intersperse treatment cycles with 7-day suspensions. Each cycle must not exceed 30 days of treatment.\u003cbr\u003eFor correct use of single-dose vials it is necessary to follow the following instructions:\u003cbr\u003e- open the protective bag and detach a single-dose vial;\u003cbr\u003e- open the single-dose vial by turning the cap until it is removed;\u003cbr\u003e- raise your head and, gently holding the lower eyelid down with a finger, instill 1-2 drops of solution into the conjunctival sac every 4-5 hours;\u003cbr\u003e- close your eye for a few seconds.\u003cbr\u003eAfter the first opening, the vial can be closed using the appropriate cap and the remaining ocular solution can be used within the following 12 hours. If necessary, the operation can be repeated in the other eye.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Isomar red eyes 0.2% 10 single-dose vials?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eThe medical device is not indicated for subjects with known hypersensitivity to the components present in the formulation. Before use, carefully read the information provided by the manufacturer. Do not exceed the recommended dose. Discontinue treatment if any side effects occur. Do not use in conjunction with other topical treatments. Do not ingest. The product is intended for ophthalmic use only. Do not puncture or tamper with the packaging. Do not use the product if the packaging is open or damaged. Do not use after the expiry date. The expiry date refers to the product in intact packaging and stored correctly. The product is intended for adult patients. There are no specific data relating to the use of the product on children and pregnant women. Keep out of the sight and reach of children. It is recommended to wash your hands thoroughly before applying the solution and not to touch the tip of the dispenser with your hands. During administration of the solution, it is recommended not to touch the conjunctival membrane with the end of the vial.\u003cbr\u003eThe solution is free of preservatives, therefore it must be used within 12 hours of first opening. For correct storage it is recommended to close the bottle correctly at the end of each use. Do not dispose of the bottle in the environment after use. In the event of a serious incident occurring in relation to the medical device, immediately report it to the manufacturer and to the Competent Authority of the member state where the incident occurred.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Isomar red eyes 0.2% 10 single-dose vials stored?\u003c\/h3\u003e\u003cp\u003eStore inside the case, in a dry place, away from light and heat, at a temperature between 5°C and 25°.\u003cbr\u003eValidity with intact packaging: 36 months.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Isomar red eyes 0.2% 10 single-dose vials?\u003c\/h3\u003e\u003cp\u003ePack containing 10 vials.\u003c\/p\u003e","brand":"Euritalia Pharma","offers":[{"title":"Default Title","offer_id":51821902364999,"sku":"989409103","price":10.14,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/euritalia-pharma-div-coswell-isomar-occhi-rossi-0-2-10-fiale-monodose-farmacia-dottor-tili-1213790965.jpg?v=1767166947"},{"product_id":"isonebial-flaconcini-20-5-ml-soluzione-isotonica","title":"Isonebial 20x5 ml vials isotonic solution","description":"\u003cp\u003e\n\u003cstrong\u003eIsonebial vials 20×5 ml isotonic solution\u003c\/strong\u003e it is the ideal choice for \u003cstrong\u003edaily cleaning of the nasal cavities\u003c\/strong\u003e of infants, children and adults. Thanks to his \u003cstrong\u003e0.9% isotonic solution\u003c\/strong\u003e enriched with \u003cstrong\u003eectoine\u003c\/strong\u003e, Isonebial favors a \u003cstrong\u003edelicate and deep cleansing of the nose\u003c\/strong\u003e, helping to \u003cstrong\u003esoften the mucus\u003c\/strong\u003e and to facilitate their elimination. This contributes to \u003cstrong\u003eimprove breathing\u003c\/strong\u003e, especially in the little ones who are not yet able to blow their nose independently.\n\u003c\/p\u003e\n\u003cp\u003e\nI \u003cstrong\u003esingle-dose vials\u003c\/strong\u003e I am \u003cstrong\u003eready for use\u003c\/strong\u003e and guarantee maximum hygiene with every application, making the product perfect for\u003cstrong\u003edaily nasal hygiene\u003c\/strong\u003e and for the \u003cstrong\u003eprevention of stuffy nose and dry nose\u003c\/strong\u003e. The saline solution, free of preservatives, is also suitable for a \u003cstrong\u003eprolonged use\u003c\/strong\u003e and can be used in aerosol therapy, offering valid support in case of allergies, colds or exposure to dust and pollutants.\n\u003c\/p\u003e\n\u003cp\u003e\nIsonebial helps \u003cstrong\u003emoisturize the nasal mucous membranes\u003c\/strong\u003e and others \u003cstrong\u003eremove bacteria, allergens and impurities\u003c\/strong\u003e present in the air, keeping the respiratory tract healthy. The package contains \u003cstrong\u003e20 single-dose vials of 5 ml\u003c\/strong\u003e each, practical to always carry with you and ideal for the whole family. Choose Isonebial for one \u003cstrong\u003edaily cleansing of the nose\u003c\/strong\u003e effective, safe and delicate.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Isonebial vials 20×5 ml isotonic solution used? What is it for?\u003c\/h3\u003e\u003cp\u003eIsotonic solution for the daily nasal hygiene of newborns, children and adults, enriched with ectoine; promotes delicate cleansing of the nose, softens mucus and facilitates its elimination, also being useful in case of colds or allergies.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Isonebial vials 20x5 ml isotonic solution contain?\u003c\/h3\u003e\u003cp\u003eSodium chloride, ectoine, sodium phosphate, polyvinylpyrrolidone, water. Isonebial does not contain preservatives.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Isonebial vials 20×5 ml isotonic solution?\u003c\/h3\u003e\u003cp\u003eTo correctly use Isonebial vials you need:\u003cbr\u003e- detach a single-dose vial and warm it in your hands before administering the solution. Open it by rotating the cap;\u003cbr\u003e- keep your head tilted to one side (never backwards), delicately insert the nozzle of the vial into the upper nostril and press lightly;\u003cbr\u003e- after having rotated your head to the other side, repeat the operation in the other nostril.\u003cbr\u003eIf using the aerosol therapy solution, it is recommended to follow the instructions on the device.\u003cbr\u003eDosage:\u003cbr\u003eInfants: instill a few drops into each nostril, several times a day, generally before feeding or before sleeping.\u003cbr\u003eChildren and Adults: 1-3 washes per nostril, several times a day.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Isonebial vials 20x5 ml isotonic solution?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eThe solution is not for injection.\u003cbr\u003eUse the product exclusively for its intended use.\u003cbr\u003eIn children under one year of age and in case of concomitant pharmacological therapy, use on medical advice.\u003cbr\u003eDo not use for more than 30 consecutive days, or consult your doctor.\u003cbr\u003eIn case of adverse reactions, discontinue use of the product and contact your doctor.\u003cbr\u003eDo not use in case of known incompatibility or allergy to any component of the preparation.\u003cbr\u003eIf using the aerosol solution, it is recommended to follow the instructions of the device.\u003cbr\u003eDo not use in case of damaged container.\u003cbr\u003eDo not use after the expiry date.\u003cbr\u003eKeep out of the reach and sight of children.\u003cbr\u003eKeep the internal instructions with the product.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Isonebial 20×5 ml isotonic solution vials stored?\u003c\/h3\u003e\u003cp\u003eThe product must be stored in a cool, dry place away from light and heat sources, do not store in the refrigerator.\u003cbr\u003eThe expiry date indicated refers to the intact and correctly stored product.\u003cbr\u003eValidity with intact packaging: 36 months.\u003cbr\u003ePost-opening shelf life: close the vial immediately. The contents of the vial must be reused within the next 12 hours after first opening.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Isonebial vials 20×5 ml isotonic solution?\u003c\/h3\u003e\u003cp\u003ePack of 20 single-dose vials of 5 ml.\u003cbr\u003eNet content: 100 ml.\u003c\/p\u003e","brand":"Buona","offers":[{"title":"Default Title","offer_id":51821902397767,"sku":"975518578","price":13.21,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/buona-spa-societa-benefit-isonebial-flaconcini-20x5-ml-soluzione-isotonica-farmacia-dottor-tili-1213790964.jpg?v=1767166929"},{"product_id":"narhinel-20-ricambi-usa-e-getta-soft","title":"Narhinel 20 disposable soft refills","description":"\u003cp\u003e\n\u003cstrong\u003eNarhinel 20 soft disposable refills\u003c\/strong\u003e they are the ideal solution to guarantee \u003cstrong\u003enasal hygiene\u003c\/strong\u003e and comfort for the little ones. These spare parts, made in \u003cstrong\u003esoft plastic\u003c\/strong\u003e, are designed to fit securely and delicately to \u003cstrong\u003ebaby's nose\u003c\/strong\u003e, making the cleaning of the \u003cstrong\u003eblocked nose\u003c\/strong\u003e simple and safe. Every spare part is \u003cstrong\u003eindividually packaged\u003c\/strong\u003e to ensure maximum hygiene and practicality of use, ideal for daily use or outside the home.\n\u003c\/p\u003e\n\u003cp\u003e\nI \u003cstrong\u003eNarhinel disposable spare parts\u003c\/strong\u003e they are equipped with a \u003cstrong\u003eabsorbent filter\u003c\/strong\u003e which effectively holds the \u003cstrong\u003emucus\u003c\/strong\u003e, ensuring deep and hygienic cleaning during vacuuming. Compatible with\u003cstrong\u003eNarhinel nasal aspirator\u003c\/strong\u003e and Narhinel Soft, these spare parts are particularly suitable in case of \u003cstrong\u003ecold\u003c\/strong\u003e or nasal congestion, helping to clear the child's airways in a way \u003cstrong\u003eeasy and safe\u003c\/strong\u003e. The package contains \u003cstrong\u003e20 pieces\u003c\/strong\u003e, ensuring a practical and always available supply for every need.\n\u003c\/p\u003e\n\u003cp\u003e\nChoose \u003cstrong\u003eNarhinel 20 soft disposable refills\u003c\/strong\u003e means relying on a product designed for \u003cstrong\u003esafety\u003c\/strong\u003e and the well-being of the little ones, offering an effective solution for cleaning the nose and preventing complications related to excess mucus.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Narhinel 20 soft disposable refills used? What is it for?\u003c\/h3\u003e\u003cp\u003eDisposable soft plastic spare parts for the Narhinel and Narhinel Soft nasal aspirator, equipped with an absorbent filter that retains mucus; indicated for the daily nasal hygiene of children, particularly in case of colds or nasal congestion.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Narhinel 20 soft disposable refills?\u003c\/h3\u003e\u003cp\u003ePack of 10 and 20 refills.\u003c\/p\u003e","brand":"Haleon","offers":[{"title":"Default Title","offer_id":51821906690375,"sku":"921399022","price":9.88,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/haleon-italy-srl-narhinel-20-ricambi-usa-e-getta-soft-farmacia-dottor-tili-1213790907.jpg?v=1767168070"},{"product_id":"narhinel-aspiratore-nasale-soft-2-ricambi","title":"Narhinel soft nasal aspirator + 2 refills","description":"\u003cp\u003e\n\u003cstrong\u003eNarhinel soft nasal aspirator + 2 spare parts\u003c\/strong\u003e it is the ideal solution for\u003cstrong\u003edaily nasal hygiene of newborns and children\u003c\/strong\u003e. Designed with a \u003cstrong\u003esoft spout\u003c\/strong\u003e and delicate, this \u003cstrong\u003esoft nasal aspirator\u003c\/strong\u003e allows you to easily and safely remove them \u003cstrong\u003enasal secretions\u003c\/strong\u003e and excess mucus, helping to clear the \u003cstrong\u003estuffy nose\u003c\/strong\u003e and to encourage freer breathing, especially during the \u003cstrong\u003echildren's colds\u003c\/strong\u003e. Regular use of Narhinel nasal aspirator is particularly recommended before feeding or sleeping, to ensure maximum comfort for the little one.\n\u003c\/p\u003e\n\u003cp\u003e\nThe device is equipped with \u003cstrong\u003e2 disposable spares\u003c\/strong\u003e with \u003cstrong\u003eabsorbent filter\u003c\/strong\u003e which ensure high hygiene during vacuuming, also protecting the parent. The materials used, such as \u003cstrong\u003epolypropylene, silicone and PVC\u003c\/strong\u003e, I am \u003cstrong\u003efree of phthalates and bisphenol A\u003c\/strong\u003e, guaranteeing maximum safety for the little ones. \u003cstrong\u003eEasy to use\u003c\/strong\u003e and practical, Narhinel soft nasal aspirator is the perfect choice for \u003cstrong\u003emucus removal\u003c\/strong\u003e and the prevention of complications related to \u003cstrong\u003enasal secretions\u003c\/strong\u003e in children. The format includes 1 aspirator and 2 soft replacements, for always effective and delicate nasal hygiene.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy do you use Narhinel soft nasal aspirator + 2 spare parts? What is it for?\u003c\/h3\u003e\u003cp\u003eNasal aspirator with soft nozzle, designed for the daily nasal hygiene of newborns and children; delicately removes excess secretions and mucus, helping to clear a stuffy nose in case of a cold, particularly before feeding or sleeping.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Narhinel soft nasal aspirator + 2 refills contain?\u003c\/h3\u003e\u003cp\u003eAspirator: polypropylene, styrene ethylene butylene styrene, silicone.\u003cbr\u003eSpare parts: PVC and melamine foam.\u003cbr\u003eIt does not contain phthalate and bisphenol A.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Narhinel soft nasal aspirator + 2 spare parts contain?\u003c\/h3\u003e\u003cp\u003e\nAspirator: polypropylene, styrene ethylene butylene styrene, silicone.\u003cbr\u003e\nSpare parts: PVC and melamine foam.\u003cbr\u003e\nIt does not contain phthalate and bisphenol A.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Narhinel soft nasal aspirator + 2 spare parts?\u003c\/h3\u003e\u003cp\u003e1. Wash your hands well before using Narhinel nasal aspirator.\u003cbr\u003e2. Place the soft nozzle of the replacement (A) on the body of the device (B).\u003cbr\u003eDo not assemble with a used nozzle.\u003cbr\u003e3. Place the suction nozzle (C) in the mouth (parent or caregiver) and insert the end of the soft nozzle (A) into one of the child's nostrils. For best results, it is recommended to keep the other nostril closed during aspiration.\u003cbr\u003e4. Suction gently, slowly and regularly through the suction nozzle (C).\u003cbr\u003e5. If the nozzle is full during suction, replace it and do not reuse it.\u003cbr\u003e6. Repeat the operation in the other nostril.\u003cbr\u003e7. Cleaning instructions: Remove the used nozzle (A) and throw it away. Clean the external surface of the suction nozzle (C) using a clean fabric moistened with warm water. Dry the external surface of the suction nozzle with a tissue. Only in case of mucus or secretion inside the central part: detach the central part (B) from the plastic tube. Rinse the central part (B) with warm water and dry before reattaching the hose.\u003cbr\u003eWash your hands well.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Narhinel soft nasal aspirator + 2 refills?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eThis product is suitable for babies and children who are not yet able to blow their nose on their own.\u003cbr\u003eIn any case, for newborns, ask your pediatrician for advice before use. For safety reasons, Narhinel nasal aspirator must be used by a parent or caregiver, who must read and understand the information and instructions for use on the packaging, distinguish the mouth, nose, ears and eyes and understand the basic concepts of hygiene. Two disposable soft nozzles are supplied with Narhinel nasal aspirator.\u003cbr\u003eEach contains an absorbent filter that ensures hygiene by blocking mucus in the filter. The soft disposable replacement nozzles are also available in packs of 10 or 20 pieces.\u003cbr\u003eKeep the product out of the sight and reach of children.\u003cbr\u003eUse only Narhinel spare parts with Narhinel nasal aspirator. Consult your doctor before using Narhinel nasal aspirator if you have a wound or recent nose surgery. Do not use the product if you are allergic to the materials of the device (see composition).\u003cbr\u003eDo not use if the product is broken or damaged, if the nozzle is damaged or already used or if the filter is missing or damaged. The product must be used on a subject in a supine position. The suction nozzle must be held firmly between your lips.\u003cbr\u003eDo not use the product after the expiry date indicated on the package.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Narhinel soft nasal aspirator + 2 spare parts?\u003c\/h3\u003e\u003cp\u003ePack containing 1 nasal aspirator (central body, part B) with 1 flexible tube and 1 suction nozzle (part C) and 2 disposable soft spare parts (part A).\u003c\/p\u003e","brand":"Haleon","offers":[{"title":"Default Title","offer_id":51821906723143,"sku":"922196783","price":8.93,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/haleon-italy-srl-narhinel-aspiratore-nasale-soft-2-ricambi-farmacia-dottor-tili-1213790906.jpg?v=1767168166"},{"product_id":"naricoss-unguento-nasale-15-g-decongestionante","title":"Naricoss nasal ointment 15 g decongestant","description":"\u003cp\u003e\u003cstrong\u003eNaricoss nasal ointment 15 g decongestant\u003c\/strong\u003e it's a \u003cstrong\u003emedical device\u003c\/strong\u003e specifically formulated to deliver an action \u003cstrong\u003elubricating, hydrating and protective on the nasal mucosa\u003c\/strong\u003e. Thanks to its composition rich in \u003cstrong\u003etocopherol acetate, D-panthenol and retinol\u003c\/strong\u003e, this ointment promotes \u003cstrong\u003ere-epithelization\u003c\/strong\u003e and the \u003cstrong\u003enasal scarring\u003c\/strong\u003e, proving particularly suitable \u003cstrong\u003eafter nasal surgery\u003c\/strong\u003e to reduce the formation of crusts, prevent adhesions and promote tissue repair.\u003c\/p\u003e\n\n\u003cp\u003eIts effectiveness makes it ideal even in case of \u003cstrong\u003edryness or atrophy of the nasal mucosa\u003c\/strong\u003e due to factors such as prolonged use of nasal sprays, aerosols, oxygen therapy, exposure to pollutants or cigarette smoke, and in the presence of \u003cstrong\u003eallergic rhinitis\u003c\/strong\u003e or other forms of \u003cstrong\u003enasal irritations\u003c\/strong\u003e. Naricoss nasal ointment is also useful for \u003cstrong\u003ereduce the consequences of epistaxis\u003c\/strong\u003e and to facilitate endoscopic examinations or tamponade maneuvers.\u003c\/p\u003e\n\n\u003cp\u003eThe presence of \u003cstrong\u003eVaseline and Vaseline oil\u003c\/strong\u003e guarantees an action \u003cstrong\u003esoothing and protective\u003c\/strong\u003e, while the \u003cstrong\u003eD-panthenol\u003c\/strong\u003e stimulates tissue regeneration and \u003cstrong\u003ehealing\u003c\/strong\u003e. The \u003cstrong\u003etocopherol acetate\u003c\/strong\u003e and the \u003cstrong\u003eretinol\u003c\/strong\u003e they carry out a powerful antioxidant action, protecting the epithelium and promoting the integrity of the mucous membranes. Naricoss is therefore the \u003cstrong\u003enasal ointment\u003c\/strong\u003e ideal for those looking for an effective product for \u003cstrong\u003epromote the repair of the nasal mucosa\u003c\/strong\u003e, prevent \u003cstrong\u003enasal dryness\u003c\/strong\u003e and protect the \u003cstrong\u003edry nose\u003c\/strong\u003e in every situation, too \u003cstrong\u003epost-operative\u003c\/strong\u003e.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Naricoss nasal ointment 15 g decongestant used? What is it for?\u003c\/h3\u003e\u003cp\u003eMedical device based on tocopherol acetate, D-panthenol and retinol, indicated for the lubrication, hydration and protection of the nasal mucosa in case of dryness or atrophy, for example after nasal surgery, prolonged use of sprays or aerosols, or in the presence of allergic rhinitis; It also helps reduce the consequences of epistaxis.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Naricoss nasal ointment 15 g decongestant contain?\u003c\/h3\u003e\u003cp\u003eVaseline; Vaseline oil; d-panthenol (5%); vitamins and acetate (2%); vitamin a palminate (0.05%); butylated hydroxyanisole.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eMEDIA ANALYSIS\u003c\/h2\u003e\n\u003ch3\u003eWhat does Naricoss nasal ointment 15 g decongestant contain?\u003c\/h3\u003e\u003cp\u003e\nTocopherol acetate: It has a notable antioxidant action, protects the mucous epithelium and promotes re-epithelialization and promotes cellular integrity by stabilizing membrane lipids.\u003cbr\u003e\nD-Panthenol: Stimulates tissue regeneration, promotes healing. It has an important action on the development and trophism of epithelial tissue. It increases the resistance of the epithelia towards infections and has a healing effect in case of injuries.\u003cbr\u003e\nRetinol: It has a notable antioxidant action, promotes the integrity of the epithelium and mucous membranes and promotes cell regeneration.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Naricoss nasal ointment 15 g decongestant?\u003c\/h3\u003e\u003cp\u003eApply an adequate amount of ointment with your finger or directly by inserting the nozzle inside the nostril 1-3 times a day or according to medical prescription then massage delicately from the outside in order to evenly distribute the product.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Naricoss nasal ointment 15 g decongestant?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eDo not use in case of hypersensitivity to the components.\u003cbr\u003eIn case of adverse reactions, discontinue use of the product and contact your doctor.\u003cbr\u003eClose the container tightly after use.\u003cbr\u003eKeep out of reach of children.\u003cbr\u003eDo not ingest.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow is Naricoss nasal ointment 15 g decongestant stored?\u003c\/h3\u003e\u003cp\u003eStore the product at room temperature not exceeding 27°C.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Naricoss nasal ointment 15 g decongestant?\u003c\/h3\u003e\u003cp\u003e15ml tube\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eBibliography\u003c\/strong\u003e\u003cbr\u003e- J. J. Thiele, S.N. Hsieh, S. Ekanayake - Mudiyanselege: “Vitamines: Critical review of its current use cosmetic and clinical dermatology” Dermatol surg 31:7 part2; July 2005\u003cbr\u003e- A. Fidanza “Vitamins” Ed. Agnesotti Rome\u003cbr\u003e- O. Song C. Antilles, G. Kaya J.H. Saurat “Retinoids in cosmeceuticals” Dermatol Therapy, Vol.19 - 2006, 289-296\u003c\/p\u003e","brand":"Medicoss","offers":[{"title":"Default Title","offer_id":51821906755911,"sku":"937492229","price":15.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/medicoss-sas-di-a-cossalter-naricoss-unguento-nasale-15-g-decongestionante-farmacia-dottor-tili-1213790905.jpg?v=1767168148"},{"product_id":"nebial-flaconcini-nasali-3-20-5-ml","title":"Nebial nasal vials 3% 20 × 5 ml","description":"\u003cp\u003e\n\u003cstrong\u003eNebial nasal vials 3% 20 × 5 ml\u003c\/strong\u003e it's one \u003cstrong\u003ehypertonic saline solution\u003c\/strong\u003e at 3% enriched with \u003cstrong\u003ehyaluronic acid\u003c\/strong\u003e, designed to offer action \u003cstrong\u003edecongestant on the nasal mucous membranes\u003c\/strong\u003e and an effective one \u003cstrong\u003efluidizing effect on mucus\u003c\/strong\u003e. Thanks to its formulation, Nebial 3% promotes the \u003cstrong\u003edrainage of secretions\u003c\/strong\u003e and the \u003cstrong\u003edaily cleaning of the nasal passages\u003c\/strong\u003e, proving particularly suitable in case of \u003cstrong\u003ecolds, allergic rhinitis, sinusitis\u003c\/strong\u003e and in all situations \u003cstrong\u003enasal congestion\u003c\/strong\u003e. The addition of hyaluronic acid helps keep the mucous membranes hydrated, making the solution more delicate and pleasant during use.\n\u003c\/p\u003e\n\u003cp\u003e\nI \u003cstrong\u003e5 ml single-dose vials\u003c\/strong\u003e they are practical and hygienic, ideal both for\u003cstrong\u003edaily nasal hygiene\u003c\/strong\u003e of adults and children, both as \u003cstrong\u003enebulization solution\u003c\/strong\u003e in aerosol therapy. Nebial 3% does not contain preservatives and uses selected ingredients such as sodium chloride, sodium hyaluronate, dibasic and monobasic potassium phosphate, and purified water. The package contains \u003cstrong\u003e20 vials\u003c\/strong\u003e single-dose, perfect for practical and safe use on any occasion.\n\u003c\/p\u003e\n\u003cp\u003e\nChoose Nebial nasal vials 3% for a \u003cstrong\u003eeffective respiratory treatment\u003c\/strong\u003e, for the \u003cstrong\u003ecleaning the nose\u003c\/strong\u003e and to promote the well-being of the respiratory tract, especially during periods of greater exposure to \u003cstrong\u003ecolds and allergies\u003c\/strong\u003e. Its targeted action helps to clear stuffy noses, improving breathing and daily comfort.\n\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINDICATIONS\u003c\/h2\u003e\n\u003ch3\u003eWhy is Nebial nasal vials 3% 20 × 5 ml used? What is it for?\u003c\/h3\u003e\u003cp\u003e3% hypertonic saline solution with hyaluronic acid in single-dose vials, indicated for draining secretions and cleaning the nasal passages in case of colds, allergic rhinitis, sinusitis and nasal congestion; can be used for daily nasal hygiene or for nebulization in aerosol therapy.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eINGREDIENTS\u003c\/h2\u003e\n\u003ch3\u003eWhat ingredients does Nebial nasal vials 3% 20 × 5 ml contain?\u003c\/h3\u003e\u003cp\u003eSodium chloride, sodium hyaluronate, dibasic potassium phosphate, dibasic potassium phosphate, water.\u003cbr\u003eIt does not contain preservatives.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eHOW TO USE\u003c\/h2\u003e\n\u003ch3\u003eHow do I use Nebial nasal vials 3% 20 × 5 ml?\u003c\/h3\u003e\u003cp\u003eò Remove a single-dose vial and warm it in your hands before administering the solution. Open it by twisting the cap.\u003cbr\u003eò Keep your head tilted to one side (never backwards), gently insert the nozzle of the vial into the upper nostril and press lightly.\u003cbr\u003eò After rotating your head to the other side, repeat the operation in the other nostril.\u003cbr\u003eIf using the aerosol therapy solution, it is recommended to follow the instructions on the device.\u003cbr\u003eInfants: instill a few drops into each nostril several times a day, generally before feeding or before sleeping.\u003cbr\u003eChildren and Adults: 1-3 washes per nostril, 2-3 times a day.\u003cbr\u003eIt is recommended to use Nebial 3% for a period not exceeding 15 days, or according to medical advice.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eWARNINGS\u003c\/h2\u003e\n\u003ch3\u003eWhat are the warnings of Nebial nasal vials 3% 20 × 5 ml?\u003c\/h3\u003e\u003cp\u003e\u003cstrong\u003eWarnings\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eThe solution is not for injection.\u003cbr\u003eUse the product exclusively for its intended use.\u003cbr\u003eIn children under 6 years of age and in case of concomitant pharmacological therapy, use on medical advice.\u003cbr\u003eIn case of adverse reactions, discontinue use of the product and contact your doctor.\u003cbr\u003eDo not use in case of known incompatibility or allergy to any component of the preparation.\u003cbr\u003eIts use is not recommended in the presence of lesions and abrasions of the nasal mucous membranes or a predisposition to nasal bleeding.\u003cbr\u003eIf using the aerosol solution, it is recommended to follow the instructions on the device.\u003cbr\u003eThe product must be stored away from light and heat sources (not in the refrigerator).\u003cbr\u003eAfter use, close the vial immediately: the contents of the vial must be reused within the next 12 hours after first opening.\u003cbr\u003eDo not use in case of damaged container.\u003cbr\u003eDo not use after the expiry date.\u003cbr\u003eThe expiry date indicated refers to the intact and correctly stored product.\u003cbr\u003eKeep out of the reach and sight of children.\u003cbr\u003eKeep the internal instructions with the product.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eCONSERVATION\u003c\/h2\u003e\n\u003ch3\u003eHow do you store Nebial nasal vials 3% 20 × 5 ml?\u003c\/h3\u003e\u003cp\u003eStore in a cool, dry place, away from light and heat sources. The minimum shelf life refers to the product correctly stored in intact packaging.\u003cbr\u003eValidity with intact packaging: 36 months.\u003cbr\u003ePost-opening validity: 12 hours.\u003c\/p\u003e\n\u003cbr\u003e\u003ch2\u003eFORMAT\u003c\/h2\u003e\n\u003ch3\u003eWhat is the format of Nebial nasal vials 3% 20 × 5 ml?\u003c\/h3\u003e\u003cp\u003ePack of 20 single-dose vials of 5 ml.\u003c\/p\u003e","brand":"Buona","offers":[{"title":"Default Title","offer_id":51821906788679,"sku":"923587164","price":14.9,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/files\/buona-spa-societa-benefit-nebial-flaconcini-nasali-3-20-x-5-ml-farmacia-dottor-tili-1213790904.jpg?v=1767168129"}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0564\/4989\/2467\/collections\/Frame_53_22.svg?v=1784273371","url":"https:\/\/www.dottortili.com\/en-eu\/collections\/nasal-decongestant-drugs.oembed?page=4","provider":"Farmacia Dottor Tili","version":"1.0","type":"link"}